Measuring brain activity during a live performance of Rhapsody in Blue at MD Anderson
Neurosurgery Research
The Neurosurgery department has developed a world-class clinical program to manage all aspects of neurosurgical oncology, including complex brain and skull base tumors, spinal tumors, and intractable, cancer-related pain disorders. We work to discover new imaging and surgical techniques and methods to effectively treat and manage pain. The goal of our research is to improve survival rates and quality of life for our patients.
In addition, we have exceptional basic and applied research programs. Our researchers investigate such topics as immune suppression therapies for malignant gliomas, gene and stem cell therapies for brain and spine tumors, molecular mechanisms, and various aspects of cancer metastasis. We have employed researchers that are recognized for their expertise in the areas implicated in tumor development and progression. The objective is to effectively move therapies from bench to bedside, and our researchers collaborate closely with physicians to integrate laboratory discoveries with clinical observations.
Brain Tumor Research Program
The Brain Tumor Research Program (within the Brain Tumor Center) is a multidisciplinary program that promotes collaborations among its members for laboratory and clinical research, and treatment strategies for brain, skull base and spinal tumors. This program spans 22 departments and involves more than 100 research and clinical scientists who focus on discovering the molecular changes that drive brain and spinal tumors and developing effective new treatments for these devastating tumors. The Brain Tumor Research Program supports interactions among its diverse group by sponsoring scientific retreats, meetings, training opportunities and collaborative projects.
Central Nervous System Tumor Analysis STream “CATALYST”
The MD Anderson Central Nervous System Tumor Analysis STream “CATALYST” is a streamlined, multi-departmental biospecimen collection and analysis pipeline that comprehensively analyzes and integrates data from every available
neurosurgical patient at MD Anderson.
CATALYST is not only unique, but highly innovative as it enhances biospecimen-based research, empowering multiple investigational initiatives toward a comprehensive assessment of primary and recurrent nervous system tumors, with the inclusion of matched blood, cerebrospinal fluid, and stool specimens. This effort is unique to MD Anderson, where we see more rare tumors than any other cancer center in the world.
Main goals of CATALYST:
- Define signatures of brain tumors through genetic and epigenetic profiling.
- Better understand the limited activity of immunotherapy in brain tumors through detailed immune profiling of matched tumor and blood samples.
- Identify nervous system tumor biomarkers and develop non-invasive approaches to diagnose cancer and follow tumor progression by characterizing cerebrospinal fluid and blood samples.
- Characterize and correlate gut and tumor microbiomes to determine if and how the microbiome affects tumor biology, treatment responses and overall patient outcomes.
Genetically Engineered Natural Killer Cell Therapy
A project that advances the use of genetically engineered natural killer (NK) cell therapy in treating glioblastoma. After learning how NK cells, a type of immune cell, are suppressed by the glioblastoma tumor microenvironment, the team is now creating NK cells that are genetically engineered to resist that immune suppression.
ACCELERATE
A project that will directly tackle the more rigorous vetting of agents that are identified in the discovery stage and considered promising for clinical trials. ACCELERATE will leverage multiple preclinical platforms to create a robust strategy for rigorous testing of novel agents so that definitive and confident Go/No-Go decisions can be made more efficiently.
Viro-Immunotherapy
The team has successfully developed Delta-24-RGD, a cold virus engineered to infect and attack glioblastoma cells. Researchers are exploring the possibility of delivering the virus directly to the tumor using stem cells derived from bone marrow called mesenchymal stem cells (MSCs).
Brain Cancer SPORE
Overview
The Brain Cancer SPORE is a translational research program funded by the National Cancer Institute to enable the rapid and efficient movement of basic scientific findings into the clinical setting. Frederick Lang, M.D., PI, and Juan Fueyo, M.D., serve as the co-principal investigators. Research projects include:
- Oncolytic Adenoviruses for Glioma Therapy
- Off-the-shelf Genetically Engineered Natural Killer Therapy for Glioblastoma
- Deciphering Germline and Somatic Genomic Landscape of Gliomas in Black and Hispanic Minority Groups
What is the Brain Cancer SPORE?
The Brain Tumor Center at MD Anderson Cancer Center established a Specialized Program of Research Excellence (SPORE) for the study of brain cancer under the leadership of principal investigator, W. K. Alfred Yung, M.D., and co-principal investigator, Oliver Bögler, Ph.D., in July of 2008. Since that time the SPORE grant has been renewed under the leadership of Frederick Lang, M.D., and Juan Fueyo, M.D., making UT MD Anderson one of only five programs in the nation with a Brain SPORE grant. This grant supports an outstanding multidisciplinary group of investigators whose research is both innovative and translational.
Oncolytic Adenovirus for Glioma Therapy
- Specific Aim 1: Test the combination of Delta-24-RGD with anti-PD-1 antibodies in patients with recurrent malignant gliomas.
- Specific Aim 2: Assess the safety and biological effects of a next-generation Delta-24-RGD expressing OX40L in patients with recurrent glioma.
- Specific Aim 3: Characterize the antiglioma-potency elicited by Delta-24-RGDOX, Delta-24-GREAT, Delta-24-ACT and their combinations.
Off-the-shelf Genetically Engineered Natural Killer Therapy for Glioblastoma
- Specific Aim 1: To initiate a Phase 1/II study of the safety and efficacy of TGF-βR2-/NR3C1-CB-NK cells in relapsed/recurrent GBM.
- Specific Aim 2: Study the fate of TGF-βR2-/NR3C1-CB-NK cells and associated immune changes in the CNS and correlate the findings with disease response.
- Specific Aim 3: Determine if the membrane-anchored IL-12, IL-21 or IL-15 can further increase the persistence and potency of TGF-βR2-/NR3C1-CB-NK cells against GBM without undue toxicity.
Deciphering Germline and Somatic Genomic Landscape of Gliomas in Black and Hispanic Minority Groups
- Specific Aim 1: Characterize the somatic genomic landscape of gliomas in Black and Hispanic patients.
- Specific Aim 2: Determine the extent to which racial and ethnic composition in Blacks and Hispanics correlates with disease-defining molecular alterations.
- Specific Aim 3: Evaluate the extent to which germline and the somatic variation in Blacks and Hispanics impacts clinical outcome.
Music-in-Medicine Research Program
The first initiative of its kind and scope in the United States, the Music-in-Medicine Initiative at MD Anderson was established in 2023 by Mei Rui, D.M.A., Director of Music-in-Medicine and Assistant Professor of Neurosurgery.
Music-in-Medicine Research Highlights
The study plans to enroll a total of 132 patients. The goal of this study is to measure pre-and post-music intervention changes in patients' vital signs, serum- and plasma-level biomarkers by broad-spectrum proteomics analysis, metabolic analysis, and perceived pain, anxiety, and mood states as measured by validated questionnaires (STAI-S, POMS-SF, and VASP). We will collect demographic information on each participant. Participants will also complete the Brief Musical Experience Questionnaire (BMEQ) to investigate potential links between susceptibility to music-induced anxiolysis and prior musical training, preference and exposure.
Protocol 2024-1393: Evaluating Occupational Stress in Surgeons and Musicians: A Multi-modal Pilot Study Using Wearable EEG, Biomarker Analysis and Validated Questionnaires
The goal of this study is to learn about occupational stress among surgeons and musicians by integrating psychological assessments, neurophysiological measures, and biomarkers. Primary Objectives: to assess the change in occupational stress among surgeons and musicians by measuring physiological and psychological stress markers. Secondary Objectives: Assessing and comparing anxiety and burnout, based on the MBI, STAI-T, M-PAS, and SCAT, in surgeons and musicians.
Concerts in The Park: Rhapsody in Blue
Concerts in The Park: The Mozart Effect
Enjoy a performance featuring chamber works by Mozart, Bologne, and Schubert performed by Da Camera violinists Astrid Nakamura and Yu-Ming Ma, violist Weilan Li, cellist Kristiana Ignatjeva, and concert pianist Dr. Mei Rui.
Concerts in The Park: Be My Valentine
Enjoy romantic chamber works by Antonín Dvořák, Camille Saint-Saëns, and Ludwig van Beethoven. Featuring New Zealand cellist Richard Belcher, violinist Eva Burmeister, River Oaks Chamber Orchestra Artistic Director Alecia Lawyer and Dr. Mei Rui.
Research Laboratories
Lang Laboratory
Welcome to the Lang Laboratory. We are a clinical and translational research laboratory in the Brain Tumor Center within the Neurosurgery department at MD Anderson Cancer Center. Our research focuses on developing “biological therapies,” which we define as naturally occurring viruses, cells or molecules, whose intrinsic properties can be exploited for treating brain tumors. Frederick Lang, M.D., is chair of the Neurosurgery department and the principal investigator for MD Anderson’s Brain Cancer SPORE grant. The goal of the laboratory is to translate innovative biological therapeutic approaches to the clinic.
McCarty Laboratory
The McCarty Laboratory uses genetically engineered animal models, primary cell culture systems and human tissue samples to study adhesion and signaling pathways that regulate brain development and cancer. In particular, we study how integrins and their extracellular matrix (ECM) protein ligands mediate bi-directional communication between glial cells or glioma cells and blood vessels in the brain microenvironment.
Akdemir Laboratory
The Akdemir lab focuses on integrative computational analyses to advance efforts for precision cancer medicine. We are analyzing multi-omics datasets from primary human tumors, such as long-read whole genome sequencing, genome-wide chromatin organization (Hi-C) and single-cell ATAC-sequencing from common (i.e. glioblastoma) or rare (i.e. chordoma) CNS tumor types to investigate how tumor evolution shapes the organization of chromatin in cancer cells and tumor microenvironment.
Ene Laboratory
PI: Chibawanye I. Ene, M.D., Ph.D.
The Ene laboratory is focused on developing novel immune therapies for the treatment of glioblastoma by reprogramming dysfunctional myeloid cells in the tumor microenvironment to promote eradication of tumor cells.
Kim Laboratory
Dr. Kim’s laboratory takes a multidisciplinary approach to the research of solid tumors with a specific focus on malignant primary and metastatic brain tumors.
Alvarez-Breckenridge Laboratory
PI: Christopher Alvarez-Breckenridge M.D., Ph.D.
The Alvarez-Breckenridge laboratory is a collaborative, translational research group that focuses on metastatic disease of the brain and spine. We study the unique tumor microenvironmental features of brain and spine metastasis and primary spine tumors by analyzing the cellular composition, associated cellular interactions, and the genetic, epigenetic and transcriptional basis of tumor formation and treatment resistance. We also explore the unique features of immune cell priming and trafficking, T-cell clonal expansion, and myeloid cell regulation within both cranial and extracranial sites of disease with a view to apply our findings to develop new immunotherapeutic, clinically translational approaches to treat these tumors.
North Laboratory
The North Laboratory focuses on developing new treatments for peripheral nerve and spinal cord dysfunction associated with cancer. Specifically, we are interested in neuropathic pain, nerve reconstruction for nerve and spinal cord injury, radiation-related injury and chemotherapy-induced peripheral neuropathy.
Tatsui Laboratory
The Tatsui Laboratory explores new therapies for metastatic tumors of the spine, minimally invasive MRI guided ablation of epidural metastasis and methods of spine stabilization. Currently, there are few options to treat spine metastases that are refractory to radiation, and our translational research aims to develop a clinical application for the use of tumor treating fields in combination with surgery for management of radiation refractory spinal tumors. We are also evaluating the radiological properties and benefits of carbon fiber pedicle screws for spine stabilization in the setting of primary or metastatic tumors of the spine.
Publications by Year
2025 Publications
Grippin AJ, Marconi C, Copling S, Li N, Braun C, Woody C, Young E, Gupta P, Wang M, Wu A, Jeong SD, Soni D, Weidert F, Xie C, Goldenberg E, Kim A, Zhao C, DeVries A, Castillo P, Lohray R, Rooney MK, Schrank BR, Wang Y, Ma Y, Chang E, Kouzy R, Dyson K, Jafarnia J, Nariman N, Gladish G, New J, Argueta A, Amaya D, Thomas N, Doty A, Chen J, Copling N, Alatrash G, Simon J, Davies AB, Dennis W, Liang R, Lewis J, Wei X, Rinsurongkawong W, Vaporciyan AA, Johns A; D3CODE Team; Lee J, Lee JH, Sun R, Sharma P, Tran H, Zhang J, Gibbons DL, Wargo J, Kim BYS, Heymach JV, Mendez-Gomez HR, Jiang W, Sayour EJ, Lin SH. SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade. Nature. 2025 Nov;647(8089):488-497. doi: 10.1038/s41586-025-09655-y. Epub 2025 Oct 22. PMID: 41125896; PMCID: PMC12611756.
Peng F, Sinjab A, Dai Y, Treekitkarnmongkol W, Yang S, Gomez Bolanos LI, Zhou T, Chen M, Serrano AG, Krishna A, Karimi N, Sharma M, Basi A, Pei G, Liao J, Liu Y, Feng J, Rahal Z, Liu Y, Jiang J, Yu K, Noun T, Liu Y, Khan K, Cho KS, Chen J, Solis LM, Mazzilli S, Dubinett S, Cascone T, Spira AE, Swisher S, Jimbo N, Hayashi T, Kishikawa S, Takamochi K, Itoh T, Yao T, Suzuki K, Kalhor N, Wistuba II, Li M, Moghaddam SJ, Fujimoto J, Burks J, Myers J, Akdemir K, Wang L, Kadara H. Multimodal spatial-omics reveal co-evolution of alveolar progenitors and proinflammatory niches in progression of lung precursor lesions. Cancer Cell. 2026 Feb 9;44(2):321-339.e13. doi: 10.1016/j.ccell.2025.10.004. Epub 2025 Nov 6. PMID: 41202811; PMCID: PMC12980502.
Grippin AJ, Lee D, Parkes EE, Jiang W, Kim BYS. Nanotechnology for immuno-oncology. Nat Cancer. 2025 Aug;6(8):1311-1325. doi: 10.1038/s43018-025-01025-x. Epub 2025 Aug 7. PMID: 40775548; PMCID: PMC12412309. Schrank BR, Wang Y, Wu A, Tran N, Lee D, Edwards J, Huntoon K, Dong S, Ha J, Ma Y, Grippin AJ, Jeong SD, Antony A, Chang M, Kang M, Gallup TD, Koong AC, Li J, Yun K, Kim BYS, Jiang W. An antibody-toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy. Nat Cancer. 2025 Mar;6(3):511-527. doi: 10.1038/s43018-025-00919-0. Epub 2025 Feb 25. PMID: 40000910; PMCID: PMC11952976.
Fields EC, Bosch WR, Albuquerque KV, Bhatia R, Chino J, Dyer B, Erickson B, Fabian D, Gaffney D, Glaser S, Han K, Hathout L, Hsu IC, Jegadeesh N, Kahn J, Kidd E, Klopp A, Leung E, Lin L, Ludwig M, Ma T, Mell L, Mayadev J, Petersen I, Portelance L, Rash D, Taunk N, Viswanathan A, Wolfson A, Yashar C, Yeung A, Yoshida E, Fisher CM. Consensus Guidelines for Delineation of Clinical Target Volumes for Intensity Modulated Radiation Therapy for Intact Cervical Cancer: An Update. Pract Radiat Oncol. 2025 Mar-Apr;15(2):171-179. doi: 10.1016/j.prro.2024.11.004. Epub 2024 Nov 13. PMID: 39547646; PMCID: PMC11954667.
You Y, Tian Y, Guo R, Shi J, Kwak KJ, Tong Y, Estania AP, Hsu WH, Liu Y, Hu S, Cao J, Yang L, Bai R, Huang P, Lee LJ, Jiang W, Kim BYS, Ma S, Liu X, Shen Z, Lan F, Phuong Nguyen PK, Lee AS. Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity. Eur Heart J. 2025 May 2;46(17):1662-1676. doi: 10.1093/eurheartj/ehae883. PMID: 39831819.
Yu KKH, Basu S, Baquer G, Ahn R, Gantchev J, Jindal S, Regan MS, Abou-Mrad Z, Prabhu MC, Williams MJ, D'Souza AD, Malinowski SW, Hopland K, Elhanati Y, Stopka SA, Stortchevoi A, Couturier C, He Z, Sun J, Chen Y, Espejo AB, Chow KH, Yerrum S, Kao PL, Kerrigan BP, Norberg L, Nielsen D; GBM TeamLab; Puduvalli VK, Huse J, Beroukhim R, Kim BYS, Goswami S, Boire A, Frisken S, Cima MJ, Holdhoff M, Lucas CG, Bettegowda C, Levine SS, Bale TA, Brennan C, Reardon DA, Lang FF, Chiocca EA, Ligon KL, White FM, Sharma P, Tabar V, Agar NYR. Investigative needle core biopsies support multimodal deep-data generation in glioblastoma. Nat Commun. 2025 Apr 28;16(1):3957. doi: 10.1038/s41467-025-58452-8. PMID: 40295505; PMCID: PMC12037860.
Morad G, Damania AV, Melendez B, Singh BB, Veguilla FJ, Soto RA, Hoballah YM, Sahasrabhojane PV, Wong MC, Ahmed MM, Rico RN, Lewis KN, Wani K, Shamsutdinova DD, Lazcano Segura RN, Ingram DR, Goethe EA, Day A, Flores II, McDaniel LK, Chelvanambi M, Johnson SB, Dimitriou F, Gupta P, Oberai S, Zal MA, Doss P, Jamal MA, Hayase E, Wathoo C, Norberg LM, Jenkins SL, Nass S, Gumin J, Long L, Yang J, Bradley GR, Bekal MP, Dono AG, Pichardo-Rojas PS, Andrewes SW, Ballester LY, Losh JS, Liang J, Huo L, Nielsen DC, Parker Kerrigan BC, Brastianos PK, Fowlkes NW, Chang CC, Jenq RR, Gomez-Manzano C, Huse JT, Davies MA, Lazar AJ, Bhat KP, Tandon N, Esquenazi Y, Peterson CB, Puduvalli VK, Lang FF, Johnston CD, Bullman S, Ajami NJ, Ferguson SD, Wargo JA. Microbial signals in primary and metastatic brain tumors. Nat Med. 2025 Nov;31(11):3675-3688. doi: 10.1038/s41591-025-03957-4. Epub 2025 Nov 14. PMID: 41238915; PMCID: PMC12618227.
Hou M, Ma Y, Deng Y, Wu Y, Zhu Y, Liu Y, Li X, Yu L, He Z, Wang Y, Dong S, Xia X, Yu J, Yu C, Kang K, Lu Y, Sun L, Kim BYS, Yuan Y, Zhang Y, Jiang W, Zhu X. Therapeutic restoration of mitochondria-endoplasmic reticulum cross talk for osteoarthritis. Proc Natl Acad Sci U S A. 2025 Sep 9;122(36):e2426992122. doi: 10.1073/pnas.2426992122. Epub 2025 Sep 2. Erratum in: Proc Natl Acad Sci U S A. 2026 Feb 3;123(5):e2600337123. doi: 10.1073/pnas.2600337123. PMID: 40892916; PMCID: PMC12435279.
Zhang H, Xing J, Sun M, Cui Y, Li Y, Hu S, Wang X, Jiang H, Zhang Y, Jiang X, Yang F, Kim BYS, Jiang W, Yang Z, Teng L. Engineered exosomes for targeted microRNA delivery to reverse liver fibrosis. Biomaterials. 2026 Jan;324:123510. doi: 10.1016/j.biomaterials.2025.123510. Epub 2025 Jun 17. PMID: 40561654.
Lawson NM, Ye L, Cho CY, Zhao B, Mitchell T, Martín-Barrio I, Beernaert B, Gupta A, Banu M, Lissanu Y, Shaffer S, Tawbi H, Li J, Gule-Monroe MK, Alvarez-Breckenridge CA, Huse JT, Murphy MB, Yin F, Lang FF, Parkes EE, Weinberg JS, Akdemir KC. Recurrent ERBB2 alterations are associated with esophageal adenocarcinoma brain metastases. medRxiv [Preprint]. 2025 Feb 26:2025.02.19.25322558. doi: 10.1101/2025.02.19.25322558. PMID: 40061311; PMCID: PMC11888521.
Sun M, Zhang H, Ma Y, Wang S, Chen J, Cui Y, Zhang Y, Hu S, Zhou D, Zhang P, Liu Y, Kim BYS, Jiang W, Wang X, Yang Z. In Situ Programming of the Tumor Microenvironment to Alleviate Immunosuppression for Pancreatic Cancer Immunotherapy. Adv Sci (Weinh). 2025 Sep;12(34):e04008. doi: 10.1002/advs.202504008. Epub 2025 Jun 23. PMID: 40548883; PMCID: PMC12442614.
Poon CC, Herbrich SM, Chen Y, Hossain A, Fuller GN, Jindal S, Basu S, Ledbetter D, Macaluso M, Phillips LM, Gumin J, He Z, Parker Kerrigan BC, Singh SK, Singh P, Zaman MF, Ng Tang D, Goswami S, Lang FF, Sharma P. Mesenchymal Stem Cells and Fibroblasts Contribute to Microvascular Proliferation in Glioblastoma and are Correlated with Immunosuppression and Poor Outcome. Cancer Immunol Res. 2025 Jun 4;13(6):804-820. doi: 10.1158/2326-6066.CIR-24-0743. PMID: 40131028; PMCID: PMC12175251.
Ling AL, Gantchev J, Prabhu MC, Basu S, Ahn R, D'Souza A, Masud N, Ball A, Nikas O, Villa GR, Regan MS, Baquer G, Ayoub G, Whittaker CA, Abou-Mrad Z, Santos A, Couturier CP, Elharouni D, Vogelzang J, Yu KKH, Chen H, He Z, Jiang W, Lucas CH, Sax HE, Lang FF, Puduvalli VK, Tabar V, W Brennan C, Boire A, Holdhoff M, Bettegowda C, Cima M, Solomon IH, Yuan Y, Tak PP; Accelerating GBM Therapies TeamLab; Sharma P, White FM, Ligon KL, Agar NYR, Reardon DA, Oliveira G, Chiocca EA. Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses. Sci Transl Med. 2025 Oct 8;17(819):eadv2881. doi: 10.1126/scitranslmed.adv2881. Epub 2025 Oct 8. PMID: 41061048.
Wang Y, Meraz IM, Qudratullah M, Kotagiri S, Han Y, Xi Y, Wang J, Akdemir KC, Roth JA, Lissanu Y. Mutation of SMARCA4 Induces Cancer Cell-Intrinsic Defects in the Enhancer Landscape and Resistance to Immunotherapy. Cancer Res. 2025 Jun 2;85(11):1997-2013. doi: 10.1158/0008-5472.CAN-24-2054. PMID: 40080526; PMCID: PMC12127800.
Tang K, Tang Z, Niu M, Kuang Z, Xue W, Wang X, Liu X, Yu Y, Jeong S, Ma Y, Wu A, Kim BYS, Jiang W, Yang Z, Li C. Allosteric targeted drug delivery for enhanced blood-brain barrier penetration via mimicking transmembrane domain interactions. Nat Commun. 2025 Apr 10;16(1):3410. doi: 10.1038/s41467-025-58746-x. PMID: 40210849; PMCID: PMC11986143.
Sahgal A, Rhines L. Editorial: Precision Medicine in Spinal Oncology. Global Spine J. 2025 Jan;15(1_suppl):5S. doi: 10.1177/21925682241250342. PMID: 39801120; PMCID: PMC11726508.
Bayraktar R, Tang Y, Dragomir MP, Ivan C, Peng X, Fabris L, Zhang J, Carugo A, Aneli S, Liu J, Chen MM, Srinivasan S, Sahnoune I, Bayraktar E, Akdemir KC, Chen M, Narayanan P, Huang W, Ott LF, Eterovic AK, Villarreal OE, Mohammad MM, Peoples MD, Walsh DM, Hernandez JA, Morgan MB, Shaw KR, Davis JS, Menter D, Tam CS, Yeh P, Dawson SJ, Rassenti LZ, Kipps TJ, Kunej T, Estrov Z, Joosse SA, Pagani L, Alix-Panabières C, Pantel K, Ferajoli A, Futreal A, Wistuba II, Radovich M, Kopetz S, Keating MJ, Draetta GF, Mattick JS, Liang H, Calin GA. The mutational landscape and functional effects of noncoding ultraconserved elements in human cancers. Sci Adv. 2025 Feb 21;11(8):eado2830. doi: 10.1126/sciadv.ado2830. Epub 2025 Feb 19. PMID: 39970212; PMCID: PMC11837999.
Alvarez-Breckenridge CA, North R, Tatsui C, Kumar N, Lo SF, Mohammed K, Reynolds J, Lazary A, Laufer I, Verlaan JJ, Gokaslan Z, Luzzati A, Cecchinato R, Shin J, Hornicek F, Disch A, Goodwin M, Goodwin R, Sahgal A, Gasbarrini A, Boriani S. Role of Posterior Carbon Fiber Implants in Spine Tumor Surgery. Global Spine J. 2025 Jan;15(1_suppl):157S-165S. doi: 10.1177/21925682241259778. PMID: 39801115; PMCID: PMC11726513.
Yeboa DN, Li J, Lin R, Prabhu SS, Beckham TH, Woodhouse K, Swanson TA, Weinberg JS, Wang X, Chi X, Ejezie CL, Suki D, Wang C, Ene C, McCutcheon IE, McGovern S, McAleer MF, Tom M, Ghia A, Perni S, Jiang W, De B, Chung C, Kim BYS, O'Brien BJ, Huse JT, Wefel JS, Court L, Tawbi H, Janku F, Guha-Thakurta N, Debnam JM, Johnson J, Taslicay CA, Alvarez-Breckenridge C, Raza SM, Heimberger AB, DeMonte F, North R, Briere TM, de Groot JF, Sawaya R, Grosshans D, Lang FF, Rao G, Ferguson SD. Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy: A Preliminary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2025 Aug 1;11(8):890-899. doi: 10.1001/jamaoncol.2025.1770. PMID: 40531511; PMCID: PMC12177721.
Wang Y, Song H, Teng Y, Huang G, Qian J, Wang H, Dong S, Ha J, Ma Y, Chang M, Jeong SD, Deng W, Schrank BR, Grippin A, Wu A, Edwards JL, Zhang Y, Lin Y, Poon W, Wilhelm S, Bi Y, Teng L, Wang Z, Kim BYS, Jiang W. A Generative Artificial Intelligence Copilot for Biomedical Nanoengineering. ACS Nano. 2025 May 27;19(20):19394-19407. doi: 10.1021/acsnano.5c03454. Epub 2025 May 14. PMID: 40367350.
Tao H, Chen D, Yang C, Nguyen DT, Abboud G, Liu R, Liu T, Chakraborty A, Hou AY, Petit NA, Abbas M, Davis RW, Zhang J, Von Roemeling C, Gbadamosi MO, Jin L, Gu T, Lin T, Wang P, Pepe A, Pedro DI, Mendez-Gomez HR, Xie C, Karachi A, Weidert F, Jin D, Wang C, Long-James K, Molchan EK, Castillo P, Ligon JA, Ghiaseddin AP, Sayour EJ, Rahman M, Deleyrolle LP, Kim BY, Mitchell DA, Sawyer WG, Huang J. Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor response. J Clin Invest. 2025 Jul 1;135(16):e184043. doi: 10.1172/JCI184043. PMID: 40591413; PMCID: PMC12352909.
Wahab R, Keshavarz A, Azam Z, Islam T, Hasan MM, Zhang X, Alobaida A, Rana M, Choi JU, Alam F, Kim IS, Byun Y, McCarty JH, Nickel NP, Roy S, Al-Hilal TA. Microfluidic captured patient-derived circulating endothelial cells identify novel targets of pulmonary arterial hypertension. Biomaterials. 2025 Dec;323:123429. doi: 10.1016/j.biomaterials.2025.123429. Epub 2025 May 19. PMID: 40408976.
Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H, Kumthekar PU, Chen CC, Aiken R, Groves MD, Ong SS, Ramakrishna R, Vogelbaum MA, Khagi S, Kaley T, Melear JM, Peereboom DM, Rodriguez A, Yankelevich M, Nair SG, Puduvalli VK, Aldape K, Gao A, López-Janeiro Á, de Andrea CE, Alonso MM, Boutros P, Robbins J, Mason WP, Sonabend AM, Stupp R, Fueyo J, Gomez-Manzano C, Lang FF, Zadeh G. Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. Nat Med. 2025 Sep;31(9):3204. doi: 10.1038/s41591-025-03895-1. Erratum for: Nat Med. 2023 Jun;29(6):1370-1378. doi: 10.1038/s41591-023-02347-y. PMID: 40691367; PMCID: PMC12443589.
Beckham TH, Cha EE, Rooney MK, Tom MC, Perni S, McAleer MF, Li J, Kudchadker RJ, Prajapati S, Zlateva Y, Kaya D, Ene CI, Ferguson SD, Huse JT, Prabhu SS, Weinberg JS. Cesium-131 collagen tile brachytherapy for salvage of recurrent intracranial metastases. J Neurooncol. 2025 Oct;175(1):165-174. doi: 10.1007/s11060-025-05113-x. Epub 2025 Jun 23. PMID: 40549120.
Ma Y, Dong S, Grippin AJ, Teng L, Lee AS, Kim BYS, Jiang W. Engineering therapeutical extracellular vesicles for clinical translation. Trends Biotechnol. 2025 Jan;43(1):61-82. doi: 10.1016/j.tibtech.2024.08.007. Epub 2024 Sep 2. PMID: 39227240; PMCID: PMC11717644.
Lang FF, Weinberg JS, Ene CI, Clark VE, Zakaria R, Al-Holou WN, Evans L, Shepard MJ, Everson RG. Introduction. Surgical management of infiltrative gliomas. Neurosurg Focus. 2025 Aug 1;59(2):E1. doi: 10.3171/2025.5.FOCUS24675. PMID: 40749244.
Muir MT, Noll K, Prinsloo S, Michener H, Traylor JI, Kumar VA, Ene CI, Ferguson S, Liu HL, Weinberg JS, Lang F, Taylor BA, Forkel SJ, Prabhu SS. Preoperative Brain Mapping Predicts Language Outcomes After Eloquent Tumor Resection. Hum Brain Mapp. 2025 Oct 15;46(15):e70340. doi: 10.1002/hbm.70340. PMID: 41099461; PMCID: PMC12529647.
De A, Forero SA, Pirani A, Morales JE, De La Fuente-Granada M, Sebastian S, Huse JT, Ballester LY, Weinberg JS, Lang FF, Akdemir KC, McCarty JH. Single cell spatial profiling of the matrisome identifies region-specific adhesion and signaling networks in glioblastoma. Commun Biol. 2025 Dec 9;9(1):17. doi: 10.1038/s42003-025-09270-7. PMID: 41366031; PMCID: PMC12769532.
Zhang H, Sun M, Chen J, Wang S, Liu J, Yang H, Liu L, Hu S, Yang F, Teng L, Chen Z, Wang X, Dong S, Ma Y, Edwards JL, Wang X, Chang YT, Kim BYS, Jiang W, Cui Y, Yang Z. Immunological conversion of triple-negative breast cancer by engineered extracellular vesicle-mediated pyroptosis. J Control Release. 2026 Jan 10;389:114493. doi: 10.1016/j.jconrel.2025.114493. Epub 2025 Dec 2. PMID: 41344487.
Khorsandi S, Huntoon K, Wang Y, Woodward A, Antony A, Endsley C, Hafeez N, Edwards JL, McCuen N, Alluri PG, Kim BYS, Jiang W, Lux J. Targeted STING Activation Using Modified Ultrasound-Responsive Microbubbles Enhances Immune Checkpoint Blockade Against Melanoma. Adv Sci (Weinh). 2025 Jun;12(22):e2416596. doi: 10.1002/advs.202416596. Epub 2025 Mar 26. PMID: 40135812; PMCID: PMC12165055.
Chan V, Gausper A, Liu A, Andras LM, Illingworth KD, Skaggs DL, Imbeault R, Dufresne J, Parent S, et al. Canadian Spine Society: 25th Annual Scientific Conference, February 25 to 28, 2025, Fairmont Le Manoir Richelieu, La Malbaie, Charlevoix,Que., Canada. Can J Surg. 2025 Dec 12;68(6suppl3):S58-S132. doi: 10.1503/cjs.020125. PMID: 41386990; PMCID: PMC12705198.
Flores A, Nitturi V, Kavoussi A, Feygin M, Andrade de Almeida RA, Ramirez Ferrer E, Anand A, Nouri S, Allam AK, Ricciardelli A, Reyes G, Reddy S, Rampalli I, Rhines L, Tatsui CE, North RY, Ghia A, Siewerdsen JH, Ropper AE, Alvarez-Breckenridge C. Generalizable model to predict new or progressing compression fractures in tumor-infiltrated thoracolumbar vertebrae in an all-comer population. J Neurosurg Spine. 2025 Jun 20;43(3):273-282. doi: 10.3171/2025.2.SPINE24872. PMID: 40540805.
Faraj CA, McCutcheon IE, Gubbiotti MA, Perni S, Gule-Monroe MK, Akdemir K, Clark VE, Bander ED, Loghin ME, Prabhu SS, Lang FF, Weinberg JS. Extra-central nervous system metastasis from high-grade glioma: a single-institution experience. J Neurooncol. 2025 May;173(1):193-204. doi: 10.1007/s11060-025-04977-3. Epub 2025 Mar 6. PMID: 40055259.
Dagher SA, Johnson JM, Mohamed RMM, Ansari S, Mawlawi O, Liu HL, Wintermark M, Schellingerhout D, Flynt L, Yeboa DN, Weinberg JS, Ferguson SD, Gule-Monroe MK. Study of 18 F-fluciclovine PET for serial assessment of glioblastoma tumor volumes during surgery and radiotherapy. J Neurooncol. 2025 Nov;175(2):549-560. doi: 10.1007/s11060-025-05146-2. Epub 2025 Jul 1. PMID: 40591209; PMCID: PMC12420720.
Kuan EC, Talati V, Patel JA, Nguyen TV, Abiri A, Pang JC, Goshtasbi K, Liu L, Craig JR, Papagiannopoulos P, Phillips KM, Tajudeen BA, Adappa ND, Palmer JN, Sedaghat AR, Wang EW, Anand V, Batra PS, Bergsneider M, Bernal-Sprekelsen M, Bleier BS, Cappabianca P, Carrau RL, Casiano RR, Castelnuovo P, Cavallo LM, Cohen MA, Dallan I, Eloy JA, El-Sayed IH, Evans JJ, Fernandez-Miranda JC, Ferrari M, Froelich S, Gardner PA, Georgalas C, Gray ST, Hanna EY, Harvey RJ, Hong SD, Hwang PH, Kelly DF, Kong DS, Lan MY, Lee JYK, Levine CG, Liu JK, Locatelli D, Meço C, McKean EL, Nicolai P, Nyquist GG, Omura K, Passeri T, Patel ZM, Celda MP, Neto CP, Prevedello DM, Rabinowitz MR, Raza SM, Recinos PF, Rosen MR, Sargi ZB, Schlosser RJ, Schwartz TH, Sindwani R, Snyderman CH, Stamm AC, Thorp BD, Turri-Zanoni M, Wang MB, Wang WH, Witterick IJ, Won TB, Woodworth BA, Wormald PJ, Zada G, Su SY. Expert Strategies: Skull Base Reconstruction-Global Perspectives, Insights, and Algorithms through a Mixed Methods Approach. Int Forum Allergy Rhinol. 2025 Oct;15(10):1032-1069. doi: 10.1002/alr.23596. Epub 2025 May 15. PMID: 40371737; PMCID: PMC12503090.
Contrera KJ, Ferrarotto R, Gunn B, Su SY, Kies MS, Glisson BS, Garden AS, Roberts D, Habna C, Hoff CO, El-Naggar A, Williams MD, Raza SM, DeMonte F, Chen MM, Chambers MS, Hanna EY. Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma. Clin Cancer Res. 2025 Jan 17;31(2):258-265. doi: 10.1158/1078-0432.CCR-24-1416. PMID: 39531535.
Brenner AJ, Patel T, Bao A, Phillips WT, Michalek JE, Youssef M, Weinberg JS, Kamiya Matsuoka C, Hedrick MH, LaFrance N, Moore M, Floyd JR. Convection enhanced delivery of Rhenium Obisbemeda in recurrent glioma: a multicenter, single arm, phase 1 clinical trial. Nat Commun. 2025 Mar 7;16(1):2079. doi: 10.1038/s41467-025-57263-1. PMID: 40055350; PMCID: PMC11889265.
Gao F, Liu X, Ma Z, Tang M, Tang Z, Wu J, Luo M, Tang Y, Wang X, Wang B, Kim BYS, Yang Z, Jiang W, Tang P, Li C. An Integrated Modular Vaccination System for Spatiotemporally Separated Perioperative Cancer Immunotherapy. Adv Mater. 2025 Mar;37(11):e2418322. doi: 10.1002/adma.202418322. Epub 2025 Feb 9. PMID: 39924759.
Rosenstock T, Picht T, Engelhardt M, Grittner U, Mönch M, Vajkoczy P, Lavrador JP, Mirallave-Pescador A, Vergani F, Schwendner M, Schroeder A, Kram L, Zhang H, Prabhu S, Prinsloo S, Meyer B, Ille S, Krieg SM. Improving postsurgical paresis in brain tumor patients by transcranial magnetic stimulation. J Neurooncol. 2025 Apr;172(2):417-428. doi: 10.1007/s11060-024-04931-9. Epub 2025 Jan 23. PMID: 39847143; PMCID: PMC11937064.
Goethe EA, Srinivasan S, Kumar S, Prabhu SS, Gubbiotti MA, Ferguson SD. High-grade astrocytoma with piloid features: a single-institution case series and literature review. Acta Neuropathol Commun. 2025 Apr 24;13(1):82. doi: 10.1186/s40478-025-01987-0. PMID: 40270074; PMCID: PMC12020207. Goethe EA, Alfattal R, Srinivasan S, Dasgupta P, Puduvalli V, Weathers SP, Ballester LY, Weinberg JS, Prabhu S, Ferguson SD, Gubbiotti MA. High-grade glioma with pleomorphic and pseudopapillary features: a single-institution series of three cases. Acta Neuropathol Commun. 2025 Aug 18;13(1):176. doi: 10.1186/s40478-025-02097-7. PMID: 40826136; PMCID: PMC12363008.
Kumar S, Pelster MS, Hasanov M, Guerrieri RA, Hudgens CW, Ledesma DA, Wang F, Fischer GM, Simon JM, Haydu LE, Katlowitz KV, Gopal YNV, McQuade JL, Kwong LN, Huse JT, Lazar AJ, Tetzlaff MT, Gershenwald JE, Joon AY, Chen K, Li Z, Ram PT, Ferguson SD, Davies MA. Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis. Acta Neuropathol Commun. 2025 Apr 15;13(1):75. doi: 10.1186/s40478-025-01978-1. PMID: 40229864; PMCID: PMC11998309.
Rubino F, Zenonos GA, Algattas H, Gardner PA, Fernandez-Miranda JC, Vigo V, DeMonte F, Raza SM. Impact of adjuvant radiation therapy on outcomes in grade 2 conventional chondrosarcoma. J Neurosurg. 2025 Aug 1;143(5):1406-1418. doi: 10.3171/2025.3.JNS242797. PMID: 40749240.
Musmar B, Adeeb N, Abdalrazeq H, Salim HA, Roy J, Tjoumakaris SI, Kandregula S, Ogilvy CS, Kondziolka D, Sheehan JP, Dmytriw AA, Aslan A, Patel P, Lan M, Baldassari MP, Koduri S, Atallah E, Zeineddine H, Pontarelli MK, Abou-Al-Shaar H, El Naamani K, Abdelsalam A, Ironside N, Kumbhare D, Gummadi S, Baskaya M, Ataoglu C, Mccarthy F, Sanchez-Forteza A, Essibayi MA, Keles A, Muram S, Sconzo D, Riina H, Rezai A, Alwakaa O, Tos SM, Mantziaris G, Park MS, Hanalioglu S, Erginoglu U, Pöppe J, Sen RD, Griessenauer CJ, Ocampo-Navia MI, Devia DA, Perez-Mendez W, Puentes JC, Abo Kasem R, Spiotta AM, Puri AS, Singh J, Kuhn AL, Burkhardt JK, Starke RM, Sekhar LN, Levitt M, Altschul D, Haranhalli N, McAvoy M, Eltiti M, Abushehab A, Foreman P, Shakir HJ, Zaidat OO, AlMajali M, Ruppert-Gomez M, See AP, Abla AA, Stapleton CJ, Patel A, Nguyen A, Koch MJ, Srinivasan VM, Chen PR, Blackburn S, Alshahrani R, Gooch MR, Rosenwasser RH, Bulsara KR, Kan P, Kim LJ, Choudhri O, Pukenas B, Simonato D, Li YL, Alaraj A, Fuschi M, Patel AB, Savardekar A, Notarianni C, Cuellar HH, Lawton MT, Guthikonda B, Morcos J, Jabbour P. Safety and efficacy of preoperative embolization in the treatment of brain arteriovenous malformations with perinidal aneurysms and single draining vein: a multicenter study with propensity score-weighting. J Neurointerv Surg. 2025 Aug 22:jnis-2025-023873. doi: 10.1136/jnis-2025-023873. Epub ahead of print. PMID: 40846482.
Kimchi G, Varela S, Zuluaga-Garcia JP, Call-Orellana F, Ramirez Ferrer E, Andrade de Almeida RA, Gubbiotti MA, Glitza IC, Bishop AJ, Grant JD, North RY, Alvarez-Breckenridge CA, Rhines LD, Tatsui CE. Primary Intramedullary Spinal Melanocytomas: Case Report and Review of Clinical Features, Diagnosis, and Management. J Clin Med. 2025 Nov 13;14(22):8047. doi: 10.3390/jcm14228047. PMID: 41303082; PMCID: PMC12653606.
Dasgupta P, Lin H, Kumar G, Soomro Z, Ayala MM, Parra ER, Weathers SP, Lang FF, Bhat KP, de Groot J, Majd NK. Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastoma. J Neurooncol. 2025 Oct;175(1):453-461. doi: 10.1007/s11060-025-05131-9. Epub 2025 Jun 25. PMID: 40560330.
Adeeb N, Salim HA, Musmar B, Aslan A, Swaid C, Cuellar M, Dibas M, Cancelliere NM, Diestro JDB, Algin O, Ghozy S, Lay SV, Guenego A, Renieri L, Carnevale J, Saliou G, Mastorakos P, Naamani KE, Shotar E, Möhlenbruch M, Kral M, Chung C, Salem MM, Lylyk I, Foreman PM, Shaikh H, Župančić V, Hafeez MU, Catapano J, Waqas M, Arslan M, Ergun O, Rabinov JD, Ren Y, Schirmer CM, Piano M, Kühn AL, Michelozzi C, Starke RM, Hassan A, Ogilvie M, Nguyen A, Jones J, Brinjikji W, Nawka MT, Psychogios M, Ulfert C, Pukenas B, Burkhardt JK, Huynh T, Martinez-Gutierrez JC, Essibayi MA, Sheth SA, Slawski D, Tawk R, Pulli B, Lubicz B, Panni P, Puri AS, Pero G, Raz E, Griessenauer CJ, Asadi H, Siddiqui A, Levy EI, Haranhalli N, Altschul D, Ducruet AF, Albuquerque FC, Regenhardt RW, Stapleton CJ, Kan P, Kalousek V, Lylyk P, Boddu S, Knopman J, Tjoumakaris SI, Jabbour PM, Clarençon F, Limbucci N, Yedavalli V, Wintermark M, Pereira VM, Patel AB, Cuellar-Saenz HH, Dmytriw AA; Worldwide Web Workgroup. Incidence and predictors of Woven EndoBridge (WEB) shape modification following treatment of intracranial aneurysms in a large multicenter study. Neurosurg Rev. 2025 Feb 25;48(1):265. doi: 10.1007/s10143-025-03344-0. PMID: 39994082; PMCID: PMC11850463.
Zuluaga-Garcia JP, Ramirez-Ferrer E, Peeters SF, DeMonte F, Raza SM. Management of skull base meningiomas with extracranial extension: resection, recurrence, and prognostic factors. J Neurooncol. 2025 Oct;175(1):143-152. doi: 10.1007/s11060-025-05111-z. Epub 2025 Jun 19. PMID: 40536633.
O'Leary S, Price A, Camarillo-Rodriguez L, Costa M, Karas P, Young CC, Srinivasan VM, Kan P. Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study. J Neurosurg. 2025 May 9;143(4):1037-1047. doi: 10.3171/2025.1.JNS242357. PMID: 40344770.
Beernaert B, Jady-Clark RL, Shah P, Ramon-Gil E, Lawson NM, Brodtman ZD, Tagore S, Stihler F, Carter AS, Clarke S, Liu T, Zhu W, Erdal E, Easton A, Campo L, Browne M, Ash S, Waddell N, Crosby T, Lord SR, Mann DA, Melero I, de Andrea CE, Tijhuis AE, Foijer F, Hammond EM, Akdemir KC, Leslie J, Izar B, Parkes EE. Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axis. bioRxiv [Preprint]. 2025 May 10:2025.05.06.652454. doi: 10.1101/2025.05.06.652454. Update in: Sci Adv. 2026 Mar 13;12(11):eaeb1611. doi: 10.1126/sciadv.aeb1611. PMID: 40654626; PMCID: PMC12248057.
Narsinh KH, Young C, Chen SR, Ansari SA, Kan P, Hetts SW. Neurointerventional oncology: the new frontier. J Neurointerv Surg. 2025 Jun 16;17(7):671-672. doi: 10.1136/jnis-2025-023050. PMID: 39880620. Fallahi MS, Maroufi SF, Parmis Maroufi S, Khorasanizadeh M, de Macêdo Filho LJM, Margetis K, Guha D, Tatsui CE, Mansouri A. Percutaneous cryoablation in the management of spinal metastases: a comprehensive systematic review and meta-analysis. J Neurooncol. 2025 Sep;174(2):303-314. doi: 10.1007/s11060-025-05064-3. Epub 2025 May 13. PMID: 40358802; PMCID: PMC12208987.
Al Farii H, Gattu N, Yeung CM, Alvarez-Breckenridge CA, North RY, Tatsui CE, Rhines LD, Lewis VO, Bird JE, Patel SS. The kiva system versus balloon kyphoplasty for vertebral compression fracture: a meta-analysis of randomized control trials. N Am Spine Soc J. 2025 Aug 6;24:100778. doi: 10.1016/j.xnsj.2025.100778. PMID: 41498048; PMCID: PMC12766080.
De la Garza Ramos R, Goodwin CR, Weber MH, Pahuta M, Patel SS, MacLean M, Sahgal A, Rhines LD, Sciubba DM, Netzer C, Dea N, Verlaan JJ, Gasbarrini A, Reynolds J, Barzilai O, Bettegowda C, Boriani S, Fisher CG, Gokaslan ZL, Lazary A, Laufer I, Shin JH, Charest-Morin R; AO Spine Knowledge Forum Tumor. An International Delphi Consensus on Defining the Optimal Surgical Composite Outcome in Metastatic Spine Disease. Spine (Phila Pa 1976). 2025 Dec 15;50(24):1683-1691. doi: 10.1097/BRS.0000000000005479. Epub 2025 Nov 11. PMID: 40851377; PMCID: PMC12637127.
Teo JM, Kumar VA, Khalaf AM, Noll KR, Ferguson SD, Ene CI, Prabhu SS, Wintermark M, Liu HL. Probabilistic template matching for detecting resting-state functional MRI language network in brain tumor patients. Med Phys. 2025 Nov;52(11):e70138. doi: 10.1002/mp.70138. PMID: 41231662; PMCID: PMC12614290. Allam AK, Larkin MB, Patel IA, Hasen M, Mears D, Dougherty P, Viswanathan A. The human spinothalamic tract: lessons from cordotomy. Brain Commun. 2025 Jun 17;7(3):fcaf237. doi: 10.1093/braincomms/fcaf237. PMID: 40574969; PMCID: PMC12198438.
Costa M, O'Leary S, Price AM, Young CC, Srinivasan VM, Kan P. Impact of GLP-1 receptor agonists on stroke, subarachnoid hemorrhage, and intracerebral hemorrhage: a propensity-matched multi-institutional cohort study. J Neurosurg. 2025 Oct 3;144(2):428-441. doi: 10.3171/2025.5.JNS25786. PMID: 41043189.
Forero SA, Chen Z, Pirani A, De A, Wise Z, Morales JE, McCarty JH. Single Cell RNA Sequencing and Spatial Profiling Identify Mechanisms of Neonatal Brain Hemorrhage Development and Resolution. bioRxiv [Preprint]. 2025 Jul 31:2025.07.30.667675. doi: 10.1101/2025.07.30.667675. Update in: Angiogenesis. 2025 Dec 7;29(1):9. doi: 10.1007/s10456-025-10019-3. PMID: 40766655; PMCID: PMC12324503.
Rutges JPHJ, Zuckerman SL, Arnold PM, Bettegowda C, Boriani S, Clarke MJ, Fehlings MG, Gokaslan ZL, Lazary A, Rhines LD, Sahgal A, Sciubba DM, Schuster JM, Weber MH, Laufer I, Fisher CG; on the behalf of the AO Spine Knowledge Forum Tumor. Advancing Metastatic Spine Tumor Research: A Review of AO Spine Knowledge Forum Tumor's Scientific Contributions Derived From the EPOSO Network, 2014-2024. Global Spine J. 2025 Jul;15(6):2999-3006. doi: 10.1177/21925682251326515. Epub 2025 Mar 12. PMID: 40074676; PMCID: PMC11907629.
Li Y, Uhelski ML, North RY, Farson LB, Bankston CB, Roland GH, Fan DH, Sheffield KN, Jia A, Orlando D, Heles M, Yaksh TL, Miller YI, Kosten TA, Dougherty PM. ApoA-I binding protein (AIBP) regulates transient receptor potential vanilloid 1 (TRPV1) activity in rat dorsal root ganglion neurons by selective disruption of toll-like receptor 4 (TLR4)-lipid rafts. Brain Behav Immun. 2025 Jan;123:644-655. doi: 10.1016/j.bbi.2024.10.017. Epub 2024 Oct 14. PMID: 39414176.
Sconzo D, Ramirez-Velandia F, Muram S, Enriquez-Marulanda A, Riordan CP, Adeeb N, Musmar B, Salim HA, Kandregula S, Dmywtriw AA, Abdelsalam A, Ataoglu C, Erginoglu U, Kondziolka D, Aslan A, Naamani KE, Sheehan J, Park MS, Zeineddine HA, Ironside N, Kumbhare D, Gummadi S, Essibayi MA, Tos SM, Keles A, Rezai A, Pöppe J, Sen RD, Baskaya MK, Griessenauer CJ, Jabbour P, Tjoumakaris SI, Atallah E, Riina H, Abushehab A, Burkhardt JK, Starke RM, Sekhar LN, Levitt MR, Altschul DJ, Haranhalli N, McAvoy M, Abla A, Stapleton C, Koch M, Srinivasan VM, Chen PR, Blackburn S, Kim LJ, Choudhri O, Pukenas B, Mantziaris G, O'Leary S, Kan P, Li YL, Simonato D, Bulsara K, Fuschi M, Alaraj A, Hanalioglu S, Patel A, Savardekar A, Cuellar H, Lawton M, Morcos J, Guthikonda B, Taussky P, Ogilvy CS; MISTA Consortiumn. Impact of smoking on occlusion rates following stereotactic radiosurgery for Spetzler Martin grade I-III brain arteriovenous malformations -A propensity score matched analysis of the MISTA consortium. J Clin Neurosci. 2025 Sep;139:111411. doi: 10.1016/j.jocn.2025.111411. Epub 2025 Jun 27. PMID: 40578008.
Forero SA, Chen Z, Pirani A, De A, Wise Z, Zheng X, Morales JE, McCarty JH. Integrative single cell RNA and spatial profiling identify mechanisms of neonatal brain hemorrhage pathophysiology and repair. Angiogenesis. 2025 Dec 7;29(1):9. doi: 10.1007/s10456-025-10019-3. PMID: 41353666; PMCID: PMC12682726. Ramirez Ferrer E, Kimchi G, Tom MC, Chakravarthy VB, Amini B, Andrade de Almeida RA, Zuluaga-Garcia JP, Call-Orellana F, North RY, Alvarez-Breckenridge CA, Rhines LD, Tatsui CE. Intraoperative ultrasound imaging features in high-grade metastatic spinal cord compression treated with separation surgery. Neurosurg Focus. 2025 May 1;58(5):E8. doi: 10.3171/2025.2.FOCUS24965. PMID: 40311208.
Qiao Y, Xiong M, Zhang YJ, Tsappidi S, Kan P, Weiss CR, Hui F, Chen SR. Current and future directions in interventional neuro-oncology-are we there yet? J Neurointerv Surg. 2025 Jan 17;17(2):205-209. doi: 10.1136/jnis-2024-021540. PMID: 38637150. Biczo A, Sahgal A, Verlaan JJ, Shreyaskumar P, Szoverfi Z, Schultheiss M, Rhines L, Reynolds J, Laufer I, Gasbarrini A, Dea N, Gokaslan Z, Fisher C, Bettegowda C, Boriani S, Hornicek F, Goodwin R, Lazary A. Latest Developments in Targeted Biological Therapies in the Management of Chordoma and Chondrosarcoma. Global Spine J. 2025 Jan;15(1_suppl):120S-131S. doi: 10.1177/21925682241227917. PMID: 39801117; PMCID: PMC11988243.
Schrank BR, Kim BYS. Uncovering the hidden landscape of tumour antigens. Nat Rev Immunol. 2025 Jul;25(7):482. doi: 10.1038/s41577-025-01198-7. PMID: 40506469.
Stringam J, Pal K, Niekamp A, Jiwani R, Paolucci I, Kuban JD, Metwalli Z, Huang S, Habibollahi P, Chen S, Yevich S, Patel M, Subudhi SK, Campbell M, Ghia A, Tatsui C, Sheth RA. Safety, Efficacy, and Adjacent-level Fracture Risk Following Vertebral Augmentation and Radiofrequency Ablation for the Treatment of Spine Metastases in Patients with Cancer. Radiol Imaging Cancer. 2025 May;7(3):e240122. doi: 10.1148/rycan.240122. PMID: 40377420; PMCID: PMC12130721.
Silva González A, Chen H, Disch AC, Kam J, O'Toole JE, Dea N, Gasbarrini A, Laufer I, Netzer C, Reynolds J, Rhines LD, Sahgal A, Verlaan JJ, Fisher CG, Barzilai O. AO Spine Clinical Practice Recommendations: Reducing the Surgical Footprint of Surgery for Spinal Metastases. Global Spine J. 2026 Jan;16(1):11-18. doi: 10.1177/21925682251352442. Epub 2025 Jun 16. PMID: 40521797; PMCID: PMC12170550.
Goethe EA, Andrade de Almeida RA, Call-Orellana F, Mikula AL, Clarke MJ, Merrell KW, Rose PS, Karim SM, Linzey JR, Szerlip NJ, Amini B, Beckham TH, Ghia AJ, Li J, Tom MC, McAleer MF, Perni S, Wang C, Yeboa DN, Price A, Alvarez-Breckenridge C, Rhines LD, Tatsui CE, North RY. Sacral fracture risk after stereotactic spinal radiosurgery: a multi-institution, retrospective analysis. J Neurosurg Spine. 2025 Jun 20;43(3):305-312. doi: 10.3171/2025.2.SPINE24770. PMID: 40540799.
Ramirez-Ferrer E, Zuluaga-Garcia JP, Weinberg JS, Ene CI, Raza SM, Lang FF, Kan PT, Chen SR, Young CC. Chronic subdural hematoma treatment in oncological patients: middle meningeal artery embolization versus surgical drainage. Neurosurg Focus. 2025 Oct 1;59(4):E14. doi: 10.3171/2025.7.FOCUS25553. PMID: 41032892.
Tomczak K, Patel MS, Bhalla AD, Peterson CB, Landers SM, Callahan SC, Zhang D, Wong J, Landry JP, Lazar AJ, Livingston JA, Guadagnolo BA, Lyu HG, Lillemoe H, Roland CL, Keung EZ, Scally CP, Hunt KK, McCutcheon IE, Slopis JM, Gu J, Scheet P, Wang L, Rai K, Torres KE. Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1. Mol Carcinog. 2025 Jan;64(1):44-56. doi: 10.1002/mc.23825. Epub 2024 Nov 26. Erratum in: Mol Carcinog. 2025 May;64(5):953. doi: 10.1002/mc.23890. PMID: 39600120; PMCID: PMC11636586.
Gubbiotti MA, McCutcheon IE, Rao P, Genovese G, Wang L, Tarasov A, Putintsev V, Berlinski A, Stupichev D, Kriukov K, Davitavyan S, Salem B, Sarachakov A, Lebedev D, Hensley M, Bagaev A, Paradiso F, Kushnarev V, Khegai G, Tannir NM, Msaouel P. A novel case of glial transdifferentiation in renal medullary carcinoma brain metastasis. Acta Neuropathol Commun. 2025 Jan 20;13(1):12. doi: 10.1186/s40478-025-01929-w. PMID: 39833894; PMCID: PMC11748356.
Kwan WC, Zuckerman SL, Fisher CG, Laufer I, Chou D, O'Toole JE, Schultheiss M, Weber MH, Sciubba DM, Pahuta M, Shin JH, Fehlings MG, Versteeg A, Goodwin ML, Boriani S, Bettegowda C, Lazary A, Gasbarrini A, Reynolds JJ, Verlaan JJ, Sahgal A, Gokaslan ZL, Rhines LD, Dea N. What is the Optimal Management of Metastatic Spine Patients With Intermediate Spinal Instability Neoplastic Scores: To Operate or Not to Operate? Global Spine J. 2025 Jan;15(1_suppl):132S-142S. doi: 10.1177/21925682231220551. PMID: 39801116; PMCID: PMC11988250.
Czyz M, Wensink EG, Coimbra B, Galgano M, Patel S, Redmond K, Rutges J, Tan JHJ, Barzilai O, Dea N, Gasbarrini A, Laufer I, Lazary A, Netzer C, Reynolds JJ, Rhines LD, Sahgal A, Fisher CG, Verlaan JJ. AO Spine Clinical Practice Recommendations: Current Systemic Oncological Treatments with the Largest Impact on Patients with Metastatic Spinal Disease. Global Spine J. 2025 May;15(4):1884-1889. doi: 10.1177/21925682251324138. Epub 2025 Mar 28. PMID: 40153520; PMCID: PMC11955994.
Snyder R, Rubino F, Seaman S, Banu M, Su SY, Hanna EY, DeMonte F, Raza SM. Impact of Previous Surgery and/or Radiation Therapy on Endoscopic Reconstruction Outcomes. Oper Neurosurg. 2025 Apr 1;28(4):496-505. doi: 10.1227/ons.0000000000001318. Epub 2024 Aug 26. PMID: 39185868.
Karandish A, Essibayi MA, Jabal MS, Salim HA, Musmar B, Adeeb N, Dibas M, Simonato D, Li YL, Grist J, Zaccagna F, Algin O, Ghozy S, Lay SV, Guenego A, Renieri L, Carnevale J, Saliou G, Mastorakos P, El Naamani K, Shotar E, Möhlenbruch M, Kral M, Chung C, Salem MM, Lylyk I, Foreman PM, Shaikh H, Župančić V, Hafeez MU, Catapano J, Waqas M, Kazanci A, Ayberk G, Rabinov JD, Maingard J, Schirmer CM, Piano M, Kühn AL, Michelozzi C, Starke RM, Hassan A, Ogilvie M, Nguyen A, Jones J, Brinjikji W, Nawka MT, Psychogios M, Ulfert C, Pukenas B, Burkhardt JK, Huynh T, Martinez-Gutierrez JC, Sheth SA, Slawski D, Tawk R, Pulli B, Lubicz B, Panni P, Puri AS, Pero G, Raz E, Griessenauer CJ, Asadi H, Siddiqui A, Levy EI, Haranhalli N, Ducruet AF, Albuquerque FC, Regenhardt RW, Stapleton CJ, Kan P, Kalousek V, Lylyk P, Boddu S, Knopman J, Tjoumakaris SI, Cuellar-Saenz HH, Jabbour PM, Clarençon F, Limbucci N, Patel AB, Fuschi M, Altschul D, Dmytriw AA; WorldWideWEB Investigators. Predictive modeling of long-term improvement in occlusion outcomes following Woven EndoBridge treatment of cerebral aneurysms: A machine learning approach. Interv Neuroradiol. 2025 Nov 3:15910199251391915. doi: 10.1177/15910199251391915. Epub ahead of print. PMID: 41182964; PMCID: PMC12583012.
Barbanti Brodano G, Griffoni C, Salamanna F, Noli LE, Monetta A, Luzzati A, Disch AC, Lazary A, Barzilai O, Laufer I, Gokaslan ZL, Fehlings MG, Verlaan JJ, Chou D, Rhines LD, Shin JH, Teixeira WGJ, Sciubba DM, Bettegowda C, Charest-Morin R, Boriani S, Goldschlager T, Weber MH, Clarke MJ, O'Toole JE, Netzer C, Goodwin CR, Mesfin A, Mummaneni PV, Dea N, Reynolds JJ, Sahgal A, Fisher CG, Gasbarrini A; AO Spine Knowledge Forum Tumor. Evaluation of Adverse Events and the Impact on Health-Related Outcomes in Patients Undergoing Surgery for Metastatic Spine Tumors: Analysis of the Metastatic Tumor Research and Outcomes Network (MTRON) Registry Dataset. Global Spine J. 2026 Jan;16(1):410-433. doi: 10.1177/21925682251347247. Epub 2025 Jun 6. PMID: 40480956; PMCID: PMC12145413.
Deva A, Rypinski TA, Pillai PS, Soni B, Sarwar O, Milhorn AC, Jones AK, Tatsui CE, Rhines LD, North RY, Alvarez-Breckenridge C, Bird JE, Siewerdsen JH. Statistical Surgical Process Modeling: Analysis of Workflow and Performance of Emerging Technologies in Image-Guided Spine Surgery. Ann Biomed Eng. 2025 Dec;53(12):3435-3455. doi: 10.1007/s10439-025-03855-3. Epub 2025 Sep 29. PMID: 41023347.
Laflamme M, Gasbarrini A, Rhines LD, Lazary A, Gokaslan ZL, Reynolds JJ, Luzzati A, Disch AC, Chou D, Clarke MJ, Wei F, Bettegowda C, Rampersaud YR, Boriani S, Shin JH, Lord E, Sciubba DM, Laufer I, Sahgal A, Fisher CG, Dea N; AO Spine Knowledge Forum Tumor. Surgical Adverse Events for Primary Tumors of the Spine and Their Impact on Outcomes: An Observational Study From the Primary Tumors Research and Outcomes Network. Neurosurgery. 2025 Feb 5;97(1):264-276. doi: 10.1227/neu.0000000000003369. PMID: 39907438; PMCID: PMC12144635.
Haisraely O, Tom MC, Perni S, Kudchadker R, Prajapati S, Zlateva Y, Weinberg JS, Yeboa DN, Li J, Ferguson SD, Alvarez-Breckenridge C, Patel CB, Ene CI, Prabhu S, Beckham TH. Cs-131 Collagen Tile Brachytherapy for Recurrent Glioblastoma: Treatment Outcomes and Toxicity. Pract Radiat Oncol. 2026 Mar-Apr;16(2):e101-e107. doi: 10.1016/j.prro.2025.11.010. Epub 2025 Dec 6. PMID: 41360286.
Muir MT, Noll K, Patel R, Prinsloo S, Michener H, Kumar VA, Ene C, Ferguson S, Weinberg JS, Lang F, Taylor BA, Prabhu SS. Toward data-driven surgical planning: multimodal mapping correlates of aphasic surgical deficits. J Neurosurg. 2025 Oct 24;144(2):324-335. doi: 10.3171/2025.6.JNS242301. PMID: 41135113.
Versteeg AL, Charest-Morin R, De La Garza Ramos R, Laufer I, Teixeira WGJ, Barzilai O, Gasbarrini A, Fehlings MG, Chou D, Gokaslan ZL, Netzer C, Luzzati A, Verlaan JJ, Goldschlager T, Shin JH, O'Toole JE, Sciubba DM, Bettegowda C, Clarke MJ, Weber MH, Mesfin A, Kawahara N, Patel SS, Goodwin CR, Disch AC, Reynolds JJ, Lazary A, Boriani S, Dea N, Sahgal A, Rhines LD, Fisher CG; AO Spine Knowledge Forum Tumor. Association Between Nutritional Status and Survival in Patients Requiring Treatment for Spinal Metastases. Neurosurgery. 2025 Nov 6. doi: 10.1227/neu.0000000000003834. Epub ahead of print. PMID: 41196049.
De la Garza Ramos R, Charest-Morin R, Goodwin CR, Zuckerman SL, Laufer I, Dea N, Sahgal A, Rhines LD, Gokaslan ZL, Bettegowda C, Versteeg AL, Chen H, Cordula N, Sciubba DM, O'Toole JE, Fehlings MG, Kumar N, Disch AC, Stephens B, Goldschlager T, Weber MH, Shin JH; AO Spine Knowledge Forum Tumor. Malnutrition in Spine Oncology: Where Are We and What Are We Measuring? Global Spine J. 2025 Jan;15(1_suppl):29S-46S. doi: 10.1177/21925682231213799. PMID: 39815762; PMCID: PMC11988249.
Andrade-Almeida RA, Call-Orellana F, Zuluaga-Garcia JP, Ramirez-Ferrer E, Kimchi G, De BS, Guimaraes AB, Alvarez-Breckenridge CA, Li J, Ghia AJ, Rhines L, Tom MC, Wang C, Beckham TH, Amini B, North RY, Tatsui CE. Local Control After Adjuvant Radiosurgery for Spinal Metastasis Treated With Decompression and Posterior Segmental Stabilization: A Comparison Between Carbon Fiber/Polyetheretherketone-Based and Metallic Implants. Adv Radiat Oncol. 2025 Jun 10;10(7):101806. doi: 10.1016/j.adro.2025.101806. PMID: 40548160; PMCID: PMC12182295.
Strong MJ, Linzey JR, Goethe P, Kathawate V, Tudrick L, Lee J, Ogunsola O, Zaki MM, Ward AL, Willett N, Joshi RS, Muhlestein W, Saadeh YS, North RY, Evans JR, Szerlip NJ, Jackson WC. Separation Surgery Followed by Conformal Postoperative Spine Stereotactic Body Radiation Therapy Does Not Increase Risk of Adjacent Spine Level Progression in the Management of Spine Metastases. Am J Clin Oncol. 2025 Apr 1;48(4):200-205. doi: 10.1097/COC.0000000000001164. Epub 2025 Jan 22. PMID: 39838517. Guerrieri RA, Fischer GM, Cortez JR, Knighton BG, Ledesma DA, Hudgens CW, Delcid YF, Hu Q, Onana CYB, Carapeto FCL, Tezlaff MT, Huse JT, Hwu P, Burton EM, Glitza Oliva IC, Davies MA, Ferguson SD. Preclinical models of melanoma leptomeningeal disease to assess intrathecal checkpoint blockade. Sci Rep. 2025 Oct 2;15(1):34352. doi: 10.1038/s41598-025-16889-3. PMID: 41038921; PMCID: PMC12491558.
Ghia AJ, Guha-Thakurta N, Munsell MF, Briere TM, Wang C, Beckham TH, Yeboa D, Tom MC, Perni S, Li J, McAleer M, Chang EL, North RY, Alvarez-Breckinridge C, Tatsui CE, Brown PD, Rhines LD. Long-term Results From a Phase 1 Study of Spinal Cord Constraint Relaxation With Single Session Spine Stereotactic Radiosurgery in the Primary Management of Patients With Inoperable, Previously Unirradiated Spinal Metastases With Epidural Extension. Int J Radiat Oncol Biol Phys. 2026 Apr 1;124(5):1219-1225. doi: 10.1016/j.ijrobp.2025.06.3871. Epub 2025 Jul 2. PMID: 40614786.
Bander ED, Noll KR, Andrade de Almeida RA, Seaman SC, Banu M, Clark VE, Suki D, Wefel JS, Bradshaw M, Ferguson S, Weinberg JS, Lang FF, Prabhu SS. Relationships Between Surgical Approach, Tumor Classification Scheme, and Early Neurocognitive Outcome After Awake Craniotomy for Resection of Insular Glioma. Oper Neurosurg. 2025 Sep 23. doi: 10.1227/ons.0000000000001767. Epub ahead of print. PMID: 40985652.
MacLean MA, Charles AJ, Georgiopoulos M, Phinney J, Charest-Morin R, Goodwin R, Laufer I, Fehlings MG, Shin J, Dea N, Rhines LD, Sahgal A, Gokaslan Z, Stephens B, Disch AC, Kumar N, O'Toole J, Sciubba DM, Netzer C, Goldschlager T, Gibbs W, Weber MH; AO Spine Knowledge Forum Tumor. A Critical Appraisal of the Application of Frailty and Sarcopenia in the Spinal Oncology Population. Global Spine J. 2025 Jan;15(1_suppl):47S-80S. doi: 10.1177/21925682231207325. PMID: 39801122; PMCID: PMC11988247.
Mikula AL, Rhines LD, Patel SS, Pennington Z, Karim SM, Morris JM, Tappa K, Alvarez-Breckenridge C, North RY, Tatsui CE, Rose PS, Clarke MJ, Bird JE. Utility of 3D-Printed Models in the Surgical Planning for Primary Spine Tumors: A Survey of International Spinal Oncology Experts. Global Spine J. 2025 May;15(4):2004-2013. doi: 10.1177/21925682241278323. Epub 2024 Aug 21. PMID: 39166967; PMCID: PMC11571598.
Simoni AD, Bird JE, Lin PP, Rhines LD, Mericli AF. Computer-Aided Design and Manufacturing to Facilitate Microvascular Free Tissue Transfer in Extremity, Pelvic, and Spinal Reconstructions. J Reconstr Microsurg. 2025 Jun;41(5):432-442. doi: 10.1055/a-2404-7819. Epub 2024 Aug 27. PMID: 39191420. Khanpara S, Calle S, Jo M, Su SY, Hanna EY, Raza SM, Wintermark M, Learned KO. Advanced Endoscopic Approaches for Skull Base Surgery: A Contemporary Imaging-Focused Review, From the AJR Special Series on Critical Anatomy. AJR Am J Roentgenol. 2025 Dec 31. doi: 10.2214/AJR.25.34072. Epub ahead of print. PMID: 41474223.
de Souza DN, Kurland DB, Vialle L, Schnake KJ, Kurpad SN, Lewis SJ, Schroeder GD, Yoon ST, Boriani S, Gokaslan Z, Rhines LD, Sahgal A, Fisher C, Laufer I. AO Spine Knowledge Forums Promote Collaboration and Elevate the Impact of Research: A Bibliometric Analysis. Global Spine J. 2026 Jan;16(1):746-758. doi: 10.1177/21925682251351012. Epub 2025 Jun 13. PMID: 40513712; PMCID: PMC12165958.
Huele EH, Gal R, Eppinga WSC, Verkooijen HM, O'Toole JE, Laufer I, Sciubba DM, Netzer C, Foppen W, Sahgal A, Fehlings MG, Lo SL, Fisher CG, Rhines LD, Reynolds JJ, Lazary A, Gasbarrini A, Dea N, Weber MH, Verlaan JJ. Risk Factors for the Development of Neurological Deficits in Metastatic Spinal Disease: An International, Multicenter Delphi Study. Global Spine J. 2025 Jan;15(1_suppl):93S-103S. doi: 10.1177/21925682231222424. PMID: 39801123; PMCID: PMC11726512.
Faraj CA, McCutcheon IE, Gubbiotti MA. PIT-1/SF-1 co-expression in pituitary neuroendocrine tumors (PitNETs) with comprehensive review of the literature: How should we best characterize these neoplasms? Ann Diagn Pathol. 2025 Feb;74:152398. doi: 10.1016/j.anndiagpath.2024.152398. Epub 2024 Nov 9. PMID: 39549524.
Zhang A, Ma Y, Liu Y, Dong S, Torres MN, Kim BYS, Liu C, Sun L, Yuan Y, Jiang W. Mannose Oligosaccharide-Conjugated In Situ Pore-Forming Injectable Hydrogels for Rheumatoid Arthritis Treatment by Reprogramming Macrophage Extracellular Vesicles. Small Methods. 2026 Feb;10(3):e2500605. doi: 10.1002/smtd.202500605. Epub 2025 Jul 15. PMID: 40662273; PMCID: PMC12893307.
Muir MT, Noll K, Traylor JI, Patel R, Kumar VA, Prabhu SS, Hou P, Liu HL, Stafford RJ, Taylor BA. Resectability of White Matter Tracts in Patients With Language-Critical Gliomas. Neurosurgery. 2025 Oct 15. doi: 10.1227/neu.0000000000003792. Epub ahead of print. PMID: 41090910.
Haisraely O, Vedala S, Al-Sharfeen A, Manzar GS, Perni S, Tom MC, Beckham TH, Wang C, Yeboa DN, Chung C, McAleer MF, Ghia AJ, Ene CI, Weathers SP, McGovern SL, Wogan CF, Roth M, Li J, De B. Glioblastoma in young adult patients: contemporary patterns of care and survival in the United States. J Neurooncol. 2025 Oct;175(1):323-331. doi: 10.1007/s11060-025-05135-5. Epub 2025 Jul 15. PMID: 40663309.
Costa M, O'Leary S, Young CC, Kan P. Impact of Antivascular Endothelial Growth Factor Therapy in Chronic Subdural Hematoma Patients: A Propensity-Matched Multi-Institutional Cohort Study. Stroke Vasc Interv Neurol. 2026 Jan;6(1):e001871. doi: 10.1161/SVIN.125.001871. Epub 2025 Dec 16. PMID: 41503088; PMCID: PMC12771978.
Chen H, Ghia AJ, Maralani PJ, Bettegowda C, Boriani S, Dea N, Fisher CG, Gasbarrini A, Gokaslan ZL, Laufer I, Lazary A, Reynolds J, Verlaan JJ, Rhines LD, Sahgal A. Advanced Radiotherapy Technologies in Spine Tumors: What the Surgeon Needs to Know. Global Spine J. 2025 Jan;15(1_suppl):104S-119S. doi: 10.1177/21925682241229665. PMID: 39801121; PMCID: PMC11726527.
Townes T, Chang EI, Sewastjanow-Silva M, Yu P, Hanna EY, DeMonte F, Raza SM, Hanasono MM, Su SY. Microvascular Free Tissue Transfer for Reconstruction of Anterior Skull Base Defects. Head Neck. 2026 Apr;48(4):967-974. doi: 10.1002/hed.70091. Epub 2025 Nov 17. PMID: 41243802.
Viswanathan L, Moshiree B. Advances in Diagnostics for the Evaluation of Neurogastroenterology & Motility Disorders: Are They Ready for Prime Time? Curr Gastroenterol Rep. 2025 Jun 27;27(1):45. doi: 10.1007/s11894-025-00999-z. PMID: 40571832.
Bartolozzi AR, Barzilai O, Laufer I, Sahgal A, Rhines LD, Sciubba DM, Lazary A, Weber MH, Schuster JM, Boriani S, Bettegowda C, Arnold PM, Clarke MJ, Fehlings MG, Gokaslan ZL, Fisher CG, Bilsky M, Dea N. Impact of surgery and radiation on radicular pain and myotomic weakness in patients with metastatic spine disease. Neurosurg Focus. 2025 May 1;58(5):E14. doi: 10.3171/2025.2.FOCUS24915. PMID: 40311205.
Pahuta M, Laufer I, Lo SL, Boriani S, Fisher C, Dea N, Weber MH, Chou D, Sahgal A, Rhines L, Reynolds J, Lazary A, Gasbarrinni A, Verlaan JJ, Gokaslan Z, Bettegowda C, Sarraj M, Barzilai O; AO Spine Knowledge Forum Tumor. Defining Spine Cancer Pain Syndromes: A Systematic Review and Proposed Terminology. Global Spine J. 2025 Jan;15(1_suppl):81S-92S. doi: 10.1177/21925682241259686. PMID: 39801118; PMCID: PMC11726517.
Goodwin ML, Loomans JI, Barzilai O, Dea N, Gasbarrini A, Lazáry A, Netzer C, Reynolds J, Rhines L, Sahgal A, Verlaan JJ, Fisher CG, Laufer I, On Behalf Of Ao Spine Knowledge Forum Tumor. Frontline Voice: AO Spine Member Survey Regarding Spine Oncology Knowledge Generation and Translation Needs. Global Spine J. 2025 Jun;15(5):2754-2766. doi: 10.1177/21925682251314497. Epub 2025 Jan 27. PMID: 39868544; PMCID: PMC11773503.
Goodwin CR, De la Garza Ramos R, Bettegowda C, Barzilai O, Shreyaskumar P, Fehlings MG, Laufer I, Sahgal A, Rhines LD, Reynolds JJ, Lazary A, Gasbarrini A, Dea N, Verlaan JJ, Sullivan PZ, Gokaslan ZL, Fisher CG, Boriani S, Shin JH, Hornicek FJ, Weber MH, Goodwin ML, Charest-Morin R; AO Spine Knowledge Forum Tumor. Overview of Molecular Prognostication for Common Solid Tumor Histologies - What the Surgeon Should Know. Global Spine J. 2025 Jan;15(1_suppl):6S-15S. doi: 10.1177/21925682241250327. PMID: 39801124; PMCID: PMC11726510.
Call-Orellana F, Andrade de Almeida RA, Ramirez-Ferrer E, Zuluaga-Garcia JP, Gubbiotti MA, North RY. Malignant mimic: pulmonary actinomycosis with contiguous vertebral involvement and spinal cord compression. Illustrative case. J Neurosurg Case Lessons. 2025 Jun 16;9(24):CASE25175. doi: 10.3171/CASE25175. PMID: 40523344; PMCID: PMC12171095.
Sheen S, Hasan P, Sun X, Wang J, Tatsui C, Nouri K, Javed S. Retrospective Analysis of Cement Extravasation Rates in Vertebroplasty, Kyphoplasty, and Bone Tumor Radiofrequency Ablation. J Clin Med. 2025 Apr 23;14(9):2908. doi: 10.3390/jcm14092908. PMID: 40363941; PMCID: PMC12072942. Stitzlein LM, Nam D, Hernandez FA, Patel KH, Poche A, Ma H, Impelman K, Gumin J, Wang H, Wang J, Gadd S, Zaky W, Becher O, Dudley RW, Lang FF, Sareddy GR, Chandra J. Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastoma. Neurooncol Adv. 2025 Nov 20;7(1):vdaf246. doi: 10.1093/noajnl/vdaf246. PMID: 41497449; PMCID: PMC12768500.
Goodman CD, DeMonte F, Nguyen TP, Garden AS, Wang CH, Wang XA, Diao K, Lee A, Reddy J, Moreno A, Spiotto M, Fuller CD, Rosenthal D, Ferrarotto R, Raza SM, Su SY, Warner A, Hanna E, Phan J. A prospective cohort study on stereotactic radiotherapy in the management of dural recurrence of olfactory neuroblastoma. Head Neck. 2025 Jan;47(1):81-89. doi: 10.1002/hed.27887. Epub 2024 Jul 29. PMID: 39073252; PMCID: PMC11729999.
Tan SK, Bettegowda C, Yip S, Sahgal A, Rhines L, Reynolds J, Lazary A, Laufer I, Gasbarrini A, Dea N, Verlaan JJ, Gokaslan ZL, Fisher CG, Boriani S, Cecchinato R, Goodwin ML, Goodwin CR, Charest-Morin R. Liquid Biopsy for Spinal Tumors: On the Frontiers of Clinical Application. Global Spine J. 2025 Jan;15(1_suppl):16S-28S. doi: 10.1177/21925682231222012. PMID: 39801114; PMCID: PMC11726521.
Mohanam S, Chintala SK, Go Y, Bhattacharya A, Venkaiah B, Boyd D, Gokaslan ZL, Sawaya R, Rao JS. Retraction Note: In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene. 2025 May;44(17):1209. doi: 10.1038/s41388-025-03393-1. PMID: 40200097.
Faraj CA, McCutcheon IE, Schomer DF, Aldape K, Quezado M, Abdullaev Z, Gubbiotti MA. A case of a (not so) diffuse leptomeningeal glioneuronal tumor with an unusual clinical history. J Neuropathol Exp Neurol. 2025 Jan 1;84(1):87-90. doi: 10.1093/jnen/nlae087. PMID: 39088579; PMCID: PMC12090050. Cherian JJ, Ma JC, Morón FE, Viswanathan C. Charcot Spinal Arthropathy Secondary to Spinal Cord Injury - A Case Report. J Orthop Case Rep. 2025 Mar;15(3):140-145. doi: 10.13107/jocr.2025.v15.i03.5364. PMID: 40092268; PMCID: PMC11907159.
Ene CI, Silva E, Noll K, Bradshaw M, Connelly K, Liu HL, Tummala R, Ferson D, Lang FF, Kumar VA. Language mapping during awake brain surgery in a deaf patient with a brain tumor: illustrative case. J Neurosurg Case Lessons. 2025 May 5;9(18):CASE2597. doi: 10.3171/CASE2597. PMID: 40324327; PMCID: PMC12051994.
Gule-Monroe M, Chasen N, Long JP, Kumar VA, Shah K, Chen M, Stafford J, Chung C, Wintermark M, Hou P, Sura E, Wang C, Weinberg J, Liu HL. Diagnostic Confidence of Contrast-Enhanced T1-Weighted MRI for the Detection of Brain Metastases: 3D FSE versus 3D GRE-Based Sequences. AJNR Am J Neuroradiol. 2025 Jun 3;46(6):1231-1237. doi: 10.3174/ajnr.A8590. PMID: 39572196; PMCID: PMC12152807.
Amhaz HH, Abi Faraj C, Wu AS, Rao G, Gubbiotti MA, McCutcheon IE. Nuances in the surgical treatment of gangliocytomas of the spinal cord: illustrative cases. J Neurosurg Case Lessons. 2025 Oct 27;10(17):CASE2570. doi: 10.3171/CASE2570. PMID: 41144990; PMCID: PMC12558348. Noll KR, Bander ED, Chen HS, Bradshaw M, Wefel JS, Kumar VA, Prabhu SS, Liu HL. Changes in functional connectivity are associated with functional independence in the early postoperative period following awake surgical resection of language-eloquent glioma. Neurooncol Adv. 2025 Sep 2;7(1):vdaf192. doi: 10.1093/noajnl/vdaf192. PMID: 41019665; PMCID: PMC12461250.
Leary OP, Setty A, Gong JH, Ali R, Fridley JS, Fisher CG, Sahgal A, Rhines LD, Reynolds JJ, Lazáry Á, Laufer I, Gasbarrini A, Dea N, Verlaan JJ, Bettegowda C, Boriani S, Mesfin A, Luzzati A, Shin JH, Cecchinato R, Hornicek FJ, Goodwin ML, Gokaslan ZL. Prevention and Management of Posterior Wound Complications Following Oncologic Spine Surgery: Narrative Review of Available Evidence and Proposed Clinical Decision-Making Algorithm. Global Spine J. 2025 Jan;15(1_suppl):143S-156S. doi: 10.1177/21925682241237486. Erratum in: Global Spine J. 2025 Nov;15(8):3991. doi: 10.1177/21925682251343890. PMID: 39801119; PMCID: PMC11726526.
Perez-Chadid DA, Dange RM, Eyre HA, Fieggen G, Vaughan KA, Sheth SA, Abdullah JM, Shehu BB, Donoho D, Browd S, Ibanez A, Gupta S, Lang F, Nanda A, Rosseau G. The Neurosurgeon's Role in the Brain Economy: How Strategic Investment in Neurosurgical Care and Innovation Will Improve Global Outcomes. World Neurosurg. 2025 Oct;202:124357. doi: 10.1016/j.wneu.2025.124357. Epub 2025 Aug 6. PMID: 40774587.
Asman P, Tasnim I, Muir M, Hall M, Noll K, Prinsloo S, Pellizzer G, Bhavsar S, Tummala S, Ince N, Prabhu S. Intraoperative Cortical Sensorimotor Mapping During Glioma Resection Monitored With Drum Playing During Awake Craniotomy: A Case Report. Case Rep Oncol Med. 2025 Feb 25;2025:4625899. doi: 10.1155/crom/4625899. PMID: 40040926; PMCID: PMC11879599.
2024 Publications
Shanley M, Daher M, Dou J, Li S, Basar R, Rafei H, Dede M, Gumin J, PantaleόnGarcίa J, Nunez Cortes AK, He S, Jones CM, Acharya S, Fowlkes NW, Xiong D, SinghS, Shaim H, Hicks SC, Liu B, Jain A, Zaman MF, Miao Q, Li Y, Uprety N, Liu E,Muniz-Feliciano L, Deyter GM, Mohanty V, Zhang P, Evans SE, Shpall EJ, Lang FF,Chen K, Rezvani K. Interleukin-21 engineering enhances NK cell activity againstglioblastoma via CEBPD. Cancer Cell. 2024 Aug 12;42(8):1450-1466.e11. doi:10.1016/j.ccell.2024.07.007. PMID: 39137729; PMCID: PMC11370652.
Gupta P, Dang M, Oberai S, Migliozzi S, Trivedi R, Kumar G, Peshoff M, MilamN, Ahmed A, Bojja K, Tran TM, Gumin J, Kamiya-Matsuoka C, Huse J, Cox K, Li J,Shehwana H, Sheth SA, Saxon R, Baohua S, Parker Kerrigan B, Maheshwari A, ParraCuentas ER, Navin NE, Heimberger AB, Lang FF, Iavarone A, Clise-Dwyer K, Wang L,Bhat KP. Immune landscape of isocitrate dehydrogenase-stratified primary andrecurrent human gliomas. Neuro Oncol. 2024 Dec 5;26(12):2239-2255. doi:10.1093/neuonc/noae139. PMID: 39126294; PMCID: PMC11630528.
Fields EC, Bosch WR, Albuquerque KV, Bhatia R, Chino J, Dyer B, Erickson B,Fabian D, Gaffney D, Glaser S, Han K, Hathout L, Hsu IC, Jegadeesh N, Kahn J,Kidd E, Klopp A, Leung E, Lin L, Ludwig M, Ma T, Mell L, Mayadev J, Petersen I,Portelance L, Rash D, Taunk N, Viswanathan A, Wolfson A, Yashar C, Yeung A,Yoshida E, Fisher CM. Consensus Guidelines for Delineation of Clinical TargetVolumes for Intensity Modulated Radiation Therapy for Intact Cervical Cancer: AnUpdate. Pract Radiat Oncol. 2025 Mar-Apr;15(2):171-179. doi:10.1016/j.prro.2024.11.004. Epub 2024 Nov 13. PMID: 39547646; PMCID:PMC11954667.
Peshoff MM, Gupta P, Oberai S, Trivedi R, Katayama H, Chakrapani P, Dang M,Migliozzi S, Gumin J, Kadri DB, Lin JK, Milam NK, Maynard ME, Vaillant BD,Parker-Kerrigan B, Lang FF, Huse JT, Iavarone A, Wang L, Clise-Dwyer K, Bhat KP.Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosisin glioblastoma. Neuro Oncol. 2024 May 3;26(5):826-839. doi:10.1093/neuonc/noad257. PMID: 38237157; PMCID: PMC11066944.
Ene CI, Abi Faraj C, Beckham TH, Weinberg JS, Andersen CR, Haider AS, Rao G,Ferguson SD, Alvarez-Brenkenridge CA, Kim BYS, Heimberger AB, McCutcheon IE,Prabhu SS, Wang CM, Ghia AJ, McGovern SL, Chung C, McAleer MF, Tom MC, Perni S,Swanson TA, Yeboa DN, Briere TM, Huse JT, Fuller GN, Lang FF, Li J, Suki D,Sawaya RE. Response of treatment-naive brain metastases to stereotacticradiosurgery. Nat Commun. 2024 May 2;15(1):3728. doi:10.1038/s41467-024-47998-8. PMID: 38697991; PMCID: PMC11066027.
Lee D, Huntoon K, Wang Y, Kang M, Lu Y, Jeong SD, Link TM, Gallup TD, Qie Y,Li X, Dong S, Schrank BR, Grippin AJ, Antony A, Ha J, Chang M, An Y, Wang L,Jiang D, Li J, Koong AC, Tainer JA, Jiang W, Kim BYS. Synthetic cationic helicalpolypeptides for the stimulation of antitumour innate immune pathways inantigen-presenting cells. Nat Biomed Eng. 2024 May;8(5):593-610. doi:10.1038/s41551-024-01194-7. Epub 2024 Apr 19. PMID: 38641710; PMCID:PMC11162332.
Wang DH, Fujita Y, Dono A, Rodriguez Armendariz AG, Shah M, Putluri N,Pichardo-Rojas PS, Patel CB, Zhu JJ, Huse JT, Parker Kerrigan BC, Lang FF,Esquenazi Y, Ballester LY. The genomic alterations in glioblastoma influence thelevels of CSF metabolites. Acta Neuropathol Commun. 2024 Jan 19;12(1):13. doi:10.1186/s40478-024-01722-1. PMID: 38243318; PMCID: PMC10799404.
Pacult MA, Przybylowski CJ, Raza SM, DeMonte F. Surgical Management of High-Grade Meningiomas. Cancers (Basel). 2024 May 23;16(11):1978. doi:10.3390/cancers16111978. PMID: 38893100; PMCID: PMC11171173. 9: Young CC, Kan P, Chen SR, Lang FF. Endovascular surgical neuro-oncology:advancing a new subspecialty. J Neurooncol. 2024 Oct;170(1):31-40. doi:10.1007/s11060-024-04782-4. Epub 2024 Sep 2. PMID: 39222190.
Li Y, Uhelski ML, North RY, Mwirigi JM, Tatsui CE, McDonough KE, Cata JP,Corrales G, Dussor G, Price TJ, Dougherty PM. Tomivosertib reduces ectopicactivity in dorsal root ganglion neurons from patients with radiculopathy.Brain. 2024 Sep 3;147(9):2991-2997. doi: 10.1093/brain/awae178. PMID: 39046204;PMCID: PMC11370786.
Dionne A, Al-Zakri M, Labelle H, Joncas J, Parent S, Mac-Thiong JM, MiyanjiF, Lonner B, Eren A, Cahill P, Parent S, Newton P, Dermott JA, et al.Canadian Spine Society: 24th Annual Scientific Conference, Wednesday, February28 - Saturday, March 2, Fairmont Chateau Whistler, Whistler, B.C., Canada. Can JSurg. 2024 Nov 13;67(6suppl1):S17-S76. doi: 10.1503/cjs.011424. PMID: 39537311;PMCID: PMC11573431.
Ma Y, Dong S, Grippin AJ, Teng L, Lee AS, Kim BYS, Jiang W. Engineeringtherapeutical extracellular vesicles for clinical translation. TrendsBiotechnol. 2025 Jan;43(1):61-82. doi: 10.1016/j.tibtech.2024.08.007. Epub 2024Sep 2. PMID: 39227240; PMCID: PMC11717644.
Wang Y, Schrank BR, Jiang W, Kim BYS. Learning what keeps nanomedicines intumours. Nat Biomed Eng. 2024 Nov;8(11):1330-1331. doi:10.1038/s41551-024-01251-1. PMID: 39271934.
Banu MA, Raza SM, Amini M, Seaman S, Rubino F, Snyder R, Patel S, DeMonte F,Conley AP. The role of systemic therapy in advanced skull base chordomas:overview of the current state and the MD Anderson protocol. Neurosurg Focus.2024 May;56(5):E15. doi: 10.3171/2024.2.FOCUS2416. PMID: 38691867.
Garcia-Moure M, Laspidea V, Gupta S, Gillard AG, Khatua S, Parthasarathy A,He J, Lang FF, Fueyo J, Alonso MM, Gomez-Manzano C. The emerging field ofviroimmunotherapy for pediatric brain tumors. Neuro Oncol. 2024 Nov4;26(11):1981-1993. doi: 10.1093/neuonc/noae160. PMID: 39148489; PMCID:PMC11534321.
Bhoopathi P, Mannangatti P, Pradhan AK, Kumar A, Maji S, Lang FF, KlibanovAL, Madan E, Cavenee WK, Keoprasert T, Sun D, Bjerkvig R, Thorsen F, Gogna R,Das SK, Emdad L, Fisher PB. Noninvasive therapy of brain cancer using a uniquesystemic delivery methodology with a cancer terminator virus. J Cell Physiol.2024 Aug;239(8):e31302. doi: 10.1002/jcp.31302. Epub 2024 May 22. PMID:38775127.
Gardner PA, Froelich S, Gokaslan ZL, MacDonald SM, Peris Celda M, Raza SM,Zenonos GA. Introduction. Chordoma: updates and advances. Neurosurg Focus. 2024May;56(5):E1. doi: 10.3171/2024.3.FOCUS23735. PMID: 38691861.
Zhang H, Grippin A, Sun M, Ma Y, Kim BYS, Teng L, Jiang W, Yang Z. Newavenues for cancer immunotherapy: Cell-mediated drug delivery systems. J ControlRelease. 2024 Nov;375:712-732. doi: 10.1016/j.jconrel.2024.09.037. Epub 2024 Sep27. PMID: 39326499.
Lam K, Kamiya-Matsuoka C, Slopis JM, McCutcheon IE, Majd NK. TherapeuticStrategies for Gliomas Associated With Cancer Predisposition Syndromes. JCOPrecis Oncol. 2024 Feb;8:e2300442. doi: 10.1200/PO.23.00442. PMID: 38394467.
Ledbetter D, de Almeida RAA, Wu X, Naveh A, Patel CB, Gonzalez Q, BeckhamTH, North R, Rhines L, Li J, Ghia A, Aten D, Tatsui C, Alvarez-Breckenridge C.Tumor treating fields suppress tumor cell growth and neurologic decline inmodels of spinal metastases. JCI Insight. 2024 Mar 21;9(9):e176962. doi:10.1172/jci.insight.176962. PMID: 38512420; PMCID: PMC11141916.
Jaffray DA, Coppes RP, McNair H, Viswanathan A. Pursuing New Horizons WithNew Collaborators: This Is the Future of Radiation Oncology. Semin Radiat Oncol.2024 Oct;34(4):367-369. doi: 10.1016/j.semradonc.2024.08.002. PMID: 39271271.
Alvarez-Breckenridge C, Brastianos PK, Cahill DP. Thrombosis, brainmetastasis formation, and the perivascular metastatic niche-Novel insights fromthe tumor microvascular circulation. Neuro Oncol. 2024 Nov 4;26(11):2100-2101.doi: 10.1093/neuonc/noae168. PMID: 39207022; PMCID: PMC11534314.
Price A, Fredricks N, Truong N, North RY. Pediatric thoracic outletsyndrome: a systematic review and meta-analysis. J Neurosurg Pediatr. 2024 Mar1;33(5):484-495. doi: 10.3171/2024.2.PEDS23511. PMID: 38428008.
Tom MC, Komatineni S, Wang C, de Almeida RAA, Ghia AJ, Beckham TH, Perni S,McAleer MF, Swanson T, Yeboa DN, De BS, Rooney MK, Bishop AJ, Reddy JP, Yang Y,Ludmir EB, Zhang S, Amini B, Alvarez-Breckenridge C, North RY, Rhines LD, Li J,Tatsui CE. Spinal laser interstitial thermal therapy and radiotherapy forthoracic metastatic epidural spinal cord compression. J Neurooncol. 2024Nov;170(2):289-296. doi: 10.1007/s11060-024-04777-1. Epub 2024 Sep 26. PMID:39325339.
Carpentier A, Stupp R, Sonabend AM, Dufour H, Chinot O, Mathon B, Ducray F,Guyotat J, Baize N, Menei P, de Groot J, Weinberg JS, Liu BP, Guemas E, DesseauxC, Schmitt C, Bouchoux G, Canney M, Idbaih A. Repeated blood-brain barrieropening with a nine-emitter implantable ultrasound device in combination withcarboplatin in recurrent glioblastoma: a phase I/II clinical trial. Nat Commun.2024 Feb 23;15(1):1650. doi: 10.1038/s41467-024-45818-7. PMID: 38396134; PMCID:PMC10891097.
Sacino AN, Chen H, Sahgal A, Bettegowda C, Rhines LD, Maralani P, RedmondKJ. Stereotactic body radiation therapy for spinal metastases: A new standard ofcare. Neuro Oncol. 2024 Mar 4;26(12 Suppl 2):S76-S87. doi:10.1093/neuonc/noad225. PMID: 38437670; PMCID: PMC10911798.
Wang C, Rooney MK, Alvarez-Breckenridge C, Beckham TH, Chung C, De BS, GhiaAJ, Grosshans D, Majd NK, McAleer MF, McGovern SL, North RY, Paulino AC, PerniS, Reddy JP, Rhines LD, Swanson TA, Tatsui CE, Tom MC, Yeboa DN, Li J. Outcomesand Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era-APopulation-Based Observational Study. Cancers (Basel). 2024 May 25;16(11):2013.doi: 10.3390/cancers16112013. PMID: 38893133; PMCID: PMC11171081.
Humphries W, Wang Y, Qiao W, Reina-Ortiz C, Abou-Ghazal MK, Crutcher LM, WeiJ, Kong LY, Sawaya R, Rao G, Weinberg J, Prabhu SS, Fuller GN, Heimberger AB.Correction: Detecting the percent of peripheral blood mononuclear cellsdisplaying p-STAT-3 in malignant glioma patients. J Transl Med. 2024 Mar21;22(1):296. doi: 10.1186/s12967-024-05093-y. Erratum for: J Transl Med. 2009Nov 09;7:92. doi: 10.1186/1479-5876-7-92. PMID: 38515188; PMCID: PMC10958894.
Teo JM, Kumar VA, Lee J, Eldaya RW, Hou P, Jen ML, Noll KR, Wei P, FergusonSD, Prabhu SS, Wintermark M, Liu HL. Probabilistic Presurgical Language fMRIAtlas of Patients with Brain Tumors. AJNR Am J Neuroradiol. 2024 Nov7;45(11):1798-1804. doi: 10.3174/ajnr.A8383. PMID: 38889968; PMCID: PMC11543082.
Bian X, Yang L, Jiang D, Grippin AJ, Ma Y, Wu S, Wu L, Wang X, Tang Z, TangK, Pan W, Dong S, Kim BYS, Jiang W, Yang Z, Li C. Regulation of cerebral bloodflow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoidnanoparticles. Nat Commun. 2024 May 11;15(1):3987. doi:10.1038/s41467-024-48461-4. PMID: 38734698; PMCID: PMC11088666.
de Almeida RAA, Ghia AJ, Amini B, Wang C, Alvarez-Breckenridge CA, Li J,Rhines LD, Tom MC, North RY, Beckham TH, Tatsui CE. Quantification of MRI Artifacts in Carbon Fiber Reinforced Polyetheretherketone Thoracolumbar PedicleScrew Constructs prior to Spinal Stereotactic Radiosurgery. Pract Radiat Oncol.2024 Mar-Apr;14(2):103-111. doi: 10.1016/j.prro.2023.10.005. Epub 2023 Oct 31.PMID: 37914081.
Beckham TH, Rooney MK, McAleer MF, Ghia AJ, Tom MC, Perni S, McGovern S,Grosshans D, Chung C, Wang C, De B, Swanson T, Paulino A, Jiang W, Ferguson S,Patel CB, Li J, Yeboa DN. Hypofractionated radiotherapy for glioblastoma: Alarge institutional retrospective assessment of 2 approaches. Neurooncol Pract.2024 Jan 18;11(3):266-274. doi: 10.1093/nop/npae004. PMID: 38737610; PMCID:PMC11085842.
Ramesh U, Contrera KJ, Shakibai N, Su SY, Brahimaj B, Roberts D, WilliamsMD, Ferrarotto R, Phan J, Gunn GB, Raza S, DeMonte F, Hanna EY. Sinonasal NUTcarcinoma: A consecutive case series and systematic review. Head Neck. 2024Jan;46(1):29-36. doi: 10.1002/hed.27553. Epub 2023 Oct 18. PMID: 37853958.
Li Y, Uhelski ML, North RY, Farson LB, Bankston CB, Roland GH, Fan DH,Sheffield KN, Jia A, Orlando D, Heles M, Yaksh TL, Miller YI, Kosten TA,Dougherty PM. ApoA-I binding protein (AIBP) regulates transient receptorpotential vanilloid 1 (TRPV1) activity in rat dorsal root ganglion neurons byselective disruption of toll-like receptor 4 (TLR4)-lipid rafts. Brain BehavImmun. 2025 Jan;123:644-655. doi: 10.1016/j.bbi.2024.10.017. Epub 2024 Oct 14.PMID: 39414176.
Wang Y, Deng W, Lee D, Yan L, Lu Y, Dong S, Huntoon K, Antony A, Li X, Ye R,Zhao Y, Zhao F, Schrank BR, Ha J, Kang M, Yang M, Gong P, Lorenzi PL, Tan L,Gallup TD, Tang SK, Yang Z, Li J, Sanford NN, Wang H, Kim BYS, Jiang W. Age-associated disparity in phagocytic clearance affects the efficacy of cancernanotherapeutics. Nat Nanotechnol. 2024 Feb;19(2):255-263. doi:10.1038/s41565-023-01502-3. Epub 2023 Sep 18. PMID: 37723279; PMCID:PMC12289334.
Beckham TH, Rooney MK, Cifter G, Bernard V, McAleer MF, De BS, Tom MC, PerniS, Wang C, Swanson T, Tatsui CE, Alvarez-Breckenridge C, North R, Rhines LD,Tang C, Logothetis C, Amini B, Li J, Yeboa DN, Ghia AJ. Stereotacticradiosurgery for prostate cancer spine metastases: local control and fracturerisk using a simultaneous integrated boost approach. J Neurosurg Spine. 2024 Jun14;41(3):436-444. doi: 10.3171/2024.3.SPINE24157. PMID: 38875722.
Saberian C, Milton DR, Simon J, Amaria RN, Diab A, McQuade J, Patel SP,Tawbi H, Yee C, Wong MK, McCutcheon IE, Davies MA, Ferguson SD, Glitza Oliva IC.Survival and treatment outcomes in patients with leptomeningeal disease frommetastatic melanoma. Neurooncol Pract. 2024 Mar 30;11(4):452-463. doi:10.1093/nop/npae026. PMID: 39006528; PMCID: PMC11241361.
Price A, File C, Call-Orellana F, Andrade de Almeida RA, North RY. Surgicaldecompression in spinal Paget's disease: illustrative case. J Neurosurg CaseLessons. 2024 Jul 22;8(4):CASE24203. doi: 10.3171/CASE24203. PMID: 39038367;PMCID: PMC11284652.
Barzilai O, Sahgal A, Rhines LD, Versteeg AL, Sciubba DM, Lazary A, WeberMH, Schuster JM, Boriani S, Bettegowda C, Arnold PM, Clarke MJ, Laufer I,Fehlings MG, Gokaslan ZL, Fisher CG; AO Spine Knowledge Forum Tumor. Patient-Reported and Clinical Outcomes of Surgically Treated Patients With SymptomaticSpinal Metastases: Results From Epidemiology, Process, and Outcomes of SpineOncology (EPOSO), a Prospective, Multi-Institutional and International Study.Neurosurgery. 2024 Nov 1;95(5):1148-1157. doi: 10.1227/neu.0000000000002989.Epub 2024 Jun 4. PMID: 38832791; PMCID: PMC11449425.
Tomczak K, Patel MS, Bhalla AD, Peterson CB, Landers SM, Callahan SC, ZhangD, Wong J, Landry JP, Lazar AJ, Livingston JA, Guadagnolo BA, Lyu HG, LillemoeH, Roland CL, Keung EZ, Scally CP, Hunt KK, McCutcheon IE, Slopis JM, Gu J,Scheet P, Wang L, Rai K, Torres KE. Plasma DNA Methylation-Based Biomarkers forMPNST Detection in Patients With Neurofibromatosis Type 1. Mol Carcinog. 2025Jan;64(1):44-56. doi: 10.1002/mc.23825. Epub 2024 Nov 26. Erratum in: MolCarcinog. 2025 May;64(5):953. doi: 10.1002/mc.23890. PMID: 39600120; PMCID:PMC11636586.
Sun L, Niu H, Wu Y, Dong S, Li X, Kim BYS, Liu C, Ma Y, Jiang W, Yuan Y.Bio-integrated scaffold facilitates large bone regeneration dominated byendochondral ossification. Bioact Mater. 2024 Feb 2;35:208-227. doi:10.1016/j.bioactmat.2024.01.019. PMID: 38327823; PMCID: PMC10847751.
Lee J, Kumar VA, Teo JM, Eldaya RW, Hou P, Noll KR, Ferguson SD, Prabhu SS,Liu HL. Comparative analysis of brain language templates with primary languageareas detected from presurgical fMRI of brain tumor patients. Brain Behav. 2024Jun;14(6):e3497. doi: 10.1002/brb3.3497. PMID: 38898620; PMCID: PMC11186848.
Shanker MD, Cavazos AP, Li J, Beckham TH, Yeboa DN, Wang C, McAleer MF,Briere TM, Amini B, Tatsui CE, North RY, Alvarez-Breckenridge CA, Cezayirli PC,Rhines LD, Ghia AJ, Bishop AJ. Definitive single fraction spine stereotacticradiosurgery for metastatic sarcoma: Simultaneous integrated boost is associatedwith high tumor control and low vertebral fracture risk. Radiother Oncol. 2024Apr;193:110119. doi: 10.1016/j.radonc.2024.110119. Epub 2024 Feb 3. PMID:38311030.
Huntoon KM, Gasco J, Glitza Oliva IC, Ferguson SD, Majd NK, McCutcheon IE.Ventriculoperitoneal shunting with an on-off valve for patients withleptomeningeal metastases and intracranial hypertension. Neurooncol Pract. 2023Sep 2;11(1):56-63. doi: 10.1093/nop/npad056. PMID: 38222058; PMCID: PMC10785578.
Li X, Huntoon K, Wang Y, Lee D, Dong S, Antony A, Walkey C, Kim BYS, JiangW. Radiation Synergizes with IL2/IL15 Stimulation to Enhance Innate ImmuneActivation and Antitumor Immunity. Mol Cancer Ther. 2024 Mar 4;23(3):330-342.doi: 10.1158/1535-7163.MCT-23-0236. PMID: 37956421.
Snyder R, Rubino F, Seaman S, Banu M, Su SY, Hanna EY, DeMonte F, Raza SM.Impact of Previous Surgery and/or Radiation Therapy on Endoscopic ReconstructionOutcomes. Oper Neurosurg. 2025 Apr 1;28(4):496-505. doi:10.1227/ons.0000000000001318. Epub 2024 Aug 26. PMID: 39185868.
Ha J, Grippin AJ, Kim BYS, Jiang W. Striking the Balance with a PD-L1×4-1BBBispecific Antibody. Cancer Res. 2024 May 15;84(10):1546-1547. doi:10.1158/0008-5472.CAN-24-0566. PMID: 38745496.
Nayyar N, de Sauvage MA, Chuprin J, Sullivan EM, Singh M, Torrini C, ZhangBS, Bandyopadhyay S, Daniels KA, Alvarez-Breckenridge C, Dahal A, Brehm MA,Brastianos PK. CDK4/6 Inhibition Sensitizes Intracranial Tumors to PD-1 Blockadein Preclinical Models of Brain Metastasis. Clin Cancer Res. 2024 Jan17;30(2):420-435. doi: 10.1158/1078-0432.CCR-23-0433. PMID: 37611074; PMCID:PMC10872577.
Shah JP, Levyn H, Valero C, Adilbay D, Eagan A, Zheng J, Gonen M, Cohen M,Patel S, Ganly I, Pai P, Castelnuovo P, Gao FJ, Piazza C, Nicolai P, Panizza B,Bowman J, Barnett C, Kowalski LP, Toledo R, Fliss DM, DeAlmeida J, Witterick I,Herman P, Fontanella W, Aniceto GS, Hosal S, Ozer S, Iyer S, Harvey R, LeemansCR, Hendrickx JJ, Figari M, Boccalatte L, Nibu KI, Clarke P, Rennie C, Ming ZY,Cernea C, Goncalves S, Schlosser R, Dias F, Sargi Z, Ahmed S, Golusinski W, KimSH, Su SY, Raza SM, DeMonte F, Hanna E. Skull base surgery for malignant tumors:The 2nd international collaborative study (1995-2015). Head Neck. 2024Nov;46(11):2762-2775. doi: 10.1002/hed.27746. Epub 2024 May 21. PMID: 38770972;PMCID: PMC11473241.
Maksimovic S, Boscolo NC, La Posta L, Barrios S, Moussa MJ, Gentile E,Pesquera PI, Li W, Chen J, Gomez JA, Basi A, Burks JK, Alvarez-Breckenridge C,Gao J, Campbell MT, Dondossola E. Antiangiogenic Tyrosine Kinase Inhibitors haveDifferential Efficacy in Clear Cell Renal Cell Carcinoma in Bone. Cancer ResCommun. 2024 Oct 1;4(10):2621-2637. doi: 10.1158/2767-9764.CRC-24-0304. PMID:39248577; PMCID: PMC11459607.
McDonald MF, Hossain A, Momin EN, Hasan I, Singh S, Adachi S, Gumin J,Ledbetter D, Yang J, Long L, Daou M, Gopakumar S, Phillips LM, Parker KerriganB, Lang FF. Tumor-specific polycistronic miRNA delivered by engineered exosomesfor the treatment of glioblastoma. Neuro Oncol. 2024 Feb 2;26(2):236-250. doi:10.1093/neuonc/noad199. PMID: 37847405; PMCID: PMC10836765.
Smalley I, Boire A, Brastianos P, Kluger HM, Hernando-Monge E, Forsyth PA,Ahmed KA, Smalley KSM, Ferguson S, Davies MA, Glitza Oliva IC. Leptomeningealdisease in melanoma: An update on the developments in pathophysiology and clinical care. Pigment Cell Melanoma Res. 2024 Jan;37(1):51-67. doi:10.1111/pcmr.13116. Epub 2023 Aug 25. PMID: 37622466; PMCID: PMC12292448.
Brahimaj BC, Contrera KJ, Rubino F, Almeida RA, Ferrarotto R, Phan J, Su SY,Hanna EY, DeMonte F, Raza SM. Induction Chemotherapy for Sinonasal Tumors inPatients Presenting with Brain Invasion and/or Neurological Deficits. J NeurolSurg B Skull Base. 2023 Sep 25;85(6):650-658. doi: 10.1055/s-0043-1774792. PMID:39483161; PMCID: PMC11524726.
Sandberg DI, Yu B. Direct Administration of Chemotherapy and Other Agentsinto the Fourth Ventricle to Treat Recurrent Malignant Brain Tumors in Children.Adv Tech Stand Neurosurg. 2024;53:119-137. doi: 10.1007/978-3-031-67077-0_8.PMID: 39287806.
Sarantopoulos A, Ene C, Aquilanti E. Therapeutic approaches to modulate theimmune microenvironment in gliomas. NPJ Precis Oncol. 2024 Oct 23;8(1):241. doi:10.1038/s41698-024-00717-4. PMID: 39443641; PMCID: PMC11500177.
Parney IF, Warnick RE, Lang FF, Rutka JT, Kalkanis S, Glick R, Rosenblum ML,Germano IM. The AANS/CNS Section on Tumors: a summary of 40 years of advocacy toadvance the care of patients with brain and spine tumors. J Neurosurg. 2024 Jan26;141(1):41-47. doi: 10.3171/2023.12.JNS232781. PMID: 38277647.
Rubino F, Brahimaj B, Hanna EY, Su SY, Phan J, Grosshans DR, DeMonte F, RazaSM. Does Time to Initiation of Adjuvant Radiotherapy Affect ReconstructionOutcomes after Endoscopic Resection of Skull Base Malignancies? J Neurol Surg BSkull Base. 2023 Jul 28;85(5):445-457. doi: 10.1055/a-2114-4563. PMID: 39228888;PMCID: PMC11368463.
Glitza Oliva IC, Ferguson SD, Bassett R Jr, Foster AP, John I, Hennegan TD,Rohlfs M, Richard J, Iqbal M, Dett T, Lacey C, Jackson N, Rodgers T, Phillips S,Duncan S, Haydu L, Lin R, Amaria RN, Wong MK, Diab A, Yee C, Patel SP, McQuadeJL, Fischer GM, McCutcheon IE, O'Brien BJ, Tummala S, Debnam M, Guha-Thakurta N,Wargo JA, Carapeto FCL, Hudgens CW, Huse JT, Tetzlaff MT, Burton EM, Tawbi HA,Davies MA. Author Correction: Concurrent intrathecal and intravenous nivolumabin leptomeningeal disease: phase 1 trial interim results. Nat Med. 2024Jun;30(6):1787. doi: 10.1038/s41591-024-02998-5. Erratum for: Nat Med. 2023Apr;29(4):898-905. doi: 10.1038/s41591-022-02170-x. PMID: 38649781; PMCID:PMC11186776.
Al Farii H, McChesney G, Patel SS, Rhines LD, Lewis VO, Bird JE. The risk ofneurological deterioration while using neoadjuvant denosumab on patients withgiant cell tumor of the spine presenting with epidural disease: a meta-analysisof the literature. Spine J. 2024 Jun;24(6):1056-1064. doi:10.1016/j.spinee.2024.01.016. Epub 2024 Jan 30. PMID: 38301904.
Ledbetter D, Gumin J, Phillips L, Ene C, Shimizu Y, Lang FF. FacilitatingRepeat Intracarotid Injections in Mouse Models by a Novel Injection Site RepairTechnique. J Vis Exp. 2024 Mar 15;(205). doi: 10.3791/66303. PMID: 38557500.
Catalino MP, Noll KR, Wefel JS, Michener H, Prinsloo S, Tummala S, Prabhu S.Decoding the clinical effects of low-grade glioma-induced cortical excitability.J Neurosurg. 2023 Jul 7;140(1):18-26. doi: 10.3171/2023.5.JNS23747. PMID:37439490.
Srinivasan VM, Garcia RL, Shekhtman O, Robledo A, Lazaro T, Rao A, O'LearyS, Husain A, Covell MM, Phillips M, Cooper P, Duncan RF, Bolanos O, Colasurdo M,Edhayan G, Chen SR, Fahed R, Kan P. Preclinical Direct Endoluminal Assessment ofEndothelialization After Flow Diversion With Microangioscopy. Stroke Vasc IntervNeurol. 2024 Jul 7;4(5):e001340. doi: 10.1161/SVIN.124.001340. PMID: 41586275;PMCID: PMC12778556.
Shin DH, Jiang H, Gillard AG, Kim D, Fan X, Singh SK, Nguyen TT, Sohoni SS,Lopez-Rivas AR, Parthasarathy A, Ene CI, Gumin J, Lang FF, Alonso MM, Gomez-Manzano C, Fueyo J. Chimeric oncolytic adenovirus evades neutralizing antibodiesfrom human patients and exhibits enhanced anti-glioma efficacy in immunizedmice. Mol Ther. 2024 Mar 6;32(3):722-733. doi: 10.1016/j.ymthe.2024.01.035. Epub2024 Feb 3. PMID: 38311852; PMCID: PMC10928285.
Chiang VL, Pugazenthi S, Leidig WA, Rodriguez A, Prabhu S, Haskell-MendozaAP, Fecci PE, Placantonakis DG, Abram SR, Lega B, Kim AH. Laser interstitialthermal therapy for new and recurrent meningioma: a prospective andretrospective case series. J Neurosurg. 2024 Mar 8;141(3):642-652. doi:10.3171/2023.12.JNS231542. PMID: 38457795.
Lovin BD, Nader ME, Qing Y, Hernandez M, Raza S, DeMonte F, Gidley PW.Losartan May Not Prevent Vestibular Schwannoma Growth or Related Hearing LossDuring Observation. Otol Neurotol. 2024 Jul 1;45(6):690-695. doi:10.1097/MAO.0000000000004214. PMID: 38865728; PMCID: PMC11178252.
Huntoon KM, Mayer RR, Fahim DK, Kumar S, Adelman DM, McCutcheon IE.Malignant primary tumors of scalp with cranial extension: multidisciplinarysurgical strategies and outcomes. J Neurosurg. 2023 Sep 29;140(4):979-986. doi:10.3171/2023.7.JNS23974. PMID: 37877964.
Ozkizilkaya HI, Vinocha A, Dono A, Ogunbona OB, Toruner GA, Aung PP, Kamiya Matsuoka C, Esquenazi Y, DeMonte F, Ballester LY. MTAP and p16 IHC as Markersfor CDKN2A/B Loss in Meningiomas. Cancers (Basel). 2024 Sep 27;16(19):3299. doi:10.3390/cancers16193299. PMID: 39409918; PMCID: PMC11476088.
Ameri M, Whyte AT, Raza SM, Gombos DS, Al-Zubidi N. Spontaneous Debulking ofa Large Skull Base Mass. J Neuroophthalmol. 2024 Dec 1;44(4):e573-e574. doi:10.1097/WNO.0000000000002022. Epub 2023 Oct 27. PMID: 37889587.
Schur S, Hanna EY, Su SY, Kupferman ME, DeMonte F, Raza SM. Long-termoncological outcomes for endoscopic endonasal versus open surgical approachesfor anatomically matched, locally advanced stage T4 sinonasal malignancies withskull base involvement. J Neurosurg. 2023 Sep 22;140(3):688-695. doi:10.3171/2023.7.JNS23786. PMID: 37877981.
Dasgupta P, McCutcheon IE, Slopis JM. A Massive Thoracic Meningocele in aPatient with NF1. Can J Neurol Sci. 2024 Oct 3:1. doi: 10.1017/cjn.2024.293.Epub ahead of print. PMID: 39358987.
Florez MA, De B, Kowalchuk R, Tang C, Bishop AJ, Kouzy R, Amini B, Briere T,Beckham TH, Wang C, Li J, Tatsui CE, Rhines LD, Brown PD, Merrell K, Ghia AJ.Validation of the prognostic index for spine metastasis (PRISM) for stratifyingsurvival in patients treated with spinal stereotactic body radiation. RadiotherOncol. 2024 Dec;201:110570. doi: 10.1016/j.radonc.2024.110570. Epub 2024 Oct 2.PMID: 39362605.
Yang W, Lee RP, Hung AL, Young CC, Sattari SA, Urrutia V, Gailloud PE, Xu R,Caplan J, Gonzalez LF. Cost-Effectiveness of a Direct-Aspiration First-PassTechnique versus Stent Retriever in Mechanical Thrombectomy. World Neurosurg.2024 Mar;183:e495-e501. doi: 10.1016/j.wneu.2023.12.129. Epub 2023 Dec 28. PMID:38159607.
Mikula AL, Rhines LD, Patel SS, Pennington Z, Karim SM, Morris JM, Tappa K,Alvarez-Breckenridge C, North RY, Tatsui CE, Rose PS, Clarke MJ, Bird JE.Utility of 3D-Printed Models in the Surgical Planning for Primary Spine Tumors:A Survey of International Spinal Oncology Experts. Global Spine J. 2025May;15(4):2004-2013. doi: 10.1177/21925682241278323. Epub 2024 Aug 21. PMID:39166967; PMCID: PMC11571598.
Simoni AD, Bird JE, Lin PP, Rhines LD, Mericli AF. Computer-Aided Design andManufacturing to Facilitate Microvascular Free Tissue Transfer in Extremity,Pelvic, and Spinal Reconstructions. J Reconstr Microsurg. 2025Jun;41(5):432-442. doi: 10.1055/a-2404-7819. Epub 2024 Aug 27. PMID: 39191420.
Price A, North R. Both ends of the scalpel: a child's journey from "Nemofin" to neurosurgeon. J Neurosurg Pediatr. 2024 Feb 23;33(6):626-629. doi:10.3171/2024.1.PEDS23515. PMID: 38394658.
Kan P, Srinivasan VM, Gumin J, Garcia R, Chen SR, Johnson JN, Collins DE,Chen MM, Ledbetter D, Huse J, Evan Luna ZA, Robledo A, Vasandani V, Rao A, SinghSK, Shpall EJ, Fueyo J, Gomez-Manzano C, Lang FF. Development of a rabbit humanglioblastoma model for testing of endovascular selective intra-arterial infusion(ESIA) of novel stem cell-based therapeutics. Neuro Oncol. 2024 Jan5;26(1):127-136. doi: 10.1093/neuonc/noad152. PMID: 37603323; PMCID:PMC10768973.
Price A, Fredricks N, Bartman M, D'Souza P, Hayworth M, Campbell G, Kan P,Lall R. Thoracic aneurysmal bone cyst secondary to osteoblastoma: uniquesurgical management. Illustrative case. J Neurosurg Case Lessons. 2024 Nov18;8(21):CASE24471. doi: 10.3171/CASE24471. PMID: 39556816; PMCID: PMC11579909.
Ye AL, Tummala S, Shah S, Tummala R, North RY, Zein M. Chronic shoulder paindue to spinal accessory nerve palsies present opportunities for improved careintegration. Pain Manag. 2024;14(7):347-353. doi: 10.1080/17581869.2024.2400992.Epub 2024 Sep 13. PMID: 39269163; PMCID: PMC11486136.
Noll KR, Asman P, Tasnim I, Hall M, Connelly K, Swamy C, Ene C, Tummala S,Grasu RM, Liu HL, Kumar VA, Muir M, Prinsloo S, Michener H, Wefel JS, Ince NF,Prabhu SS. Intraoperative language mapping guided by real-time visualization of gamma band modulation electrocorticograms: Case report and proof of concept.Neurooncol Pract. 2023 Sep 18;11(1):92-100. doi: 10.1093/nop/npad059. PMID:38222047; PMCID: PMC10785572.
Jones AK, Ahmad M, Raza SM, Chen SR, Siewerdsen JH. Cone-beam CT with anoncircular (sine-on-sphere) orbit: imaging performance of a clinical system forimage-guided interventions. J Med Imaging (Bellingham). 2024 Jul;11(4):043503.doi: 10.1117/1.JMI.11.4.043503. Epub 2024 Aug 22. PMID: 39185476; PMCID:PMC11342057.
Faraj CA, McCutcheon IE, Gubbiotti MA. PIT-1/SF-1 co-expression in pituitaryneuroendocrine tumors (PitNETs) with comprehensive review of the literature: Howshould we best characterize these neoplasms? Ann Diagn Pathol. 2025Feb;74:152398. doi: 10.1016/j.anndiagpath.2024.152398. Epub 2024 Nov 9. PMID:39549524.
Kumar VA, Perez A, Young AL, Jones J, O'Brien BJ, Lang FF, Huse JT, FullerGN. Collision tumor: Multinodular and vacuolating neuronal tumor with isocitratedehydrogenase-mutant diffuse astrocytoma. Neuropathology. 2024Oct;44(5):333-337. doi: 10.1111/neup.12968. Epub 2024 Feb 27. PMID: 38414131.
Ladbury C, Sueyoshi MH, Brovold NM, Kumar R, Andraos TY, Gogineni E, Kim M,Klopp A, Albuquerque K, Kunos C, Leung E, Mantz C, Biswas T, Beriwal S, Small WJr, Erickson B, Gaffney D, Lo SS, Viswanathan AN. Stereotactic Body RadiationTherapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society PracticeReview. Pract Radiat Oncol. 2024 May-Jun;14(3):252-266. doi:10.1016/j.prro.2023.09.008. Epub 2023 Oct 22. PMID: 37875223.
Chakraborty S, Wei D, Tran M, Lang FF, Newman RA, Yang P. PBI-05204, asupercritical CO2 extract of Nerium oleander, suppresses glioblastomastem cells by inhibiting GRP78 and inducing programmed necroptotic cell death.Neoplasia. 2024 Aug;54:101008. doi: 10.1016/j.neo.2024.101008. Epub 2024 May 31.PMID: 38823209; PMCID: PMC11177059.
Andrade de Almeida RA, Call-Orellana F, Young CC, Rubino F, Thrower SL, ChenSR, North RY. Hybrid open-endovascular onyx embolization of spinal type IVbperimedullary spinal arteriovenous fistula through direct posterior spinal veinaccess: A case report. Surg Neurol Int. 2024 Sep 27;15:343. doi:10.25259/SNI_384_2024. PMID: 39373004; PMCID: PMC11450883.
Arjuna S, Shah M, Dono A, Nunez-Rubiano L, Pichardo-Rojas PS, Zhu JJ,Riascos RF, Luthra R, Roy-Chowdhuri S, Duose D, Wang DH, Lang FF, Esquenazi Y,Ballester LY. Rapid detection of mutations in CSF-cfTNA with the GenexusIntegrated Sequencer. J Neurooncol. 2024 Jan;166(1):39-49. doi:10.1007/s11060-023-04487-0. Epub 2023 Dec 30. PMID: 38160230; PMCID:PMC11264431.
Reynolds JJ, Charest-Morin R, Versteeg AL, Galgano M, Lubelski D, Newman WC,Patel SS, Sullivan PLZ, Dea N, Gasbarrini A, Lazary A, Rhines LD, Sahgal A,Verlaan JJ, Fisher CG, Laufer I. Streamlining the Journey of Research IntoClinical Practice: Making Your Patients and Practice Flourish Understanding andSetting Treatment Expectations for Patients With Metastatic Spine Tumors. GlobalSpine J. 2024 Sep;14(7):1880-1888. doi: 10.1177/21925682241264406. Epub 2024 Jul25. PMID: 39052928; PMCID: PMC11418664.
Leong VWS, Khan S, Sharma P, Wu S, Thomas RR, Li X, Singh SK, Lang FF, YungAWK, Koul D. MGMT function determines the differential response of ATRinhibitors with DNA-damaging agents in glioma stem cells for GBM therapy.Neurooncol Adv. 2023 Dec 19;6(1):vdad165. doi: 10.1093/noajnl/vdad165. PMID:38213834; PMCID: PMC10783493.
Katlowitz KA, Beckham TH, Kudchadker RJ, Wefel J, Elamin YY, Weinberg JS. ANovel Multimodal Approach to Refractory Brain Metastases: A Case Report. AdvRadiat Oncol. 2023 Aug 15;9(2):101349. doi: 10.1016/j.adro.2023.101349. PMID:38405307; PMCID: PMC10885573.
Goodman CD, DeMonte F, Nguyen TP, Garden AS, Wang CH, Wang XA, Diao K, LeeA, Reddy J, Moreno A, Spiotto M, Fuller CD, Rosenthal D, Ferrarotto R, Raza SM,Su SY, Warner A, Hanna E, Phan J. A prospective cohort study on stereotacticradiotherapy in the management of dural recurrence of olfactory neuroblastoma.Head Neck. 2025 Jan;47(1):81-89. doi: 10.1002/hed.27887. Epub 2024 Jul 29. PMID:39073252; PMCID: PMC11729999.
Gubbiotti MA, Weinberg JS, Weathers SP, Dasgupta P, Tom MC, Aldape K,Quezado M, Abdullaev Z, Huse JT, Ballester LY. An incidental finding of a high-grade glioma with pleomorphic and pseudopapillary features (HPAP) with PBRM1mutation. J Neuropathol Exp Neurol. 2024 Jan 19;83(2):139-141. doi:10.1093/jnen/nlad114. PMID: 38164987; PMCID: PMC11032702.
Bollo RJ, Ho WS, Strauss I, Ferguson SD, Menacho ST. Introduction.Calibrating the utility of laser interstitial thermal therapy in neurosurgery: aonce-novel surgical treatment finds it place in the armamentarium. NeurosurgFocus. 2024 Nov 1;57(5):E1. doi: 10.3171/2024.9.FOCUS23741. PMID: 39486074.
Tatsui CE, Carlson KW, Patel CB. Tumor treating fields (TTFields) for spinalmetastasis-The case for bone removal and spinal implants as waveguides toenhance field strength at the target. Neurooncol Adv. 2024 Jan 3;6(1):vdad170.doi: 10.1093/noajnl/vdad170. PMID: 38288093; PMCID: PMC10824159.
Neto EB, de Almeida Bastos DC, Yoshikawa MH, Figueiredo EG, de Assis deSouza Filho F, Prabhu S. Short-term predictors of stereotactic radiosurgeryoutcome for untreated single non-small cell lung cancer brain metastases: arestrospective cohort study. Neurosurg Rev. 2024 Apr 19;47(1):172. doi:10.1007/s10143-024-02415-y. PMID: 38639882.
2023 Publications
You Y, Tian Y, Yang Z, Shi J, Kwak KJ, Tong Y, Estania AP, Cao J, Hsu WH, LiuY, Chiang CL, Schrank BR, Huntoon K, Lee D, Li Z, Zhao Y, Zhang H, Gallup TD, HaJ, Dong S, Li X, Wang Y, Lu WJ, Bahrani E, Lee LJ, Teng L, Jiang W, Lan F, Kim BYS, Lee AS. Intradermally delivered mRNA-encapsulating extracellular vesiclesfor collagen-replacement therapy. Nat Biomed Eng. 2023 Jul;7(7):887-900. doi:10.1038/s41551-022-00989-w. Epub 2023 Jan 12. PMID: 36635419.
Li J, Lan Z, Liao W, Horner JW, Xu X, Liu J, Yoshihama Y, Jiang S, Shim HS,Slotnik M, LaBella KA, Wu CJ, Dunner K Jr, Hsu WH, Lee R, Khanduri I, Terranova C, Akdemir K, Chakravarti D, Shang X, Spring DJ, Wang YA, DePinho RA. Histonedemethylase KDM5D upregulation drives sex differences in colon cancer. Nature.2023 Jul;619(7970):632-639. doi: 10.1038/s41586-023-06254-7. Epub 2023 Jun 21.PMID: 37344599; PMCID: PMC10529424.
Glitza Oliva IC, Ferguson SD, Bassett R Jr, Foster AP, John I, Hennegan TD,Rohlfs M, Richard J, Iqbal M, Dett T, Lacey C, Jackson N, Rodgers T, Phillips S,Duncan S, Haydu L, Lin R, Amaria RN, Wong MK, Diab A, Yee C, Patel SP, McQuadeJL, Fischer GM, McCutcheon IE, O'Brien BJ, Tummala S, Debnam M, Guha-Thakurta N,Wargo JA, Carapeto FCL, Hudgens CW, Huse JT, Tetzlaff MT, Burton EM, Tawbi HA,Davies MA. Concurrent intrathecal and intravenous nivolumab in leptomeningealdisease: phase 1 trial interim results. Nat Med. 2023 Apr;29(4):898-905. doi:10.1038/s41591-022-02170-x. Epub 2023 Mar 30. Erratum in: Nat Med. 2024Jun;30(6):1787. doi: 10.1038/s41591-024-02998-5. PMID: 36997799; PMCID:PMC10115650.
Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, DarasM, Cloughesy TF, Colman H, Kumthekar PU, Chen CC, Aiken R, Groves MD, Ong SS, Ramakrishna R, Vogelbaum MA, Khagi S, Kaley T, Melear JM, Peereboom DM,Rodriguez A, Yankelevich M, Nair SG, Puduvalli VK, Aldape K, Gao A, López-Janeiro Á, de Andrea CE, Alonso MM, Boutros P, Robbins J, Mason WP, Sonabend AM, Stupp R, Fueyo J, Gomez-Manzano C, Lang FF, Zadeh G. Oncolytic DNX-2401virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. NatMed. 2023 Jun;29(6):1370-1378. doi: 10.1038/s41591-023-02347-y. Epub 2023 May 15. Erratum in: Nat Med. 2025 Sep;31(9):3204. doi: 10.1038/s41591-025-03895-1.PMID: 37188783; PMCID: PMC10287560.
Liu CC, Wang N, Chen Y, Inoue Y, Shue F, Ren Y, Wang M, Qiao W, Ikezu TC, LiZ, Zhao J, Martens Y, Doss SV, Rosenberg CL, Jeevaratnam S, Jia L, Raulin AC, QiF, Zhu Y, Alnobani A, Knight J, Chen Y, Linares C, Kurti A, Fryer JD, Zhang B,Wu LJ, Kim BYS, Bu G. Cell-autonomous effects of APOE4 in restricting microglialresponse in brain homeostasis and Alzheimer's disease. Nat Immunol. 2023Nov;24(11):1854-1866. doi: 10.1038/s41590-023-01640-9. Epub 2023 Oct 19. PMID:37857825; PMCID: PMC11980647.
Dong S, Liu X, Bi Y, Wang Y, Antony A, Lee D, Huntoon K, Jeong S, Ma Y, Li X,Deng W, Schrank BR, Grippin AJ, Ha J, Kang M, Chang M, Zhao Y, Sun R, Sun X,Yang J, Chen J, Tang SK, Lee LJ, Lee AS, Teng L, Wang S, Teng L, Kim BYS, Yang Z, Jiang W. Adaptive design of mRNA-loaded extracellular vesicles for targetedimmunotherapy of cancer. Nat Commun. 2023 Oct 19;14(1):6610. doi:10.1038/s41467-023-42365-5. PMID: 37857647; PMCID: PMC10587228.
Goswami S, Raychaudhuri D, Singh P, Natarajan SM, Chen Y, Poon C, HennesseyM, Tannir AJ, Zhang J, Anandhan S, Kerrigan BP, Macaluso MD, He Z, Jindal S,Lang FF, Basu S, Sharma P. Myeloid-specific KDM6B inhibition sensitizesglioblastoma to PD1 blockade. Nat Cancer. 2023 Oct;4(10):1455-1473. doi:10.1038/s43018-023-00620-0. Epub 2023 Aug 31. PMID: 37653141.
Ray PR, Shiers S, Caruso JP, Tavares-Ferreira D, Sankaranarayanan I, UhelskiML, Li Y, North RY, Tatsui C, Dussor G, Burton MD, Dougherty PM, Price TJ. RNAprofiling of human dorsal root ganglia reveals sex differences in mechanismspromoting neuropathic pain. Brain. 2023 Feb 13;146(2):749-766. doi:10.1093/brain/awac266. PMID: 35867896; PMCID: PMC10169414.
Altan M, Wang Y, Song J, Welsh J, Tang C, Guha-Thakurta N, Blumenschein GR,Carter BW, Wefel JS, Ghia AJ, Yeboa DN, McAleer MF, Chung C, Woodhouse KD,McGovern SL, Wang C, Kim BYS, Weinberg JS, Briere TM, Elamin YY, Le X, CasconeT, Negrao MV, Skoulidis F, Ferrarotto R, Heymach JV, Li J. Nivolumab andipilimumab with concurrent stereotactic radiosurgery for intracranial metastasesfrom non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial. J Immunother Cancer. 2023Jul;11(7):e006871. doi: 10.1136/jitc-2023-006871. Erratum in: J ImmunotherCancer. 2023 Jul;11(7):e006871corr1. doi: 10.1136/jitc-2023-006871corr1. PMID:37402581; PMCID: PMC10335483.
Huntoon K, Lee D, Dong S, Antony A, Kim BYS, Jiang W. Targeting phagocytosisto enhance antitumor immunity. Trends Cancer. 2023 Aug;9(8):650-665. doi:10.1016/j.trecan.2023.04.006. Epub 2023 May 5. Erratum in: Trends Cancer. 2024Jun;10(6):571. doi: 10.1016/j.trecan.2023.09.009. PMID: 37150626.
Oue H, Yamazaki Y, Qiao W, Yuanxin C, Ren Y, Kurti A, Shue F, Parsons TM, Perkerson RB, Kawatani K, Wang N, Starling SC, Roy B, Mosneag IE, Aikawa T, HolmML, Liu CC, Inoue Y, Sullivan PM, Asmann YW, Kim BY, Bu G, Kanekiyo T. LRP1 invascular mural cells modulates cerebrovascular integrity and function in thepresence of APOE4. JCI Insight. 2023 Apr 10;8(7):e163822. doi:10.1172/jci.insight.163822. PMID: 37036005; PMCID: PMC10132158.
Zheng C, Wei Y, Zhang Q, Sun M, Wang Y, Hou J, Zhang P, Lv X, Su D, Jiang Y,Gumin J, Sahni N, Hu B, Wang W, Chen X, McGrail DJ, Zhang C, Huang S, Xu H, ChenJ, Lang FF, Hu J, Chen Y. Multiomics analyses revealDARS1-AS1/YBX1-controlled posttranscriptional circuits promotingglioblastoma tumorigenesis/radioresistance. Sci Adv. 2023 Aug 4;9(31):eadf3984.doi: 10.1126/sciadv.adf3984. Epub 2023 Aug 4. PMID: 37540752; PMCID:PMC10403220.
Akdemir KC, Le VT, Chandran S, Li Y, Verhaak RG, Beroukhim R, Campbell PJ,Chin L, Dixon JR, Futreal PA; PCAWG Structural Variation Working Group; PCAWG Consortium. Author Correction: Disruption of chromatin folding domains bysomatic genomic rearrangements in human cancer. Nat Genet. 2023 Jun;55(6):1079.doi: 10.1038/s41588-023-01318-w. Erratum for: Nat Genet. 2020 Mar;52(3):294-305.doi: 10.1038/s41588-019-0564-y. PMID: 36944735; PMCID: PMC10260394.
Mikula AL, Pennington Z, Lakomkin N, Prablek M, Amini B, Karim SM, Patel SS,Lubelski D, Sciubba DM, Alvarez-Breckenridge C, North RY, Tatsui CE, Bydon M,Fogelson JL, Elder BD, Krauss WE, Bird JE, Rose PS, Clarke MJ, Rhines LD. Risk factors for sacral fracture following en bloc chordoma resection. J NeurosurgSpine. 2023 Apr 14;39(5):611-617. doi: 10.3171/2023.3.SPINE221108. PMID:37060308.
McCarty JH. MMP9 Clears the Way for Metastatic Cell Penetration Across theBlood-Brain Barrier. Cancer Res. 2023 Apr 14;83(8):1167-1169. doi:10.1158/0008-5472.CAN-23-0151. PMID: 37057598; PMCID: PMC11696691. 1 6: Allam AK, Viswanathan A, Schwalb JM, Patil PG, Larkin MB. Editorial:Surgical techniques for the management of pain. Front Pain Res (Lausanne). 2023Feb 13;4:1120174. doi: 10.3389/fpain.2023.1120174. PMID: 36860332; PMCID:PMC9969155.
Haider AS, McCutcheon IE, Ene CI, Fuller GN, Schomer DF, Gule-Monroe M,DeMonte F, Ferguson SD, Lang FF, Prabhu SS, Raza SM, Suki D, Weinberg JS, SawayaR. Subependymomas of the fourth ventricle: To operate or not to operate? J ClinNeurosci. 2023 Dec;118:147-152. doi: 10.1016/j.jocn.2023.10.025. Epub 2023 Nov7. PMID: 37944358.
Huntoon K, Jiang W, Kim BY. Waking immune-resistant tumors with neddylation.J Clin Invest. 2023 Feb 15;133(4):e167894. doi: 10.1172/JCI167894. PMID:36787255; PMCID: PMC9927922.
Bahouth SM, Yeboa DN, Ghia AJ, Tatsui CE, Alvarez-Breckenridge CA, BeckhamTH, Bishop AJ, Li J, McAleer MF, North RY, Rhines LD, Swanson TA, Chenyang W,Amini B. Advances in the management of spinal metastases: what the radiologistneeds to know. Br J Radiol. 2023 Jan 1;96(1141):20220267. doi:10.1259/bjr.20220267. Epub 2022 Aug 24. PMID: 35946551; PMCID: PMC10997009.
Pokhylevych H, Khose S, Gule-Monroe MK, Chen MM, Fuller G, Gruschkus SK,Sadighi Z, Zaky W, Sandberg DI, McGovern SL, Johnson JM. Contrast EnhancementPatterns in Pediatric Glioblastomas. J Comput Assist Tomogr. 2023 Jan-Feb01;47(1):115-120. doi: 10.1097/RCT.0000000000001379. Epub 2022 Sep 7. PMID:36112052.
Sherry AD, Maroongroge S, De B, Amini B, Conley AP, Bishop AJ, Wang C,Beckham T, Tom M, Briere T, Li J, Yeboa DN, McAleer MF, North R, Tatsui CE,Rhines LD, Ghia AJ. Management of chordoma and chondrosarcoma with definitivedose-escalated single-fraction spine stereotactic radiosurgery. J Neurooncol.2023 Sep;164(2):377-386. doi: 10.1007/s11060-023-04432-1. Epub 2023 Sep 4. PMID:37667065; PMCID: PMC11917496.
Denu RA, Yang RK, Lazar AJ, Patel SS, Lewis VO, Roszik J, Livingston JA,Wang WL, Shaw KR, Ratan R, Zarzour MA, Bird J, Raza S, Akdemir KC, Rodon AhnertJ, Subbiah V, Patel S, Conley AP. Clinico-Genomic Profiling of Conventional andDedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated withWorse Outcomes. Clin Cancer Res. 2023 Dec 1;29(23):4844-4852. doi:10.1158/1078-0432.CCR-23-1703. PMID: 37747813; PMCID: PMC10835757.
Hasanov M, Milton DR, Davies AB, Sirmans E, Saberian C, Posada EL, OpusunjuS, Gershenwald JE, Torres-Cabala CA, Burton EM, Colen RR, Huse JT, Glitza OlivaIC, Chung C, McAleer MF, McGovern SL, Yeboa DN, Kim BYS, Prabhu SS, McCutcheonIE, Weinberg JS, Lang FF, Tawbi HA, Li J, Haydu LE, Davies MA, Ferguson SD. Changes in outcomes and factors associated with survival in melanoma patientswith brain metastases. Neuro Oncol. 2023 Jul 6;25(7):1310-1320. doi:10.1093/neuonc/noac251. PMID: 36510640; PMCID: PMC10326492.
Chiang CL, Ma Y, Hou YC, Pan J, Chen SY, Chien MH, Zhang ZX, Hsu WH, Wang X,Zhang J, Li H, Sun L, Fallen S, Lee I, Chen XY, Chu YS, Zhang C, Cheng TS, JiangW, Kim BYS, Reategui E, Lee R, Yuan Y, Liu HC, Wang K, Hsiao M, Huang CF, ShanYS, Lee AS, James Lee L. Dual targeted extracellular vesicles regulate oncogenicgenes in advanced pancreatic cancer. Nat Commun. 2023 Oct 23;14(1):6692. doi:10.1038/s41467-023-42402-3. PMID: 37872156; PMCID: PMC10593751.
De A, Lattier JM, Morales JE, Kelly JR, Zheng X, Chen Z, Sebastian S,Nassiri Toosi Z, Huse JT, Lang FF, McCarty JH. Glial Cell Adhesion Molecule(GlialCAM) Determines Proliferative versus Invasive Cell States in Glioblastoma.J Neurosci. 2023 Nov 22;43(47):8043-8057. doi: 10.1523/JNEUROSCI.1401-23.2023.PMID: 37722850; PMCID: PMC10669794.
Przybylowski CJ, Suki D, Raza SM, DeMonte F. Volumetric extent of resectionand survival for recurrent atypical meningioma. J Neurosurg. 2023 Jan27;139(3):769-779. doi: 10.3171/2022.12.JNS221815. PMID: 36708533.
Hunt PJ, Amit M, Kabotyanski KE, Aashiq M, Hanna EY, Kupferman ME, Su SY,Gidley PW, Nader ME, DeMonte F, Raza SM. Predictors of postoperative performancestatus after surgical management of infratemporal fossa malignancies. Neurosurg Rev. 2023 Jun 29;46(1):157. doi: 10.1007/s10143-023-02063-8. PMID: 37386212.
Lovin BD, Wilkinson AJ, Qing Y, Hernandez M, Nader ME, Raza S, DeMonte F,Gidley PW. The Effect of Metformin on Vestibular Schwannoma Growth: A SystematicReview and Meta-analysis. Laryngoscope. 2023 Sep;133(9):2066-2072. doi:10.1002/lary.30601. Epub 2023 Feb 6. PMID: 36744870; PMCID: PMC10404300.
Alvarez-Breckenridge C, de Almeida R, Haider A, Muir M, Bird J, North R,Rhines L, Tatsui C. Carbon Fiber-Reinforced Polyetheretherketone Spinal Implants for Treatment of Spinal Tumors: Perceived Advantages and Limitations.Neurospine. 2023 Mar;20(1):317-326. doi: 10.14245/ns.2244920.460. Epub 2023 Mar31. PMID: 37016879; PMCID: PMC10080433.
Germscheid N, Cheung JPY, Neva MH, Öner FC, Kwon BK, Valacco M, Awwad W,Sciubba DM, Lewis SJ, Rhines LD, Yoon ST, Alini M, Grad S, Fisher CG, Samartzis D. Research Practices and Needs Among Spine Surgeons Worldwide. Global Spine J.2023 Sep;13(7):1894-1908. doi: 10.1177/21925682211058158. Epub 2021 Dec 6. PMID:34870488; PMCID: PMC10556911.
Paolucci I, Albuquerque Marques Silva J, Lin YM, Fellman BM, Jones KA,Tatsui CE, Weinberg JS, Ruiz J, Tan J, Brock KK, Bale R, Odisio BC. StudyProtocol STEREOLAB: Stereotactic Liver Ablation Assisted with Intra-Arterial CTHepatic Arteriography and Ablation Confirmation Software Assessment. CardiovascIntervent Radiol. 2023 Dec;46(12):1748-1754. doi: 10.1007/s00270-023-03524-9.Epub 2023 Aug 10. PMID: 37563313.
de Almeida RAA, Ghia AJ, Amini B, Wang C, Alvarez-Breckenridge CA, Li J,Rhines LD, Tom MC, North RY, Beckham TH, Tatsui CE. Quantification of MRI Artifacts in Carbon Fiber Reinforced Polyetheretherketone Thoracolumbar PedicleScrew Constructs prior to Spinal Stereotactic Radiosurgery. Pract Radiat Oncol.2024 Mar-Apr;14(2):103-111. doi: 10.1016/j.prro.2023.10.005. Epub 2023 Oct 31.PMID: 37914081.
Ramesh U, Contrera KJ, Shakibai N, Su SY, Brahimaj B, Roberts D, WilliamsMD, Ferrarotto R, Phan J, Gunn GB, Raza S, DeMonte F, Hanna EY. Sinonasal NUTcarcinoma: A consecutive case series and systematic review. Head Neck. 2024Jan;46(1):29-36. doi: 10.1002/hed.27553. Epub 2023 Oct 18. PMID: 37853958.
Wang Y, Deng W, Lee D, Yan L, Lu Y, Dong S, Huntoon K, Antony A, Li X, Ye R,Zhao Y, Zhao F, Schrank BR, Ha J, Kang M, Yang M, Gong P, Lorenzi PL, Tan L,Gallup TD, Tang SK, Yang Z, Li J, Sanford NN, Wang H, Kim BYS, Jiang W. Age-associated disparity in phagocytic clearance affects the efficacy of cancernanotherapeutics. Nat Nanotechnol. 2024 Feb;19(2):255-263. doi:10.1038/s41565-023-01502-3. Epub 2023 Sep 18. PMID: 37723279; PMCID:PMC12289334.
Huntoon K, Anderson SK, Ballman KV, Twohy E, Dooley K, Jiang W, An Y, Li J,von Roemeling C, Qie Y, Ross OA, Cerhan JH, Whitton AC, Greenspoon JN, Parney IF, Ashman JB, Bahary JP, Hadjipanayis C, Urbanic JJ, Farace E, Khuntia D, Laack NN, Brown PD, Roberge D, Kim BYS. Association of circulating markers withcognitive decline after radiation therapy for brain metastasis. Neuro Oncol.2023 Jun 2;25(6):1123-1131. doi: 10.1093/neuonc/noac262. Erratum in: NeuroOncol. 2023 May 4;25(5):1010. doi: 10.1093/neuonc/noad062. PMID: 36472389;PMCID: PMC10237411.
Contrera KJ, Phan J, Waguespack SG, Aldehaim M, Wang X, Lim TY, Roberts DB,Fuller CD, Spiotto MT, Raza SM, DeMonte F, Hanna EY, Su SY. Prevalence ofpituitary hormone dysfunction following radiotherapy for sinonasal andnasopharyngeal malignancies. Head Neck. 2023 Oct;45(10):2525-2532. doi:10.1002/hed.27476. Epub 2023 Aug 3. PMID: 37534890; PMCID: PMC10766346.
Snyder R, Gadot R, Gidley PW, Nader ME, Hanna EY, Su SY, DeMonte F, Raza SM.Patient, Disease, and Treatment-Related Factors Affecting Progression-Free andDisease-Specific Survival in Recurrent Chondrosarcomas of the Skull Base. OperNeurosurg. 2023 Jan 1;24(1):33-43. doi: 10.1227/ons.0000000000000445. Epub 2022Nov 1. PMID: 36519877.
Zhang J, Rima XY, Wang X, Nguyen LTH, Huntoon K, Ma Y, Palacio PL, NguyenKT, Albert K, Duong-Thi MD, Walters N, Kwak KJ, Yoon MJ, Li H, Doon-Ralls J,Hisey CL, Lee D, Wang Y, Ha J, Scherler K, Fallen S, Lee I, Palmer AF, Jiang W,Magaña SM, Wang K, Kim BYS, Lee LJ, Reátegui E. Engineering a tunablemicropattern-array assay to sort single extracellular vesicles and particles to detect RNA and protein in situ. J Extracell Vesicles. 2023 Nov;12(11):e12369.doi: 10.1002/jev2.12369. PMID: 37908159; PMCID: PMC10618633.
Ucisik FE, Huell D, Choi J, Gidley PW, DeMonte F, Hanna EY, Learned KO.Post-Treatment Imaging Evaluation of the Skull Base. Semin Roentgenol. 2023Jul;58(3):217-236. doi: 10.1053/j.ro.2023.03.004. Epub 2023 Apr 15. PMID:37507165.
Contrera KJ, Shakibai N, Su SY, Gule-Monroe MK, Roberts D, Brahimaj B,Williams MD, Ferrarotto R, Phan J, Gunn B, Raza S, DeMonte F, Hanna EY. Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient SinonasalCarcinoma. Otolaryngol Head Neck Surg. 2023 Aug;169(2):435-440. doi:10.1002/ohn.310. Epub 2023 Mar 1. PMID: 36856048.
Alhalabi O, Thouvenin J, Négrier S, Vano YA, Campedel L, Hasanov E, BakounyZ, Hahn AW, Bilen MA, Msaouel P, Choueiri TK, Viswanathan SR, Sircar K, AlbigesL, Malouf GG, Tannir NM. Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas. Oncologist. 2023 May8;28(5):433-439. doi: 10.1093/oncolo/oyac262. PMID: 36640141; PMCID:PMC10166175.
Rubino F, Schur S, McGovern SL, Kamiya-Matsuoka C, DeMonte F, Raza SM.Impact of salvage surgery with or without reirradiation for skull basemeningiomas recurring after prior radiotherapy. J Neurosurg. 2023 Feb3;139(3):798-809. doi: 10.3171/2022.12.JNS222010. PMID: 36738459.
Huntoon KM, Gasco J, Glitza Oliva IC, Ferguson SD, Majd NK, McCutcheon IE.Ventriculoperitoneal shunting with an on-off valve for patients withleptomeningeal metastases and intracranial hypertension. Neurooncol Pract. 2023Sep 2;11(1):56-63. doi: 10.1093/nop/npad056. PMID: 38222058; PMCID: PMC10785578.
Ozkizilkaya HI, Johnson JM, O'Brien BJ, McCutcheon IE, Prabhu SS, Ghia AJ,Fuller GN, Huse JT, Ballester LY. Intracranial mesenchymal tumor, FET::CREB fusion-positive in the lateral ventricle. Neurooncol Adv. 2023 Mar21;5(1):vdad026. doi: 10.1093/noajnl/vdad026. PMID: 37051329; PMCID:PMC10084497.
Smalley I, Boire A, Brastianos P, Kluger HM, Hernando-Monge E, Forsyth PA,Ahmed KA, Smalley KSM, Ferguson S, Davies MA, Glitza Oliva IC. Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care. Pigment Cell Melanoma Res. 2024 Jan;37(1):51-67. doi:10.1111/pcmr.13116. Epub 2023 Aug 25. PMID: 37622466; PMCID: PMC12292448.
Brahimaj BC, Contrera KJ, Rubino F, Almeida RA, Ferrarotto R, Phan J, Su SY, Hanna EY, DeMonte F, Raza SM. Induction Chemotherapy for Sinonasal Tumors in Patients Presenting with Brain Invasion and/or Neurological Deficits. J NeurolSurg B Skull Base. 2023 Sep 25;85(6):650-658. doi: 10.1055/s-0043-1774792. PMID:39483161; PMCID: PMC11524726.
Chen Z, Kelly JR, Morales JE, Sun RC, De A, Burkin DJ, McCarty JH. Thealpha7 integrin subunit in astrocytes promotes endothelial blood-brain barrier integrity. Development. 2023 Mar 15;150(6):dev201356. doi: 10.1242/dev.201356.Epub 2023 Mar 24. PMID: 36960827; PMCID: PMC10112902.
Garg AK, Hernandez M, Schlembach PJ, Bowers JR, McAleer MF, Brown PD, GopalR, Wiederhold L, Swanson T, Shah SJ, Li J, Ferguson SD, Philip NV, DeGracia L,Bloom ES, Chun SG. A phase II clinical trial of frameless, fractionatedstereotactic radiation therapy for brain metastases. JNCI Cancer Spectr. 2023Oct 31;7(6):pkad093. doi: 10.1093/jncics/pkad093. PMID: 37944053; PMCID:PMC10715838.
Rubino F, Brahimaj B, Hanna EY, Su SY, Phan J, Grosshans DR, DeMonte F, RazaSM. Does Time to Initiation of Adjuvant Radiotherapy Affect Reconstruction Outcomes after Endoscopic Resection of Skull Base Malignancies? J Neurol Surg BSkull Base. 2023 Jul 28;85(5):445-457. doi: 10.1055/a-2114-4563. PMID: 39228888;PMCID: PMC11368463. 50: Wu X, Alvarez-Breckenridge C. Moving the Pendulum for Glioblastoma Treatment: One Injection at a Time. Oncologist. 2023 Aug 3;28(8):651-653. doi:10.1093/oncolo/oyad104. PMID: 37130338; PMCID: PMC10400156.
No HJ, Wu YF, Dworkin ML, Manjappa R, Skinner L, Ashraf MR, Lau B,Melemenidis S, Viswanathan V, Yu AS, Surucu M, Schüler E, Graves EE, Maxim PG,Loo BW Jr. Clinical Linear Accelerator-Based Electron FLASH: Pathway for Practical Translation to FLASH Clinical Trials. Int J Radiat Oncol Biol Phys.2023 Oct 1;117(2):482-492. doi: 10.1016/j.ijrobp.2023.04.011. Epub 2023 Apr 25.PMID: 37105403; PMCID: PMC12359654.
Ziyaee H, Cardenas CE, Yeboa DN, Li J, Ferguson SD, Johnson J, Zhou Z,Sanders J, Mumme R, Court L, Briere T, Yang J. Automated Brain Metastases Segmentation With a Deep Dive Into False-positive Detection. Adv Radiat Oncol.2022 Sep 28;8(1):101085. doi: 10.1016/j.adro.2022.101085. PMID: 36299565; PMCID:PMC9589017.
Catalino MP, Noll KR, Wefel JS, Michener H, Prinsloo S, Tummala S, Prabhu S.Decoding the clinical effects of low-grade glioma-induced cortical excitability. J Neurosurg. 2023 Jul 7;140(1):18-26. doi: 10.3171/2023.5.JNS23747. PMID:37439490.
Yarabarla V, Mylarapu A, Han TJ, McGovern SL, Raza SM, Beckham TH.Intracranial meningiomas: an update of the 2021 World Health Organizationclassifications and review of management with a focus on radiation therapy. Front Oncol. 2023 Aug 22;13:1137849. doi: 10.3389/fonc.2023.1137849. PMID:37675219; PMCID: PMC10477988.
Florez MA, De B, Cavazos A, Farooqi A, Beckham TH, Wang C, Yeboa DN, BishopAJ, McAleer MF, Briere T, Amini B, Li J, Tatsui CE, Rhines LD, Ghia AJ. Safety and Efficacy of Dose-Escalated Radiation Therapy With a Simultaneous Integrated Boost for the Treatment of Spinal Metastases. Pract Radiat Oncol. 2023 Jan-Feb;13(1):e7-e13. doi: 10.1016/j.prro.2022.08.010. Epub 2022 Oct 24. PMID:36604100.
Goodwin CR, Price M, Goodwin AN, Dalton T, Versteeg AL, Sahgal A, Rhines LD,Schuster JM, Weber MH, Lazary A, Boriani S, Bettegowda C, Fehlings MG, ArnoldPM, Dea N, Charest-Morin R, Shin J, Laufer I, Chou D, Gokaslan ZL, Clarke MJ,Fisher CG, Sciubba DM; AO Spine Knowledge Forum Tumor. Gender and SexDifferences in Health-related Quality of Life, Clinical Outcomes and Survivalafter Treatment of Metastatic Spine Disease. Spine (Phila Pa 1976). 2023 Dec 27.doi: 10.1097/BRS.0000000000004910. Epub ahead of print. PMID: 38149519.
Huntoon KM, Mayer RR, Fahim DK, Kumar S, Adelman DM, McCutcheon IE.Malignant primary tumors of scalp with cranial extension: multidisciplinarysurgical strategies and outcomes. J Neurosurg. 2023 Sep 29;140(4):979-986. doi:10.3171/2023.7.JNS23974. PMID: 37877964.
Ameri M, Whyte AT, Raza SM, Gombos DS, Al-Zubidi N. Spontaneous Debulking ofa Large Skull Base Mass. J Neuroophthalmol. 2024 Dec 1;44(4):e573-e574. doi:10.1097/WNO.0000000000002022. Epub 2023 Oct 27. PMID: 37889587.
Fowler MJ, Riley CO, Tomasson E, Mehta S, Grande-Allen J, Ballester L,Sandberg DI, Janssen CF, Sirianni RW. Engineering subarachnoid trabeculae withelectrospun poly(caprolactone) (PCL) scaffolds to study leptomeningealmetastasis in medulloblastoma. Biomater Adv. 2023 Dec;155:213646. doi:10.1016/j.bioadv.2023.213646. Epub 2023 Sep 30. PMID: 37918168.
Versteeg AL, Sahgal A, Laufer I, Rhines LD, Sciubba DM, Schuster JM, WeberMH, Lazary A, Boriani S, Bettegowda C, Fehlings MG, Clarke MJ, Arnold PM,Gokaslan ZL, Fisher CG; AO Spine Knowledge Forum Tumor. Correlation Between the Spinal Instability Neoplastic Score (SINS) and Patient Reported Outcomes. GlobalSpine J. 2023 Jun;13(5):1358-1364. doi: 10.1177/21925682211033591. Epub 2021 Jul 26. PMID: 34308697; PMCID: PMC10416601.
Schur S, Hanna EY, Su SY, Kupferman ME, DeMonte F, Raza SM. Long-termoncological outcomes for endoscopic endonasal versus open surgical approachesfor anatomically matched, locally advanced stage T4 sinonasal malignancies withskull base involvement. J Neurosurg. 2023 Sep 22;140(3):688-695. doi:10.3171/2023.7.JNS23786. PMID: 37877981.
MacLean MA, Georgiopoulos M, Charest-Morin R, Goodwin CR, Laufer I, Dea N,Shin JH, Gokaslan ZL, Rhines LD, O'Toole JE, Sciubba DM, Fehlings MG, StephensBF, Bettegowda C, Myrehaug S, Disch AC, Netzer C, Kumar N, Sahgal A, GermscheidNM, Weber MH; AO Spine Knowledge Forum Tumor. Perception of frailty in spinalmetastatic disease: international survey of the AO Spine community. J NeurosurgSpine. 2023 Mar 3:1-11. doi: 10.3171/2023.1.SPINE221433. Epub ahead of print. PMID: 36883617.
Chan M, Tatter S, Chiang V, Fecci P, Strowd R, Prabhu S, Hadjipanayis C,Kirkpatrick J, Sun D, Sinicrope K, Mohammadi AM, Sevak P, Abram S, Kim AH,Leuthardt E, Chao S, Phillips J, Lacroix M, Williams B, Placantonakis D,Silverman J, Baumgartner J, Piccioni D, Laxton A. Efficacy of laser interstitialthermal therapy for biopsy-proven radiation necrosis in radiographicallyrecurrent brain metastases. Neurooncol Adv. 2023 Mar 28;5(1):vdad031. doi:10.1093/noajnl/vdad031. PMID: 37114245; PMCID: PMC10129388.
Jiang H, Shin DH, Yi Y, Fan X, Gumin J, He J, Gillard AG, Lang FF, Gomez-Manzano C, Fueyo J. Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOXAfter Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to SustainSystemic Antitumor Immunity. Cancer Res Commun. 2023 Jun 27;3(6):1118-1131. doi:10.1158/2767-9764.CRC-23-0054. PMID: 37379361; PMCID: PMC10295804.
Florez MA, De B, Chapman BV, Prayongrat A, Thomas JG, Beckham TH, Wang C,Yeboa DN, Bishop AJ, Briere T, Amini B, Li J, Tatsui CE, Rhines LD, Ghia AJ.Safety and efficacy of salvage conventional re-irradiation followingstereotactic radiosurgery for spine metastases. Radiat Oncol J. 2023Mar;41(1):12-22. doi: 10.3857/roj.2022.00353. Epub 2023 Mar 14. PMID: 37013414;PMCID: PMC10073838.
Hirase T, McChesney GR, Garvin L 2nd, Tappa K, Satcher RL, Mericli AF,Rhines LD, Bird JE. Advances in Virtual Cutting Guide and StereotacticNavigation for Complex Tumor Resections of the Sacrum and Pelvis: Case Serieswith Short-Term Follow-Up. Bioengineering (Basel). 2023 Nov 22;10(12):1342. doi:10.3390/bioengineering10121342. PMID: 38135933; PMCID: PMC10740571.
Stitzlein LM, Gangadharan A, Walsh LM, Nam D, Espejo AB, Singh MM, Patel KH,Lu Y, Su X, Ezhilarasan R, Gumin J, Singh S, Sulman E, Lang FF, Chandra J.Comparison of pharmacological inhibitors of lysine-specific demethylase 1 inglioblastoma stem cells reveals inhibitor-specific efficacy profiles. FrontNeurol. 2023 Apr 4;14:1112207. doi: 10.3389/fneur.2023.1112207. PMID: 37082446;PMCID: PMC10111022.
Yang W, Lee RP, Hung AL, Young CC, Sattari SA, Urrutia V, Gailloud PE, Xu R,Caplan J, Gonzalez LF. Cost-Effectiveness of a Direct-Aspiration First-PassTechnique versus Stent Retriever in Mechanical Thrombectomy. World Neurosurg.2024 Mar;183:e495-e501. doi: 10.1016/j.wneu.2023.12.129. Epub 2023 Dec 28. PMID:38159607.
Asman P, Pellizzer G, Tummala S, Tasnim I, Bastos D, Bhavsar S, Prabhu S,Ince NF. Long-latency gamma modulation after median nerve stimulation delineatesthe central sulcus and contrasts the states of consciousness. Clin Neurophysiol.2023 Jan;145:1-10. doi: 10.1016/j.clinph.2022.10.008. Epub 2022 Oct 31. PMID:36370685; PMCID: PMC11905291.
Li Y, Uhelski ML, North RY, Mwirigi JM, Tatsui CE, Cata JP, Corrales G,Price TJ, Dougherty PM. MNK inhibitor eFT508 (Tomivosertib) suppresses ectopicactivity in human dorsal root ganglion neurons from dermatomes with radicularneuropathic pain. bioRxiv [Preprint]. 2023 Jun 14:2023.06.13.544811. doi:10.1101/2023.06.13.544811. PMID: 37398249; PMCID: PMC10312735.
Buszek SM, Tran B, Long JP, Luo D, Suki D, Li J, Ferguson S, Chung C.Postoperative Management of Recurrence After Radiosurgery and Surgical Resectionfor Brain Metastases and Predicting Benefit From Adjuvant Radiation. PractRadiat Oncol. 2023 Nov-Dec;13(6):e499-e503. doi: 10.1016/j.prro.2023.05.010.Epub 2023 Jun 8. PMID: 37295724.
Muir M, Gadot R, Prinsloo S, Michener H, Traylor J, Athukuri P, Tummala S,Kumar VA, Prabhu SS. Comparative study of preoperative functional imagingcombined with tractography for prediction of iatrogenic motor deficits. JNeurosurg. 2022 Nov 25;139(1):65-72. doi: 10.3171/2022.10.JNS221684. PMID:36433877. 73: Alvarez-Breckenridge C, Anderson KG, Correia AL, Demehri S, Dinh HQ, DixonKO, Dunn GP, Evgin L, Goc J, Good Z, Hacohen N, Han P, Hanč P, Hickey J, KerstenK, Liu BC, Buque A, Miao Y', Milner JJ, Pritykin Y, Pucci F, Scharping NE,Sudmeier L, Wang Y, Wieland A, Williams MM. Lessons for the Next Generation ofScientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium. Cancer Immunol Res. 2023 Dec 1;11(12):1571-1577. doi:10.1158/2326-6066.CIR-23-0522. PMID: 37906619; PMCID: PMC10696930. 74: Haider AS, Ene CI, Palmisciano P, Haider M, Rao G, Ballester LY, Fuller GN.Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report. Front Oncol. 2023 Apr 3;13:1071792. doi: 10.3389/fonc.2023.1071792. PMID: 37077830; PMCID:PMC10108912.
Noll KR, Asman P, Tasnim I, Hall M, Connelly K, Swamy C, Ene C, Tummala S,Grasu RM, Liu HL, Kumar VA, Muir M, Prinsloo S, Michener H, Wefel JS, Ince NF,Prabhu SS. Intraoperative language mapping guided by real-time visualization of gamma band modulation electrocorticograms: Case report and proof of concept.Neurooncol Pract. 2023 Sep 18;11(1):92-100. doi: 10.1093/nop/npad059. PMID:38222047; PMCID: PMC10785572. 76: Disch AC, Boriani S, Luzzati A, Rhines LD, Fisher CG, Lazary A, Gokaslan ZL,Chou D, Clarke MJ, Fehlings MG, Schaser KD, Germscheid NM, Reynolds JJ, The AoSpine Knowledge Forum Tumor. Extradural Primary Malignant Spinal Tumors in aPopulation Younger than 25 Years: An Ambispective International Multicenter Study on Onco-Surgical Outcomes. Cancers (Basel). 2023 Jan 30;15(3):845. doi:10.3390/cancers15030845. PMID: 36765803; PMCID: PMC9913243.
Ladbury C, Sueyoshi MH, Brovold NM, Kumar R, Andraos TY, Gogineni E, Kim M,Klopp A, Albuquerque K, Kunos C, Leung E, Mantz C, Biswas T, Beriwal S, Small WJr, Erickson B, Gaffney D, Lo SS, Viswanathan AN. Stereotactic Body RadiationTherapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society PracticeReview. Pract Radiat Oncol. 2024 May-Jun;14(3):252-266. doi:10.1016/j.prro.2023.09.008. Epub 2023 Oct 22. PMID: 37875223.
Gregory TA, Mastall M, Lin H, Hess KR, Yuan Y, Martin-Bejarano Garcia M,Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI,Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, WeathersSP, Harrison RA, de Groot JF, Puduvalli VK, Penas-Prado M, Majd NK.Characterization of recurrence patterns and outcomes of medulloblastoma inadults: The University of Texas MD Anderson Cancer Center experience. Neurooncol Adv. 2023 Apr 13;5(1):vdad032. doi: 10.1093/noajnl/vdad032. PMID: 37114244;PMCID: PMC10129387.
Disch AC, Boriani S, Lazary A, Rhines LD, Luzzati A, Gokaslan ZL, Fisher CG,Fehlings MG, Clarke MJ, Chou D, Germscheid NM, Schaser KD, Reynolds JJ, The AoSpine Knowledge Forum Tumor. Outcomes of Surgical Treatment for ExtraduralBenign Primary Spinal Tumors in Patients Younger than 25 Years: An AmbispectiveInternational Multicenter Study. Cancers (Basel). 2023 Jan 20;15(3):650. doi:10.3390/cancers15030650. PMID: 36765605; PMCID: PMC9913733.
Lazaro TT, Katlowitz KA, Karas PJ, Srinivasan VM, Walls E, Collier G, RazaSM, Curry DJ, Ropper AE, Fuentes A, Gopinath SP, Rao G, Patel AJ. The impact ofa night float system on operative experience in neurosurgery residency. JNeurosurg. 2022 Sep 9;138(4):1117-1123. doi: 10.3171/2022.4.JNS212612. PMID:36087325.
Arjuna S, Shah M, Dono A, Nunez-Rubiano L, Pichardo-Rojas PS, Zhu JJ,Riascos RF, Luthra R, Roy-Chowdhuri S, Duose D, Wang DH, Lang FF, Esquenazi Y,Ballester LY. Rapid detection of mutations in CSF-cfTNA with the GenexusIntegrated Sequencer. J Neurooncol. 2024 Jan;166(1):39-49. doi:10.1007/s11060-023-04487-0. Epub 2023 Dec 30. PMID: 38160230; PMCID:PMC11264431.
Almeida RAA, Tatsui CE. Commentary on "Surgical Outcomes of SymptomaticIntramedullary Spinal Cord Cavernous Malformations: Analysis of ConsecutiveCases in a Single Center". Neurospine. 2023 Sep;20(3):822-823. doi:10.14245/ns.2346902.451. Epub 2023 Sep 30. PMID: 37798976; PMCID: PMC10562246.
Gendreau J, Jimenez A, Lozinsky S, Zenonos G, Gardner P, Raza S, Dea N,Gokaslan Z, Choby G, Van Gompel J, Redmond K, Gallia G, Bettegowda C, Rowan N,Kuo CC, Mukherjee D. Radiotherapy After Gross Total Resection of Skull BaseChordoma: A Surveillance, Epidemiology, and End Results Database Analysis of Survival Outcomes. World Neurosurg. 2023 Apr;172:e68-e76. doi:10.1016/j.wneu.2022.12.012. Epub 2022 Dec 9. PMID: 36509323.
Leong VWS, Khan S, Sharma P, Wu S, Thomas RR, Li X, Singh SK, Lang FF, YungAWK, Koul D. MGMT function determines the differential response of ATRinhibitors with DNA-damaging agents in glioma stem cells for GBM therapy.Neurooncol Adv. 2023 Dec 19;6(1):vdad165. doi: 10.1093/noajnl/vdad165. PMID:38213834; PMCID: PMC10783493.
Chelariu-Raicu A, Piha-Paul SA, Chavez-MacGregor M, Johnson J, Sawaya R,McAleer MF, Nguyen A, Hartnett A, Tsimberidou AM, Meric-Bernstam F, Dumbrava EE.Multidisciplinary Care of a Large Brain Metastasis in a Patient with Hormone-Receptor-Positive Breast Cancer with Ataxia-Telangiectasia Mutation. JImmunother Precis Oncol. 2023 Jun 28;6(3):158-161. doi: 10.36401/JIPO-22-33.PMID: 37637237; PMCID: PMC10448731.
Katlowitz KA, Beckham TH, Kudchadker RJ, Wefel J, Elamin YY, Weinberg JS. ANovel Multimodal Approach to Refractory Brain Metastases: A Case Report. AdvRadiat Oncol. 2023 Aug 15;9(2):101349. doi: 10.1016/j.adro.2023.101349. PMID:38405307; PMCID: PMC10885573.
Becco Neto E, Chaves de Almeida Bastos D, Telles JPM, Figueiredo EG,Teixeira MJ, de Assis de Souza Filho F, Prabhu S. Predictors of Survival After Stereotactic Radiosurgery for Untreated Single Non-Small Cell Lung Cancer Brain Metastases: 5- and 10-year Results. World Neurosurg. 2023 Apr;172:e447-e452.doi: 10.1016/j.wneu.2023.01.049. Epub 2023 Jan 19. PMID: 36682534.
Larkin MB, Goethe EA, Mohammad M, Tummala S, North RY. Ulnar fascicle tobrachialis branch of musculocutaneous nerve for restoration of elbow flexionassociated with spinal cord tumor and radiation-induced lower motor neurondisease. Neurosurg Focus Video. 2023 Jan 1;8(1):V9. doi:10.3171/2022.10.FOCVID2299. PMID: 36628102; PMCID: PMC9815210.
2022 Publications
Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, van den Bent M, Wallace HJ, Weinberg JS, Zadeh G, Schiff D. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. J ClinOncol. 2022 Feb 10;40(5):492-516. doi: 10.1200/JCO.21.02314. Epub 2021 Dec 21.Erratum in: J Clin Oncol. 2022 Apr 20;40(12):1392. doi: 10.1200/JCO.22.00593.PMID: 34932393.
Abdelfattah N, Kumar P, Wang C, Leu JS, Flynn WF, Gao R, Baskin DS, Pichumani K, Ijare OB, Wood SL, Powell SZ, Haviland DL, Parker Kerrigan BC, Lang FF, Prabhu SS, Huntoon KM, Jiang W, Kim BYS, George J, Yun K. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat Commun. 2022 Feb 9;13(1):767. doi: 10.1038/s41467-022-28372-y. PMID:35140215; PMCID: PMC8828877.
Gállego Pérez-Larraya J, Garcia-Moure M, Labiano S, Patiño-García A, Dobbs J, Gonzalez-Huarriz M, Zalacain M, Marrodan L, Martinez-Velez N, Puigdelloses M, Laspidea V, Astigarraga I, Lopez-Ibor B, Cruz O, Oscoz Lizarbe M, Hervas-Stubbs S, Alkorta-Aranburu G, Tamayo I, Tavira B, Hernandez-Alcoceba R, Jones C, Dharmadhikari G, Ruiz-Moreno C, Stunnenberg H, Hulleman E, van der Lugt J, Idoate MÁ, Diez-Valle R, Esparragosa Vázquez I, Villalba M, de Andrea C, Núñez-Córdoba JM, Ewald B, Robbins J, Fueyo J, Gomez-Manzano C, Lang FF, Tejada S, Alonso MM. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma. N Engl J Med. 2022 Jun 30;386(26):2471-2481. doi: 10.1056/NEJMoa2202028.PMID: 35767439.
Liu CC, Zhao J, Fu Y, Inoue Y, Ren Y, Chen Y, Doss SV, Shue F, Jeevaratnam S, Bastea L, Wang N, Martens YA, Qiao W, Wang M, Zhao N, Jia L, Yamazaki Y, Yamazaki A, Rosenberg CL, Wang Z, Kong D, Li Z, Kuchenbecker LA, Trottier ZA, Felton L, Rogers J, Quicksall ZS, Linares C, Knight J, Chen Y, Kurti A, Kanekiyo T, Fryer JD, Asmann YW, Storz P, Wang X, Peng J, Zhang B, Kim BYS, Bu G. Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function. Nat Neurosci. 2022 Aug;25(8):1020-1033.doi: 10.1038/s41593-022-01127-0. Epub 2022 Aug 1. PMID: 35915180; PMCID:PMC10009873.
Bakouny Z, Sadagopan A, Ravi P, Metaferia NY, Li J, AbuHammad S, Tang S, Denize T, Garner ER, Gao X, Braun DA, Hirsch L, Steinharter JA, Bouchard G, Walton E, West D, Labaki C, Dudani S, Gan CL, Sethunath V, Carvalho FLF, Imamovic A, Ricker C, Vokes NI, Nyman J, Berchuck JE, Park J, Hirsch MS, Haq R, Mary Lee GS, McGregor BA, Chang SL, Feldman AS, Wu CJ, McDermott DF, Heng DYC, Signoretti S, Van Allen EM, Choueiri TK, Viswanathan SR. Integrative clinical and molecular characterization of translocation renal cell carcinoma. Cell Rep.2022 Jan 4;38(1):110190. doi: 10.1016/j.celrep.2021.110190. PMID: 34986355;PMCID: PMC9127595.
McCutcheon IE. Seizures and pseudoseizures: The great divide. Prog Brain Res.2022;272(1):143-151. doi: 10.1016/bs.pbr.2022.03.003. Epub 2022 May 14. PMID:35667799.
Chen SR, Lang FF, Kan P. Preclinical animal brain tumor models for interventional neuro-oncology. J Neurointerv Surg. 2022May;14(5):neurintsurg-2022-018968. doi: 10.1136/neurintsurg-2022-018968. PMID:35414632.
Ene CI, Ferguson SD. Surgical Management of Brain Metastasis: Challenges and Nuances. Front Oncol. 2022 Mar 14;12:847110. doi: 10.3389/fonc.2022.847110.PMID: 35359380; PMCID: PMC8963990.
Hasanov E, Yeboa DN, Tucker MD, Swanson TA, Beckham TH, Rini B, Ene CI, Hasanov M, Derks S, Smits M, Dudani S, Heng DYC, Brastianos PK, Bex A, Hanalioglu S, Weinberg JS, Hirsch L, Carlo MI, Aizer A, Brown PD, Bilen MA, Chang EL, Jaboin J, Brugarolas J, Choueiri TK, Atkins MB, McGregor BA, Halasz LM, Patel TR, Soltys SG, McDermott DF, Elder JB, Baskaya MK, Yu JB, Timmerman R, Kim MM, Mut M, Markert J, Beal K, Tannir NM, Samandouras G, Lang FF, Giles R, Jonasch E. An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma. CA Cancer J Clin. 2022 Sep;72(5):454-489.doi: 10.3322/caac.21729. Epub 2022 Jun 16. PMID: 35708940.
Bahouth SM, Yeboa DN, Ghia AJ, Tatsui CE, Alvarez-Breckenridge CA, Beckham TH, Bishio AJ, Li J, McAleer MF, North RY, Rhines LD, Swanson TA, Chenyang W, Amini B. Multidisciplinary management of spinal metastases: what the radiologist needs to know. Br J Radiol. 2022 Sep 1;95(1138):20220266. doi:10.1259/bjr.20220266. Epub 2022 Aug 10. PMID: 35856792; PMCID: PMC9815745.
Bahouth SM, Yeboa DN, Ghia AJ, Tatsui CE, Alvarez-Breckenridge CA, Beckham TH, Bishop AJ, Li J, McAleer MF, North RY, Rhines LD, Swanson TA, Chenyang W, Amini B. Advances in the management of spinal metastases: what the radiologist needs to know. Br J Radiol. 2023 Jan 1;96(1141):20220267. doi:10.1259/bjr.20220267. Epub 2022 Aug 24. PMID: 35946551; PMCID: PMC10997009.
Haider AS, El Ahmadieh TY, Haider M, Hatanpaa KJ, Pinho MC, Mickey BE, Sawaya R, Fuller GN, Schomer DF, Gule-Monroe M. Imaging characteristics of 4th ventricle sub ependymoma. Neuroradiology. 2022 Sep;64(9):1795-1800. doi:10.1007/s00234-022-02944-7. Epub 2022 Apr 15. PMID: 35426054; PMCID: PMC9365749.
Pokhylevych H, Khose S, Gule-Monroe MK, Chen MM, Fuller G, Gruschkus SK, Sadighi Z, Zaky W, Sandberg DI, McGovern SL, Johnson JM. Contrast Enhancement Patterns in Pediatric Glioblastomas. J Comput Assist Tomogr. 2023 Jan-Feb01;47(1):115-120. doi: 10.1097/RCT.0000000000001379. Epub 2022 Sep 7. PMID:36112052.
Karz A, Dimitrova M, Kleffman K, Alvarez-Breckenridge C, Atkins MB, Boire A, Bosenberg M, Brastianos P, Cahill DP, Chen Q, Ferguson S, Forsyth P, Glitza Oliva IC, Goldberg SB, Holmen SL, Knisely JPS, Merlino G, Nguyen DX, Pacold ME, Perez-Guijarro E, Smalley KSM, Tawbi HA, Wen PY, Davies MA, Kluger HM, Mehnert JM, Hernando E. Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities. Pigment Cell Melanoma Res. 2022Nov;35(6):554-572. doi: 10.1111/pcmr.13059. Epub 2022 Sep 1. PMID: 35912544;PMCID: PMC10171356.
Fomchenko EI, Bayley JC, Alvarez-Breckenridge C, Rhines LD, Tatsui CE. Spinal Metastases and the Evolving Role of Molecular Targeted Therapy, Chemotherapy, and Immunotherapy. Neurospine. 2022 Dec;19(4):978-993. doi:10.14245/ns.2244290.145. Epub 2022 Dec 31. PMID: 36597635; PMCID: PMC9816609.
Mateescu B, Jones JC, Alexander RP, Alsop E, An JY, Asghari M, Boomgarden A, Bouchareychas L, Cayota A, Chang HC, Charest A, Chiu DT, Coffey RJ, Das S, DeHoff P, deMello A, D'Souza-Schorey C, Elashoff D, Eliato KR, Franklin JL, Galas DJ, Gerstein MB, Ghiran IH, Go DB, Gould S, Grogan TR, Higginbotham JN, Hladik F, Huang TJ, Huo X, Hutchins E, Jeppesen DK, Jovanovic-Talisman T, Kim BYS, Kim S, Kim KM, Kim Y, Kitchen RR, Knouse V, LaPlante EL, Lebrilla CB, Lee LJ, Lennon KM, Li G, Li F, Li T, Liu T, Liu Z, Maddox AL, McCarthy K, Meechoovet B, ManiyaN, Meng Y, Milosavljevic A, Min BH, Morey A, Ng M, Nolan J, De Oliveira Junior GP, Paulaitis ME, Phu TA, Raffai RL, Reátegui E, Roth ME, Routenberg DA, Rozowsky J, Rufo J, Senapati S, Shachar S, Sharma H, Sood AK, Stavrakis S,Stürchler A, Tewari M, Tosar JP, Tucker-Schwartz AK, Turchinovich A, Valkov N, Van Keuren-Jensen K, Vickers KC, Vojtech L, Vreeland WN, Wang C, Wang K, Wang Z, Welsh JA, Witwer KW, Wong DTW, Xia J, Xie YH, Yang K, Zaborowski MP, Zhang C, Zhang Q, Zivkovic AM, Laurent LC. Phase 2 of extracellular RNA communication consortium charts next-generation approaches for extracellular RNA research. iScience. 2022 Jun 23;25(8):104653. doi: 10.1016/j.isci.2022.104653. PMID:35958027; PMCID: PMC9358052.
Al-Holou WN, Suki D, Hodges TR, Everson RG, Freeman J, Ferguson SD, McCutcheon IE, Prabhu SS, Weinberg JS, Sawaya R, Lang FF. Circumferential sulcus-guided resection technique for improved outcomes of low-grade gliomas. JNeurosurg. 2022 Jan 7;137(4):1015-1025. doi: 10.3171/2021.9.JNS21718. PMID:34996044.
Shepard MJ, Haider AS, Prabhu SS, Sawaya R, DeMonte F, McCutcheon IE, Weinberg JS, Ferguson SD, Suki D, Fuller GN, Lang FF. Long term outcomes following surgery for pineal region tumors. J Neurooncol. 2022Feb;156(3):491-498. doi: 10.1007/s11060-021-03919-z. Epub 2022 Jan 27. PMID:35083579.
Alvarez-Breckenridge CA, Cahill DP, Brastianos PK. Trabectedin for recurrent WHO grade 2 or 3 meningiomas-Paving the road for new opportunities. Neuro Oncol.2022 May 4;24(5):768-769. doi: 10.1093/neuonc/noac017. PMID: 35100424; PMCID:PMC9071327.
Rubino F, Alvarez-Breckenridge C, Akdemir K, Conley AP, Bishop AJ, Wang WL, Lazar AJ, Rhines LD, DeMonte F, Raza SM. Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels. Front Oncol. 2022 Sep 29;12:997506. doi: 10.3389/fonc.2022.997506. PMID:36248987; PMCID: PMC9557284.
Abdelmeguid AS, Bell D, Roberts D, Ferrarotto R, Phan J, Su SY, Kupferman M, Raza S, DeMonte F, Hanna E. Long-Term Outcomes of Olfactory Neuroblastoma: MD Anderson Cancer Center Experience and Review of the Literature. Laryngoscope.2022 Feb;132(2):290-297. doi: 10.1002/lary.29732. Epub 2021 Jul 17. PMID:34272876.
Bishop AJ, Amini B, Lin H, Raza SM, Patel S, Grosshans DR, Ghia A, Farooqi A, Guadagnolo BA, Mitra D, Akdemir KC, Lazar AJ, Wang WL, Alvarez-Breckenridge C, Bird J, Rhines LD, Somaiah N, Conley AP. Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma. J Immunother. 2022 Oct1;45(8):374-378. doi: 10.1097/CJI.0000000000000431. Epub 2022 Aug 4. PMID:35943386; PMCID: PMC9452485.
Piña Y, Yadugiri S, Yeboa DN, Ferguson SD, Forsyth PA, Oliva ICG. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma. Curr OncolRep. 2022 Jan;24(1):43-54. doi: 10.1007/s11912-021-01162-3. Epub 2022 Jan 20.PMID: 35059999.
Li X, Khorsandi S, Wang Y, Santelli J, Huntoon K, Nguyen N, Yang M, Lee D, Lu Y, Gao R, Kim BYS, de Gracia Lux C, Mattrey RF, Jiang W, Lux J. Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles. Nat Nanotechnol. 2022 Aug;17(8):891-899. doi:10.1038/s41565-022-01134-z. Epub 2022 May 30. PMID: 35637356; PMCID: PMC9378430.
Dong S, Bi Y, Sun X, Zhao Y, Sun R, Hao F, Sun Y, Wang Y, Li X, Deng W, LiuX, Ha J, Teng L, Gong P, Xie J, Kim BYS, Yang Z, Jiang W, Teng L. Dual-Loaded Liposomes Tagged with Hyaluronic Acid Have Synergistic Effects in Triple-Negative Breast Cancer. Small. 2022 Apr;18(16):e2107690. doi:10.1002/smll.202107690. Epub 2022 Mar 11. PMID: 35277914; PMCID: PMC11878215.
Ferguson SD, Fomchenko EI, Guerrieri RA, Glitza Oliva IC. Challenges and Advances in Diagnosis and Treatment of Leptomeningeal Disease (LMD). FrontOncol. 2022 Jan 12;11:800053. doi: 10.3389/fonc.2021.800053. PMID: 35096602;PMCID: PMC8789647.
Yeh MY, Chen HS, Hou P, Kumar VA, Johnson JM, Noll KR, Prabhu SS, Ferguson SD, Schomer DF, Peng HH, Liu HL. Cerebrovascular Reactivity Mapping Using Resting-State Functional MRI in Patients With Gliomas. J Magn Reson Imaging.2022 Dec;56(6):1863-1871. doi: 10.1002/jmri.28194. Epub 2022 Apr 9. PMID:35396789; PMCID: PMC11846080.
Chen SR, Chen MM, Ene C, Lang FF, Kan P. Perfusion-guided endovascular super-selective intra-arterial infusion for treatment of malignant brain tumors. J Neurointerv Surg. 2022 Jun;14(6):533-538. doi:10.1136/neurintsurg-2021-018190. Epub 2021 Nov 25. PMID: 34824133.
Upadhyay R, Khose S, Pokhylevych H, Paulino AC, McAleer MF, Ghia A, Li J, Yeboa DN, Loghin M, Harrison R, O'Brien B, Kamiya-Matsuoka C, De Groot J, Puduvalli VK, Tatsui C, Alvarez-Breckenridge C, Prabhu S, Rhines L, Zaky W, Lin F, Weinberg JS, Fuller G, Sandberg DI, Johnson JM, McGovern SL. Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis. Neurooncol Adv. 2022 Aug 20;4(1):vdac129. doi:10.1093/noajnl/vdac129. PMID: 36128585; PMCID: PMC9476222.
Allam AK, Larkin MB, McGinnis JP, Viswanathan A. Neuroablative central lateral thalamotomy for chronic neuropathic pain. Front Pain Res (Lausanne).2022 Sep 13;3:999891. doi: 10.3389/fpain.2022.999891. PMID: 36176711; PMCID:PMC9513204.
Xu Z, Lee DS, Chandran S, Le VT, Bump R, Yasis J, Dallarda S, Marcotte S, Clock B, Haghani N, Cho CY, Akdemir KC, Tyndale S, Futreal PA, McVicker G, Wahl GM, Dixon JR. Structural variants drive context-dependent oncogene activation in cancer. Nature. 2022 Dec;612(7940):564-572. doi: 10.1038/s41586-022-05504-4.Epub 2022 Dec 7. PMID: 36477537; PMCID: PMC9810360.
Li T, Mehraein-Ghomi F, Forbes ME, Namjoshi SV, Ballard EA, Song Q, Chou PC, Wang X, Parker Kerrigan BC, Lang FF, Lesser G, Debinski W, Yang X, Zhang W.HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion. MolTher. 2022 Apr 6;30(4):1610-1627. doi: 10.1016/j.ymthe.2022.02.009. Epub 2022Feb 10. PMID: 35151844; PMCID: PMC9077375.
Lee S, Srivatsan A, Srinivasan VM, Chen SR, Burkhardt JK, Johnson JN, Raper DMS, Weinberg JS, Kan P. Middle meningeal artery embolization for chronic subdural hematoma in cancer patients with refractory thrombocytopenia. JNeurosurg. 2021 Oct 8;136(5):1273-1277. doi: 10.3171/2021.5.JNS21109. PMID:34624863.
Woodhouse KD, Devlin PM, Kollmeier M, Lin LL, Orio P, Ouhib Z, Song D, Viswanathan AN, Watanabe Y, Yu Y, Small W Jr, Schechter NR. ACR-ABS-ASTRO Practice Parameter for the Performance of Low-Dose-Rate Brachytherapy. Am J ClinOncol. 2022 Jun 1;45(6):243-248. doi: 10.1097/COC.0000000000000912. Epub 2022Apr 29. PMID: 35485607.
Huntoon K, Shepard MJ, Lukas RV, McCutcheon IE, Daniels AB, Asthagiri AR. Hemangioblastoma diagnosis and surveillance in von Hippel-Lindau disease: a consensus statement. J Neurosurg. 2021 Oct 1;136(6):1511-1516. doi:10.3171/2021.3.JNS204203. PMID: 34598132.
Strickland MR, Alvarez-Breckenridge C, Gainor JF, Brastianos PK. Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity. Cancer Discov. 2022 May 2;12(5):1199-1216. doi:10.1158/2159-8290.CD-21-0976. PMID: 35394521; PMCID: PMC11440428.
Muir M, Rhines L, Demonte F, Tatsui C, Raza SM. Impact of Radiation Therapy on Outcomes After Spinal Instrumentation for Craniocervical Junction Malignancies. Neurospine. 2022 Jun;19(2):434-440. doi: 10.14245/ns.2244034.017.Epub 2022 May 15. PMID: 35577332; PMCID: PMC9260556.
Morales JE, De A, Miller AA, Chen Z, McCarty JH. Mlc1-ExpressingPerivascular Astrocytes Promote Blood-Brain Barrier Integrity. J Neurosci. 2022Feb 23;42(8):1406-1416. doi: 10.1523/JNEUROSCI.1918-21.2021. Epub 2021 Dec 29.PMID: 34965971; PMCID: PMC8883848.
Lu Y, Huntoon K, Lee D, Wang Y, Ha J, Qie Y, Li X, Schrank BR, Dong S, Gallup TD, Kang M, Zhao H, An Y, Yang Z, Li J, Kim BYS, Jiang W. Immunological conversion of solid tumors using a bispecific nanobioconjugate for cancer immunotherapy. Nat Nanotechnol. 2022 Dec;17(12):1332-1341. doi:10.1038/s41565-022-01245-7. Epub 2022 Nov 10. PMID: 36357792; PMCID:PMC10036139.
Hill C, Deville C Jr, Kiess A, Narang A, Ratnanather T, Bienstock J, Brinckerhoff L, Hodukavich A, Anderson R, Alcorn S, DeWeese T, Viswanathan A, Page BR. Establishing a Deaf and American Sign Language Inclusive Residency Program. Acad Med. 2022 Mar 1;97(3):357-363. doi: 10.1097/ACM.0000000000004469.PMID: 34670241.
Gibson M, Michalowicz M, Chrisinger JSA, Bell D, Shah K, Demonte F, Gidley PW. Osteoblastoma of the Temporal Bone in a Child. Otol Neurotol. 2022 Feb1;43(2):e276-e278. doi: 10.1097/MAO.0000000000003381. PMID: 35015753.
Snyder R, Gadot R, Gidley PW, Nader ME, Hanna EY, Su SY, DeMonte F, Raza SM. Patient, Disease, and Treatment-Related Factors Affecting Progression-Free and Disease-Specific Survival in Recurrent Chondrosarcomas of the Skull Base. OperNeurosurg. 2023 Jan 1;24(1):33-43. doi: 10.1227/ons.0000000000000445. Epub 2022Nov 1. PMID: 36519877.
Bhalla AD, Landers SM, Singh AK, Landry JP, Yeagley MG, Myerson GSB, Delgado-Baez CB, Dunnand S, Nguyen T, Ma X, Bolshakov S, Menegaz BA, Lamhamedi-Cherradi SE, Mao X, Song X, Lazar AJ, McCutcheon IE, Slopis JM, Ludwig JA, Lev DC, Rai K, Torres KE. Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor. Lab Invest. 2022Jun;102(6):658-666. doi: 10.1038/s41374-022-00734-6. Epub 2022 Feb 28. PMID:35228656; PMCID: PMC11959861.
Mehta GU, Passer JZ, Raza SM, Kim BYS, Su SY, Kupferman ME, Hanna EY, DeMonte F. The neurosurgical management of sinonasal malignancies involving the anterior skull base: a 28-year experience at The MD Anderson Cancer Center. JNeurosurg. 2021 Oct 8;136(6):1583-1591. doi: 10.3171/2021.5.JNS21772. PMID:34624857.
Vogelbaum MA, Li G, Heimberger AB, Lang FF, Fueyo J, Gomez-Manzano C, SanaiN. A Window of Opportunity to Overcome Therapeutic Failure in Neuro-Oncology. AmSoc Clin Oncol Educ Book. 2022 Apr;42:1-8. doi: 10.1200/EDBK_349175. PMID:35580289.
Zamler DB, Shingu T, Kahn LM, Huntoon K, Kassab C, Ott M, Tomczak K, Liu J,Li Y, Lai I, Zorilla-Veloz R, Yee C, Rai K, Kim BY, Watowich SS, Heimberger AB, Draetta GF, Hu J. Immune landscape of a genetically engineered murine model of glioma compared with human glioma. JCI Insight. 2022 Jun 22;7(12):e148990. doi:10.1172/jci.insight.148990. PMID: 35653194; PMCID: PMC9309065.
MacLean MA, Touchette CJ, Georgiopoulos M, Brunette-Clément T, Abduljabbar FH, Ames CP, Bettegowda C, Charest-Morin R, Dea N, Fehlings MG, Gokaslan ZL, Goodwin CR, Laufer I, Netzer C, Rhines LD, Sahgal A, Shin JH, Sciubba DM, Stephens BF, Fourney DR, Weber MH; AO Spine Knowledge Forum Tumor. Systemic considerations for the surgical treatment of spinal metastatic disease: a scoping literature review. Lancet Oncol. 2022 Jul;23(7):e321-e333. doi:10.1016/S1470-2045(22)00126-7. PMID: 35772464; PMCID: PMC9844540.
Modrek AS, Eskilsson E, Ezhilarasan R, Wang Q, Goodman LD, Ding Y, Zhang ZY, Bhat KPL, Le TT, Barthel FP, Tang M, Yang J, Long L, Gumin J, Lang FF, Verhaak RGW, Aldape KD, Sulman EP. PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells. Front Oncol. 2022 Aug 10;12:941657. doi:10.3389/fonc.2022.941657. PMID: 36059614; PMCID: PMC9434399.
Muir M, Prinsloo S, Traylor JI, Patel R, Ene C, Tummala S, Prabhu SS. Transcranial magnetic stimulation tractography and the facilitation of gross total resection in a patient with a motor eloquent glioblastoma: illustrative case. J Neurosurg Case Lessons. 2022 May 16;3(20):CASE22128. doi:10.3171/CASE22128. PMID: 36303481; PMCID: PMC9379643.
Schur SE, Hanna EY, Su SY, Kupferman ME, DeMonte F, Raza SM. Impact of salvage surgery for recurrent sinonasal cancers with skull base and intracranial involvement. J Neurosurg. 2022 Feb 4;137(4):961-968. doi:10.3171/2021.12.JNS212278. PMID: 35120325.
Alvarez-Breckenridge C, Markson SC, Stocking JH, Nayyar N, Lastrapes M, Strickland MR, Kim AE, de Sauvage M, Dahal A, Larson JM, Mora JL, Navia AW, Klein RH, Kuter BM, Gill CM, Bertalan M, Shaw B, Kaplan A, Subramanian M, Jain A, Kumar S, Danish H, White M, Shahid O, Pauken KE, Miller BC, Frederick DT, Hebert C, Shaw M, Martinez-Lage M, Frosch M, Wang N, Gerstner E, Nahed BV, Curry WT, Carter B, Cahill DP, Boland GM, Izar B, Davies MA, Sharpe AH, Suvà ML, Sullivan RJ, Brastianos PK, Carter SL. Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition. CancerImmunol Res. 2022 Aug 3;10(8):996-1012. doi: 10.1158/2326-6066.CIR-21-0870.PMID: 35706413; PMCID: PMC10201927.
Rogers JL, De La Cruz Minyety J, Vera E, Acquaye AA, Payén SS, Weinberg JS, Armstrong TS, Weathers SS. Assessing mobility in primary brain tumor patients: A descriptive feasibility study using two established mobility tests. Neurooncol Pract. 2022 Feb 17;9(3):219-228. doi: 10.1093/nop/npac013. PMID: 35601968;PMCID: PMC9113321.
Muir M, Prinsloo S, Michener H, Traylor JI, Patel R, Gadot R, de Almeida Bastos DC, Kumar VA, Ferguson S, Prabhu SS. TMS Seeded Diffusion Tensor Imaging Tractography Predicts Permanent Neurological Deficits. Cancers (Basel). 2022 Jan11;14(2):340. doi: 10.3390/cancers14020340. PMID: 35053503; PMCID: PMC8774180.
George J, Chen Y, Abdelfattah N, Yamamoto K, Gallup TD, Adamson SI, Rybinski B, Srivastava A, Kumar P, Lee MG, Baskin DS, Jiang W, Choi JM, Flavahan W, Chuang JH, Kim BY, Xu J, Jung SY, Yun K. Cancer stem cells, not bulk tumor cells, determine mechanisms of resistance to SMO inhibitors. Cancer Res Commun.2022 Jun;2(6):402-416. doi: 10.1158/2767-9764.crc-22-0124. Epub 2022 Jun 6.PMID: 36688010; PMCID: PMC9853917.
Ziyaee H, Cardenas CE, Yeboa DN, Li J, Ferguson SD, Johnson J, Zhou Z, Sanders J, Mumme R, Court L, Briere T, Yang J. Automated Brain Metastases Segmentation With a Deep Dive Into False-positive Detection. Adv Radiat Oncol.2022 Sep 28;8(1):101085. doi: 10.1016/j.adro.2022.101085. PMID: 36299565; PMCID:PMC9589017.
Nguyen TT, Shin DH, Sohoni S, Singh SK, Rivera-Molina Y, Jiang H, Fan X, Gumin J, Lang FF, Alvarez-Breckenridge C, Godoy-Vitorino F, Zhu L, Zheng WJ, Zhai L, Ladomersky E, Lauing KL, Alonso MM, Wainwright DA, Gomez-Manzano C, Fueyo J. Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry. J Immunother Cancer. 2022 Jul;10(7):e004935. doi:10.1136/jitc-2022-004935. PMID: 35902132; PMCID: PMC9341188.
Amit M, Xie T, Gleber-Netto FO, Hunt PJ, Mehta GU, Bell D, Silverman DA, Yaman I, Ye Y, Burks JK, Fuller GN, Gidley PW, Nader ME, Raza SM, DeMonte F. Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology. J Exp Clin Cancer Res. 2022 Oct 4;41(1):292.doi: 10.1186/s13046-022-02473-4. PMID: 36195959; PMCID: PMC9531347.
Xu J, Wu PJ, Lai TH, Sharma P, Canella A, Welker AM, Beattie CE, Elder JB, Easley M, Lonser R, Jacob NK, Pietrzak M, Timmers CM, Lang F, Sampath D, Puduvalli VK. Disruption of DNA Repair and Survival Pathways through Heat Shock Protein Inhibition by Onalespib to Sensitize Malignant Gliomas to Chemoradiation Therapy. Clin Cancer Res. 2022 May 2;28(9):1979-1990. doi:10.1158/1078-0432.CCR-20-0468. PMID: 35140124; PMCID: PMC9064967.
Muir M, Patel R, Traylor JI, de Almeida Bastos DC, Kamiya C, Li J, Rao G, Prabhu SS. Laser interstitial thermal therapy for newly diagnosed glioblastoma. Lasers Med Sci. 2022 Apr;37(3):1811-1820. doi: 10.1007/s10103-021-03435-6. Epub2021 Oct 23. PMID: 34687390.
Johnson JN, Srivatsan A, Chueh J, Arslanian R, Gounis MJ, Puri AS, Srinivasan VM, Chen SR, Burkhardt JK, Kan P. Impact of histological clot composition on pre-procedure imaging and mechanical thrombectomy. Brain Circ.2022 Jun 30;8(2):87-93. doi: 10.4103/bc.bc_81_21. PMID: 35909711; PMCID:PMC9336592.
Thouvenin J, Alhalabi O, Carlo M, Carril-Ajuria L, Hirsch L, Martinez-Chanza N, Négrier S, Campedel L, Martini D, Borchiellini D, Chahoud J, Lodi M, Barthélémy P, Hasanov E, Hahn AW, Gil T, Viswanathan SR, Bakouny Z, Msaouel P, Asim Bilen M, Choueiri TK, Albiges L, Tannir NM, Malouf GG. Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas. Oncologist. 2022 Dec 9;27(12):1041-1047. doi: 10.1093/oncolo/oyac158. PMID:35979929; PMCID: PMC10249266.
De A, Morales JE, Chen Z, Sebastian S, McCarty JH. The β8 integrin cytoplasmic domain activates extracellular matrix adhesion to promote brain neurovascular development. Development. 2022 Mar 15;149(6):dev200472. doi:10.1242/dev.200472. Epub 2022 Mar 18. PMID: 35217866; PMCID: PMC8977100.
Mattogno PP, Marciano F, Catalino MP, Mattavelli D, Cocca P, Lopomo NF, Nicolai P, Laws ER Jr, Witterick I, Raza SM, Devaiah AK, Lauretti L, Olivi A, Fontanella MM, Gentili F, Doglietto F. Ergonomics in Endoscopic Transsphenoidal Surgery: A Survey of the North American Skull Base Society. J Neurol Surg B Skull Base. 2021 May 17;83(Suppl 2):e380-e385. doi: 10.1055/s-0041-1729906.PMID: 35832944; PMCID: PMC9272277.
Schur S, Passer JZ, Hanna EY, Su SY, Kupferman ME, DeMonte F, Raza SM. The impact of expanded endoscopic approaches on oncologic and functional outcomes for clival malignancies: a case series. J Neurooncol. 2022 Sep;159(3):627-635.doi: 10.1007/s11060-022-04103-7. Epub 2022 Aug 16. PMID: 35972674.
Habib A, Edem I, Bell D, Su SY, Hanna EY, Kupferman ME, DeMonte F, Raza SM. Soft Tissue Sarcomas of the Head and Neck Region with Skull Base/Intracranial Invasion: Review of Surgical Outcomes and Multimodal Treatment Strategies: A Retrospective Case Series. Curr Oncol. 2022 Sep 14;29(9):6540-6550. doi:10.3390/curroncol29090514. PMID: 36135083; PMCID: PMC9498209.
Uhelski ML, Gorur A, Shi T, Corrales G, Du KN, Li Y, Amit M, Tatsui CE, Rhines LD, Dougherty PM, Cata JP. Fadu head and neck squamous cell carcinoma induces hyperexcitability of primary sensory neurons in an in vitro co culture model. Pain Rep. 2022 May 16;7(3):e1012. doi: 10.1097/PR9.0000000000001012.PMID: 35620249; PMCID: PMC9113206.
Najem H, Ott M, Kassab C, Rao A, Rao G, Marisetty A, Sonabend AM, Horbinski C, Verhaak R, Shankar A, Krishnan SN, Varn FS, Arrieta VA, Gupta P, Ferguson SD, Huse JT, Fuller GN, Long JP, Winkowski DE, Freiberg BA, James CD, Platanias LC, Lesniak MS, Burks JK, Heimberger AB. Central nervous system immune interactomeis a function of cancer lineage, tumor microenvironment, and STAT3 expression. JCI Insight. 2022 May 9;7(9):e157612. doi: 10.1172/jci.insight.157612. PMID:35316217; PMCID: PMC9090258.
North RY, Odem MA, Li Y, Tatsui CE, Cassidy RM, Dougherty PM, Walters ET. Electrophysiological Alterations Driving Pain-Associated Spontaneous Activity in Human Sensory Neuron Somata Parallel Alterations Described in Spontaneously Active Rodent Nociceptors. J Pain. 2022 Aug;23(8):1343-1357. doi:10.1016/j.jpain.2022.02.009. Epub 2022 Mar 12. PMID: 35292377; PMCID:PMC9357108.
Groot J, Ott M, Wei J, Kassab C, Fang D, Najem H, O'Brien B, Weathers SP, Matsouka CK, Majd NK, Harrison RA, Fuller GN, Huse JT, Long JP, Sawaya R, Rao G, MacDonald TJ, Priebe W, DeCuypere M, Heimberger AB. A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma. CNS Oncol. 2022 Jun 1;11(2):CNS87. doi: 10.2217/cns-2022-0005. Epub 2022 May 16. PMID: 35575067; PMCID: PMC9134932.
Bishop AJ, Zheng J, Subramaniam A, Ghia AJ, Wang C, McGovern SL, Patel S, Guadagnolo BA, Mitra D, Farooqi A, Reardon MJ, Kim B, Guha-Thakurta N, Li J, Ravi V. Cardiac Angiosarcomas: Risk of Brain Metastasis and Hemorrhage Warrants Frequent Surveillance Imaging and Early Intervention. Am J Clin Oncol. 2022 Jun1;45(6):258-263. doi: 10.1097/COC.0000000000000913. Epub 2022 Apr 26. PMID:35588225; PMCID: PMC9179017.
Muir M, Patel R, Traylor J, de Almeida Bastos DC, Prinsloo S, Liu HL, NollK, Wefel J, Tummala S, Kumar V, Prabhu S. Validation of Non-invasive Language Mapping Modalities for Eloquent Tumor Resection: A Pilot Study. Front Neurosci.2022 Mar 1;16:833073. doi: 10.3389/fnins.2022.833073. PMID: 35299624; PMCID:PMC8923233.
Sharma P, Xu J, Williams K, Easley M, Elder JB, Lonser R, Lang FF, Lapalombella R, Sampath D, Puduvalli VK. Inhibition of nicotinamide phosphoribosyl transferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress. Neuro Oncol. 2022 Feb 1;24(2):229-244.doi: 10.1093/neuonc/noab175. PMID: 34260721; PMCID: PMC8804900.
Jorge PG, Melemenidis S, Grilj V, Buchillier T, Manjappa R, Viswanathan V,Gondré M, Vozenin MC, Germond JF, Bochud F, Moeckli R, Limoli C, Skinner L, No HJ, Wu YF, Surucu M, Yu AS, Lau B, Wang J, Schüler E, Bush K, Graves EE, Maxim PG, Loo BW Jr, Bailat C. Design and validation of a dosimetric comparison scheme tailored for ultra-high dose-rate electron beams to support multicenter FLASH preclinical studies. Radiother Oncol. 2022 Oct;175:203-209. doi:10.1016/j.radonc.2022.08.023. Epub 2022 Aug 27. PMID: 36030934.
Muir M, Traylor JI, Gadot R, Patel R, Prabhu SS. Repeat laser interstitial thermal therapy for recurrent primary and metastatic intracranial tumors. SurgNeurol Int. 2022 Jul 22;13:311. doi: 10.25259/SNI_418_2022. PMID: 35928321;PMCID: PMC9345120.
Bell D, Phan J, DeMonte F, Hanna EY. High-grade transformation of low-grade biphenotypic sinonasal sarcoma: Radiological, morphophenotypic variation and confirmatory molecular analysis. Ann Diagn Pathol. 2022 Apr;57:151889. doi:10.1016/j.anndiagpath.2021.151889. Epub 2022 Jan 10. PMID: 35030392.
de Groot JF, Kim AH, Prabhu S, Rao G, Laxton AW, Fecci PE, O'Brien BJ, SloanA, Chiang V, Tatter SB, Mohammadi AM, Placantonakis DG, Strowd RE, Chen C, Hadjipanayis C, Khasraw M, Sun D, Piccioni D, Sinicrope KD, Campian JL, Kurz SC, Williams B, Smith K, Tovar-Spinoza Z, Leuthardt EC. Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent IDH wild-type glioblastoma. Neurooncol Adv. 2022 Apr 6;4(1):vdac040. doi:10.1093/noajnl/vdac040. PMID: 35611270; PMCID: PMC9122789.
Asman P, Pellizzer G, Tummala S, Tasnim I, Bastos D, Bhavsar S, Prabhu S, Ince NF. Long-latency gamma modulation after median nerve stimulation delineates the central sulcus and contrasts the states of consciousness. Clin Neurophysiol.2023 Jan;145:1-10. doi: 10.1016/j.clinph.2022.10.008. Epub 2022 Oct 31. PMID:36370685; PMCID: PMC11905291.
Muir M, Prinsloo S, Michener H, Shetty A, de Almeida Bastos DC, Traylor J, Ene C, Tummala S, Kumar VA, Prabhu SS. Transcranial magnetic stimulation (TMS)seeded tractography provides superior prediction of eloquence compared to anatomic seeded tractography. Neurooncol Adv. 2022 Sep 15;4(1):vdac126. doi:10.1093/noajnl/vdac126. PMID: 36128584; PMCID: PMC9476227.
Viswanathan V, Cao H, Saiki J, Jiang D, Mattingly A, Nambiar D, Bloomstein J, Li Y, Jiang S, Chamoli M, Sirjani D, Kaplan M, Holsinger FC, Liang R, VonEyben R, Jiang H, Guan L, Lagory E, Feng Z, Nolan G, Ye J, Denko N, Knox S, Rosen DM, Le QT. Aldehyde dehydrogenase 3A1 deficiency leads to mitochondrial dysfunction and impacts salivary gland stem cell phenotype. PNAS Nexus. 2022 Jun9;1(2):pgac056. doi: 10.1093/pnasnexus/pgac056. Erratum in: PNAS Nexus. 2024 Jan30;3(1):pgad460. doi: 10.1093/pnasnexus/pgad460. PMID: 35707206; PMCID:PMC9186046.
Muir M, Gadot R, Prinsloo S, Michener H, Traylor J, Athukuri P, Tummala S,Kumar VA, Prabhu SS. Comparative study of preoperative functional imaging combined with tractography for prediction of iatrogenic motor deficits. JNeurosurg. 2022 Nov 25;139(1):65-72. doi: 10.3171/2022.10.JNS221684. PMID:36433877.
van Putten EHP, Kleijn A, van Beusechem VW, Noske D, Lamers CHJ, de Goede AL, Idema S, Hoefnagel D, Kloezeman JJ, Fueyo J, Lang FF, Teunissen CE, Vernhout RM, Bakker C, Gerritsen W, Curiel DT, Vulto A, Lamfers MLM, Dirven CMF. Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies. ClinCancer Res. 2022 Apr 14;28(8):1572-1585. doi: 10.1158/1078-0432.CCR-21-3324.PMID: 35176144; PMCID: PMC9365362.
Allam AK, Larkin MB, Katlowitz KA, Shofty B, Viswanathan A. Case report: MR-guided laser induced thermal therapy for palliative cingulotomy. Front Pain Res(Lausanne). 2022 Nov 1;3:1028424. doi: 10.3389/fpain.2022.1028424. PMID:36387414; PMCID: PMC9663803.
Ege E, Vangeison C, Chai T, Roldan CJ, Borman D, Huh BK, Viswanathan A. Cingulotomy for Refractory Pain in Metastatic Clear Cell Sarcoma. Pain Med CaseRep. 2022 Sep;6(5):183-188. PMID: 41299932.
Gates EDH, Suki D, Celaya A, Weinberg JS, Prabhu SS, Sawaya R, Huse JT, Long JP, Fuentes D, Schellingerhout D. Cellular Density in Adult Glioma, Estimated with MR Imaging Data and a Machine Learning Algorithm, Has Prognostic Power Approaching World Health Organization Histologic Grading in a Cohort of 1181Patients. AJNR Am J Neuroradiol. 2022 Oct;43(10):1411-1417. doi:10.3174/ajnr.A7620. Epub 2022 Sep 15. PMID: 36109124; PMCID: PMC9575543.
Alvarez-Breckenridge C, Remon J, Piña Y, Nieblas-Bedolla E, Forsyth P, Hendriks L, Brastianos PK. Emerging Systemic Treatment Perspectives on Brain Metastases: Moving Toward a Better Outlook for Patients. Am Soc Clin Oncol EducBook. 2022 Apr;42:1-19. doi: 10.1200/EDBK_352320. PMID: 35522917.
Versteeg AL, Elkaim LM, Sahgal A, Rhines LD, Sciubba DM, Schuster JM, Fehlings MG, Lazary A, Clarke MJ, Arnold PM, Bettegowda C, Boriani S, Gokaslan ZL, Fisher CG, Weber MH; AO Spine Knowledge Forum Tumor. Steroids in the Management of Preoperative Neurological Deficits in Metastatic Spine Disease: Results From the EPOSO Study. Neurospine. 2022 Mar;19(1):43-50. doi:10.14245/ns.2142768.384. Epub 2022 Jan 30. PMID: 35130426; PMCID: PMC8987562.
Hernández-Verdin I, Akdemir KC, Ramazzotti D, Caravagna G, Labreche K, Mokhtari K, Hoang-Xuan K, Peyre M, Bielle F, Touat M, Idbaih A, Duval A, Sanson M, Alentorn A. Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response. NPJ Precis Oncol. 2022Dec 1;6(1):89. doi: 10.1038/s41698-022-00331-2. PMID: 36456685; PMCID:PMC9715662.
Haghshenas V, Moghimi M, Haghshenas MP, Shin C, Holderread BM, Hirase T, Hanson DS, Rhines L, Marco R. Scoliosis Following Chest Wall Resection for Tumor With and Without Prophylactic Fixation: Case Series. Cureus. 2022 Jan11;14(1):e21115. doi: 10.7759/cureus.21115. PMID: 35165572; PMCID: PMC8830437.
Gopakumar S, McDonald MF, Sharma H, Tatsui CE, Fuller GN, Rao G. RecurrentHGNET-MN1 altered (astroblastoma MN1-altered) of the foramen magnum: Case report and molecular classification. Surg Neurol Int. 2022 Apr 15;13:139. doi:10.25259/SNI_1208_2021. PMID: 35509530; PMCID: PMC9062895.
Lazaro TT, Katlowitz KA, Karas PJ, Srinivasan VM, Walls E, Collier G, Raza SM, Curry DJ, Ropper AE, Fuentes A, Gopinath SP, Rao G, Patel AJ. The impact of a night float system on operative experience in neurosurgery residency. JNeurosurg. 2022 Sep 9;138(4):1117-1123. doi: 10.3171/2022.4.JNS212612. PMID:36087325.
Danussi C, Bose P, Parthasarathy PT, Silberman PC, Van Arnam JS, Vitucci M, Tang OY, Heguy A, Wang Y, Chan TA, Riggins GJ, Sulman EP, Lang FF, Creighton CJ, Deneen B, Miller CR, Picketts DJ, Kannan K, Huse JT. Author Correction: Atrxinactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling. Nat Commun. 2022 Jan 5;13(1):190. doi:10.1038/s41467-021-27820-5. Erratum for: Nat Commun. 2018 Mar 13;9(1):1057. doi:10.1038/s41467-018-03476-6. PMID: 34987156; PMCID: PMC8733027.
Jiang B, Murray C, Cole BL, Glover JNM, Chan GK, Deschenes J, Mani RS, Subedi S, Nerva JD, Wang AC, Lockwood CM, Mefford HC, Leary SES, Ojemann JG, Weinfeld M, Ene CI. Mutations of the DNA repair gene PNKP in a patient with microcephaly, seizures, and developmental delay (MCSZ) presenting with a high-grade brain tumor. Sci Rep. 2022 Mar 30;12(1):5386. doi:10.1038/s41598-022-09097-w. PMID: 35354845; PMCID: PMC8967877.
Gendreau J, Jimenez A, Lozinsky S, Zenonos G, Gardner P, Raza S, Dea N, Gokaslan Z, Choby G, Van Gompel J, Redmond K, Gallia G, Bettegowda C, Rowan N, Kuo CC, Mukherjee D. Radiotherapy After Gross Total Resection of Skull Base Chordoma: A Surveillance, Epidemiology, and End Results Database Analysis of Survival Outcomes. World Neurosurg. 2023 Apr;172:e68-e76. doi:10.1016/j.wneu.2022.12.012. Epub 2022 Dec 9. PMID: 36509323.
Chino J, Yashar C, Klopp A, Viswanathan A. Limiting Access to Abortion Will Potentially Harm Patients With Gynecologic Cancers. Int J Radiat Oncol BiolPhys. 2022 Nov 1;114(3):396-398. doi: 10.1016/j.ijrobp.2022.07.1845. Epub 2022Aug 10. PMID: 35963471.
Shimizu Y, Gumin J, Gao F, Hossain A, Shpall EJ, Kondo A, Parker Kerrigan BC, Yang J, Ledbetter D, Fueyo J, Gomez-Manzano C, Lang FF. Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma. J Neurosurg. 2021 Aug27;136(3):757-767. doi: 10.3171/2021.3.JNS203045. PMID: 34450587; PMCID:PMC10193507.
2021 Publications
Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, DunnI F, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, van den Bent M, Wallace HJ, Weinberg JS, Zadeh G, Schiff D. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. J ClinOncol. 2022 Feb 10;40(5):492-516. doi: 10.1200/JCO.21.02314. Epub 2021 Dec 21.Erratum in: J Clin Oncol. 2022 Apr 20;40(12):1392. doi: 10.1200/JCO.22.00593.PMID: 34932393.
Small W Jr, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK. NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):413-424. doi:10.1016/j.ijrobp.2020.08.061. Epub 2020 Sep 6. PMID: 32905846; PMCID:PMC7856050.
Shaim H, Shanley M, Basar R, Daher M, Gumin J, Zamler DB, Uprety N, Wang F, Huang Y, Gabrusiewicz K, Miao Q, Dou J, Alsuliman A, Kerbauy LN, Acharya S, Mohanty V, Mendt M, Li S, Lu J, Wei J, Fowlkes NW, Gokdemir E, Ensley EL, Kaplan M, Kassab C, Li L, Ozcan G, Banerjee PP, Shen Y, Gilbert AL, Jones CM, Bdiwi M, Nunez-Cortes AK, Liu E, Yu J, Imahashi N, Muniz-Feliciano L, Li Y, Hu J, Draetta G, Marin D, Yu D, Mielke S, Eyrich M, Champlin RE, Chen K, Lang FF, Shpall EJ, Heimberger AB, Rezvani K. Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells. J Clin Invest. 2021 Jul15;131(14):e142116. doi: 10.1172/JCI142116. PMID: 34138753; PMCID: PMC8279586.
Bakouny Z, Braun DA, Shukla SA, Pan W, Gao X, Hou Y, Flaifel A, Tang S, Bosma-Moody A, He MX, Vokes N, Nyman J, Xie W, Nassar AH, Abou Alaiwi S, Flippot R, Bouchard G, Steinharter JA, Nuzzo PV, Ficial M, Sant'Angelo M, Forman J, Berchuck JE, Dudani S, Bi K, Park J, Camp S, Sticco-Ivins M, Hirsch L, Baca SC, Wind-Rotolo M, Ross-Macdonald P, Sun M, Lee GM, Chang SL, Wei XX, McGregor BA, Harshman LC, Genovese G, Ellis L, Pomerantz M, Hirsch MS, Freedman ML, Atkins MB, Wu CJ, Ho TH, Linehan WM, McDermott DF, Heng DYC, Viswanathan SR, Signoretti S, Van Allen EM, Choueiri TK. Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma. Nat Commun. 2021 Feb 5;12(1):808.doi: 10.1038/s41467-021-21068-9. PMID: 33547292; PMCID: PMC7865061.
Jiang W, Wang Y, Wargo JA, Lang FF, Kim BYS. Considerations for designing preclinical cancer immune nanomedicine studies. Nat Nanotechnol. 2021Jan;16(1):6-15. doi: 10.1038/s41565-020-00817-9. Epub 2020 Dec 21. PMID:33349682; PMCID: PMC8103921.
Rogers CM, Jones PS, Weinberg JS. Intraoperative MRI for Brain Tumors. JNeurooncol. 2021 Feb;151(3):479-490. doi: 10.1007/s11060-020-03667-6. Epub 2021Feb 21. PMID: 33611714.
Passer JZ, Alvarez-Breckenridge C, Rhines L, DeMonte F, Tatsui C, Raza SM. Surgical Management of Skull Base and Spine Chordomas. Curr Treat Options Oncol.2021 Mar 20;22(5):40. doi: 10.1007/s11864-021-00838-z. PMID: 33743089.
Lee D, Huntoon K, Wang Y, Jiang W, Kim BYS. Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy. Adv Mater. 2021 Jul;33(27):e2007576. doi:10.1002/adma.202007576. Epub 2021 May 29. PMID: 34050699.
Srinivasan VM, Lang FF, Kan P. Intraarterial delivery of virotherapy for glioblastoma. Neurosurg Focus. 2021 Feb;50(2):E7. doi:10.3171/2020.11.FOCUS20845. PMID: 33524944.
Zakaria R, Weinberg JS. Challenges Associated with Reoperation in Patients with Glioma. Neurosurg Clin N Am. 2021 Jan;32(1):129-135. doi:10.1016/j.nec.2020.09.004. Epub 2020 Nov 5. PMID: 33223021.
Srinivasan VM, Hadley CC, Patel AJ, Ehni BL, Weiner HL, Rao G, Lang FF, Sawaya RE, Yoshor D. The history of neurosurgery at Baylor College of Medicine. J Neurosurg. 2021 Feb 19;135(4):1259-1269. doi: 10.3171/2020.7.JNS201196. PMID:33607618.
Ma Y, Dong S, Li X, Kim BYS, Yang Z, Jiang W. Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy. Front Oncol. 2021 Feb 8;10:606906.doi: 10.3389/fonc.2020.606906. PMID: 33628730; PMCID: PMC7897670.
Abdelmeguid AS, Bell D, Roberts D, Ferrarotto R, Phan J, Su SY, Kupferman M, Raza S, DeMonte F, Hanna E. Long-Term Outcomes of Olfactory Neuroblastoma: MD Anderson Cancer Center Experience and Review of the Literature. Laryngoscope.2022 Feb;132(2):290-297. doi: 10.1002/lary.29732. Epub 2021 Jul 17. PMID:34272876.
Yamazaki Y, Liu CC, Yamazaki A, Shue F, Martens YA, Chen Y, Qiao W, Kurti A, Oue H, Ren Y, Li Y, Aikawa T, Cherukuri Y, Fryer JD, Asmann YW, Kim BYS, Kanekiyo T, Bu G. Vascular ApoE4 Impairs Behavior by Modulating Gliovascular Function. Neuron. 2021 Feb 3;109(3):438-447.e6. doi:10.1016/j.neuron.2020.11.019. Epub 2020 Dec 14. PMID: 33321072; PMCID:PMC7864888.
Ferguson SD, Fomchenko EI, Guerrieri RA, Glitza Oliva IC. Challenges and Advances in Diagnosis and Treatment of Leptomeningeal Disease (LMD). FrontOncol. 2022 Jan 12;11:800053. doi: 10.3389/fonc.2021.800053. PMID: 35096602;PMCID: PMC8789647.
Chen SR, Chen MM, Ene C, Lang FF, Kan P. Perfusion-guided endovascular super-selective intra-arterial infusion for treatment of malignant brain tumors. J Neurointerv Surg. 2022 Jun;14(6):533-538. doi:10.1136/neurintsurg-2021-018190. Epub 2021 Nov 25. PMID: 34824133.
Germscheid N, Cheung JPY, Neva MH, Öner FC, Kwon BK, Valacco M, Awwad W, Sciubba DM, Lewis SJ, Rhines LD, Yoon ST, Alini M, Grad S, Fisher CG, Samartzis D. Research Practices and Needs Among Spine Surgeons Worldwide. Global Spine J.2023 Sep;13(7):1894-1908. doi: 10.1177/21925682211058158. Epub 2021 Dec 6. PMID:34870488; PMCID: PMC10556911.
Kamp MA, Malzkorn B, von Sass C, DiMeco F, Hadjipanayis CG, Senft C, Rapp M, Gepfner-Tuma I, Fountas K, Krieg SM, Neukirchen M, Florian IȘ, Schnell O, Mijderwijk HJ, Perin A, Baumgarten P, van Lieshout JH, Thon N, Renovanz M, Kahlert U, Spoor JKH, Hänggi D, McLean AL, Mäurer M, Sarrubbo S, Freyschlag CF, Schmidt NO, Vergani F, Jungk C, Stein M, Forster MT, Weinberg JS, Sinclair J, Belykh E, Bello L, Mandonnet E, Moiyadi A, Sabel M. Proposed definition of competencies for surgical neuro-oncology training. J Neurooncol. 2021May;153(1):121-131. doi: 10.1007/s11060-021-03750-6. Epub 2021 Apr 21. PMID:33881726; PMCID: PMC8131302.
Palmisciano P, Haider AS, Nwagwu CD, Wahood W, Yu K, Ene CI, O'Brien BJ, Aoun SG, Cohen-Gadol AA, El Ahmadieh TY. The Role of Immune CheckpointInhibitors in Leptomeningeal Disease: A Systematic Review. Anticancer Res. 2021Nov;41(11):5333-5342. doi: 10.21873/anticanres.15346. PMID: 34732403; PMCID:PMC9358987.
Lee S, Srivatsan A, Srinivasan VM, Chen SR, Burkhardt JK, Johnson JN, Raper DMS, Weinberg JS, Kan P. Middle meningeal artery embolization for chronic subdural hematoma in cancer patients with refractory thrombocytopenia. JNeurosurg. 2021 Oct 8;136(5):1273-1277. doi: 10.3171/2021.5.JNS21109. PMID:34624863.
Weinberg J. Clinical Trials in Progress: ROADS Trial. Oncology (WillistonPark). 2021 Aug 8;35(8):495. doi: 10.46883/ONC.2021.3508.0495. PMID: 34398588.
Guerrero-Calderon JD, Lozano K, DeBenedectis CM, Shannon L, Viswanathan C, Kagetsu NJ. Disability: An Important Dimension of Diversity. J Am Coll Radiol.2021 Nov;18(11):1585-1587. doi: 10.1016/j.jacr.2021.07.013. Epub 2021 Aug 12.PMID: 34390679.
Srinivasan VM, Ene C, Kerrigan BP, Lang FF. Window of Opportunity Clinical Trials to Evaluate Novel Therapies for Brain Tumors. Neurosurg Clin N Am. 2021Jan;32(1):93-104. doi: 10.1016/j.nec.2020.09.002. Epub 2020 Nov 5. PMID:33223031; PMCID: PMC7927773.
Huntoon K, Shepard MJ, Lukas RV, McCutcheon IE, Daniels AB, Asthagiri AR. Hemangioblastoma diagnosis and surveillance in von Hippel-Lindau disease: a consensus statement. J Neurosurg. 2021 Oct 1;136(6):1511-1516. doi:10.3171/2021.3.JNS204203. PMID: 34598132.
Noll KR, Chen HS, Wefel JS, Kumar VA, Hou P, Ferguson SD, Rao G, Johnson JM, Schomer DF, Suki D, Prabhu SS, Liu HL. Alterations in Functional Connectomics Associated With Neurocognitive Changes Following Glioma Resection. Neurosurgery.2021 Feb 16;88(3):544-551. doi: 10.1093/neuros/nyaa453. PMID: 33080024; PMCID:PMC7884148.
Traylor JI, Christiano LD, Esmaeli B, Hanasono MM, Yu P, Suki D, Zhang W, Raza SM, Hanna EY, DeMonte F. Outcomes of orbital exenteration for craniofacial lesions. Cancer. 2021 Jul 15;127(14):2465-2475. doi: 10.1002/cncr.33526. Epub2021 Apr 2. PMID: 33799313.
Choi KY, Amit M, Tam S, Bell D, Phan J, Garden AS, Williams MD, Ferrarotto R, El-Naggar AK, Raza SM, DeMonte F, Kupferman ME, Hanna EY, Su SY. Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies. Laryngoscope. 2021 May;131(5):E1468-E1475. doi:10.1002/lary.29102. Epub 2020 Sep 18. PMID: 32946597.
Ene CI, Fueyo J, Lang FF. Delta-24 adenoviral therapy for glioblastoma: evolution from the bench to bedside and future considerations. Neurosurg Focus.2021 Feb;50(2):E6. doi: 10.3171/2020.11.FOCUS20853. PMID: 33524949.
Morales JE, De A, Miller AA, Chen Z, McCarty JH. Mlc1-ExpressingPerivascular Astrocytes Promote Blood-Brain Barrier Integrity. J Neurosci. 2022Feb 23;42(8):1406-1416. doi: 10.1523/JNEUROSCI.1918-21.2021. Epub 2021 Dec 29.PMID: 34965971; PMCID: PMC8883848.
Traylor JI, Sheppard HE, Ravikumar V, Breshears J, Raza SM, Lin CY, Patel SR, DeMonte F. Computational Drug Repositioning Identifies Potentially Active Therapies for Chordoma. Neurosurgery. 2021 Jan 13;88(2):428-436. doi:10.1093/neuros/nyaa398. PMID: 33017025; PMCID: PMC7803434.
Liu Y, Yang Z, Wang L, Sun L, Kim BYS, Jiang W, Yuan Y, Liu C. Spatiotemporal Immunomodulation Using Biomimetic Scaffold Promotes Endochondral Ossification-Mediated Bone Healing. Adv Sci (Weinh). 2021 Jun;8(11):e2100143.doi: 10.1002/advs.202100143. Epub 2021 Mar 16. PMID: 34105266; PMCID:PMC8188258.
Mehta GU, Passer JZ, Raza SM, Kim BYS, Su SY, Kupferman ME, Hanna EY, DeMonte F. The neurosurgical management of sinonasal malignancies involving the anterior skull base: a 28-year experience at The MD Anderson Cancer Center. JNeurosurg. 2021 Oct 8;136(6):1583-1591. doi: 10.3171/2021.5.JNS21772. PMID:34624857.
Shin DH, Nguyen T, Ozpolat B, Lang F, Alonso M, Gomez-Manzano C, Fueyo J. Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy. J Immunother Cancer. 2021 Apr;9(4):e002086. doi:10.1136/jitc-2020-002086. PMID: 33795384; PMCID: PMC8021759.
Mehta GU, McCutcheon IE. Stereotactic Radiosurgery for Pituitary Carcinoma. Acta Neurochir Suppl. 2021;128:43-49. doi: 10.1007/978-3-030-69217-9_5. PMID:34191060.
Sun X, Yu K, Zhou Y, Dong S, Hu W, Sun Y, Li Y, Xie J, Lee RJ, Sun F, Ma Y, Wang S, Kim BYS, Wang Y, Yang Z, Jiang W, Li Y, Teng L. Self-Assembled pH-Sensitive Polymeric Nanoparticles for the Inflammation-Targeted Delivery of Cu/Zn-Superoxide Dismutase. ACS Appl Mater Interfaces. 2021 Apr21;13(15):18152-18164. doi: 10.1021/acsami.1c03589. Epub 2021 Mar 25. PMID:33764751.
Li Y, Marri T, North RY, Rhodes HR, Uhelski ML, Tatsui CE, Rhines LD, Rao G, Corrales G, Abercrombie TJ, Johansson CA, Dougherty PM. Chemotherapy-induced peripheral neuropathy in a dish: dorsal root ganglion cells treated in vitro with paclitaxel show biochemical and physiological responses parallel to that seen in vivo. Pain. 2021 Jan;162(1):84-96. doi: 10.1097/j.pain.0000000000002005.PMID: 32694383; PMCID: PMC7744394.
Khalafallah AM, Rakovec M, Bettegowda C, Jackson CM, Gallia GL, Weingart JD, Lim M, Esquenazi Y, Zacharia BE, Goldschmidt E, Ziu M, Ivan ME, Venteicher AS, Nduom EK, Mamelak AN, Chu RM, Yu JS, Sheehan JP, Nahed BV, Carter BS, Berger MS, Sawaya R, Mukherjee D. A Crowd-sourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary Glioblastoma. Neurosurgery. 2021 Sep 15;89(4):712-719. doi: 10.1093/neuros/nyab257. PMID:34320218; PMCID: PMC8440068.
Gates EDH, Weinberg JS, Prabhu SS, Lin JS, Hamilton J, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes DT, Schellingerhout D. Estimating Local Cellular Density in Glioma Using MR Imaging Data. AJNR Am J Neuroradiol. 2021Jan;42(1):102-108. doi: 10.3174/ajnr.A6884. Epub 2020 Nov 26. PMID: 33243897;PMCID: PMC7814791.
Asa SL, Mete O, Cusimano MD, McCutcheon IE, Perry A, Yamada S, Nishioka H, Casar-Borota O, Uccella S, La Rosa S, Grossman AB, Ezzat S; Attendees of the 15th Meeting of the International Pituitary Pathology Club, Istanbul October2019. Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification. Mod Pathol. 2021 Sep;34(9):1634-1650. doi:10.1038/s41379-021-00820-y. Epub 2021 May 21. PMID: 34017065.
Abdelmeguid AS, Teeramatwanich W, Roberts DB, Amit M, Ferraroto R, Glisson BS, Kupferman ME, Su SY, Phan J, Garden AS, Raza SM, DeMonte F, Hanna EY. Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses. Cancer. 2021 Jun 1;127(11):1788-1795. doi:10.1002/cncr.33452. Epub 2021 Feb 10. PMID: 33567468.
Ferguson SD, Hodges TR, Majd NK, Alfaro-Munoz K, Al-Holou WN, Suki D, deGroot JF, Fuller GN, Xue L, Li M, Jacobs C, Rao G, Colen RR, Xiu J, Verhaak R, Spetzler D, Khasraw M, Sawaya R, Long JP, Heimberger AB. A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram. Neurooncol Adv. 2020 Oct 31;3(1):vdaa146. doi: 10.1093/noajnl/vdaa146. PMID:33426529; PMCID: PMC7780842.
Chen C, Lee I, Tatsui C, Elder T, Sloan AE. Laser interstitial thermotherapy(LITT) for the treatment of tumors of the brain and spine: a brief review. JNeurooncol. 2021 Feb;151(3):429-442. doi: 10.1007/s11060-020-03652-z. Epub 2021Feb 21. PMID: 33611709; PMCID: PMC7897607.
Breshears JD, DeMonte F, Habib A, Gidley PW, Raza SM. Management of Recurrent or Progressing Skull Base Chondrosarcomas: Predictors of Long-Term Outcomes. J Neurol Surg B Skull Base. 2021 Jul;82(Suppl 3):e155-e165. doi:10.1055/s-0040-1701523. Epub 2020 Feb 7. PMID: 34306931; PMCID: PMC8289497.
Alvarez-Breckenridge C, Muir M, Rhines LD, Tatsui CE. The Use of Skin Staples as Fiducial Markers to Confirm Intraoperative Spinal Navigation Registration and Accuracy. Oper Neurosurg. 2021 Aug 16;21(3):E193-E198. doi:10.1093/ons/opab132. PMID: 34038952. 4
McCutcheon IE, Preul MC. Historical Perspective on Surgery and Survival with Glioblastoma: How Far Have We Come? World Neurosurg. 2021 May;149:148-168. doi:10.1016/j.wneu.2021.02.047. Epub 2021 Feb 19. PMID: 33610867.
Baiomy A, Schellingerhout D, Chapin BF, Weinberg JS, Raza SM, Macapinlac H, Ravizzini G. Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer. Nucl Med Commun. 2021 Jul 1;42(7):755-762. doi:10.1097/MNM.0000000000001389. PMID: 33741867.
Lesage AC, Simmons A, Sen A, Singh S, Chen M, Cazoulat G, Weinberg JS, Brock KK. Viscoelastic biomechanical models to predict inward brain-shift using public benchmark data. Phys Med Biol. 2021 Oct 12;66(20). doi:10.1088/1361-6560/ac22dc. PMID: 34469879.
Srivatsan A, Mohanty A, Saleem Y, Srinivasan VM, Wagner K, Seeley J, Burkhardt JK, Chen SR, Johnnson JN, Kan P. Cognitive outcomes after unruptured intracranial aneurysm treatment with endovascular coiling. J Neurointerv Surg.2021 May;13(5):430-433. doi: 10.1136/neurintsurg-2020-016362. Epub 2020 Jul 22.PMID: 32699175.
White MD, Klein RH, Shaw B, Kim A, Subramanian M, Mora JL, Giobbie-Hurder A, Nagabhushan D, Jain A, Singh M, Kuter BM, Nayyar N, Bertalan MS, Stocking JH, Markson SC, Lastrapes M, Alvarez-Breckenridge C, Cahill DP, Gydush G, Rhoades J, Rotem D, Adalsteinsson VA, Mahar M, Kaplan A, Oh K, Sullivan RJ, Gerstner E, Carter SL, Brastianos PK. Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid. JAMA Netw Open. 2021 Aug 2;4(8):e2120040. doi:10.1001/jamanetworkopen.2021.20040. PMID: 34369989; PMCID: PMC8353541.
Muir M, Patel R, Traylor JI, de Almeida Bastos DC, Kamiya C, Li J, Rao G, Prabhu SS. Laser interstitial thermal therapy for newly diagnosed glioblastoma. Lasers Med Sci. 2022 Apr;37(3):1811-1820. doi: 10.1007/s10103-021-03435-6. Epub2021 Oct 23. PMID: 34687390.
Palmisciano P, El Ahmadieh TY, Haider AS, Bin Alamer O, Robertson FC, Plitt AR, Aoun SG, Yu K, Cohen-Gadol A, Moss NS, Patel TR, Sawaya R. Thalamic gliomas in adults: a systematic review of clinical characteristics, treatment strategies, and survival outcomes. J Neurooncol. 2021 Dec;155(3):215-224. doi:10.1007/s11060-021-03898-1. Epub 2021 Nov 19. PMID: 34797525.
Bastos DCA, Vega RA, Traylor JI, Ghia AJ, Li J, Oro M, Bishop AJ, Yeboa DN, Amini B, Kumar VA, Rao G, Rhines LD, Tatsui CE. Spinal laser interstitial thermal therapy: single-center experience and outcomes in the first 120 cases. JNeurosurg Spine. 2020 Dec 11;34(3):354-363. doi: 10.3171/2020.7.SPINE20661.PMID: 33307530.
Gidley PW, Passer JZ, Page JC, DeMonte F. Middle cranial fossa approach for acoustic neuroma. Neurosurg Focus Video. 2021 Oct 1;5(2):V12. doi:10.3171/2021.7.FOCVID21124. PMID: 36285238; PMCID: PMC9551638.
Yang Z, Shi J, Xie J, Wang Y, Sun J, Liu T, Zhao Y, Zhao X, Wang X, Ma Y,Malkoc V, Chiang C, Deng W, Chen Y, Fu Y, Kwak KJ, Fan Y, Kang C, Yin C, Rhee J, Bertani P, Otero J, Lu W, Yun K, Lee AS, Jiang W, Teng L, Kim BYS, Lee LJ. Author Correction: Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat Biomed Eng. 2021 Aug;5(8):944-945. doi:10.1038/s41551-021-00725-w. Erratum for: Nat Biomed Eng. 2020 Jan;4(1):69-83.doi: 10.1038/s41551-019-0485-1. PMID: 34131325.
Wang Q, Hernández-Ochoa EO, Viswanathan MC, Blum ID, Do DC, Granger JM, Murphy KR, Wei AC, Aja S, Liu N, Antonescu CM, Florea LD, Talbot CC Jr, Mohr D, Wagner KR, Regot S, Lovering RM, Gao P, Bianchet MA, Wu MN, Cammarato A, Schneider MF, Bever GS, Anderson ME. CaMKII oxidation is a critical performance/disease trade-off acquired at the dawn of vertebrate evolution. NatCommun. 2021 May 26;12(1):3175. doi: 10.1038/s41467-021-23549-3. PMID: 34039988;PMCID: PMC8155201.
Khan S, Mahalingam R, Sen S, Martinez-Ledesma E, Khan A, Gandy K, Lang FF, Sulman EP, Alfaro-Munoz KD, Majd NK, Balasubramaniyan V, de Groot JF. Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells. Cancers (Basel). 2021 Oct 21;13(21):5284. doi:10.3390/cancers13215284. PMID: 34771447; PMCID: PMC8582372.
Catignas KK, Frick LR, Pellegatta M, Hurley E, Kolb Z, Addabbo K, McCarty JH, Hynes RO, van der Flier A, Poitelon Y, Wrabetz L, Feltri ML. αVintegrins in Schwann cells promote attachment to axons, but are dispensable in vivo. Glia. 2021 Jan;69(1):91-108. doi: 10.1002/glia.23886. Epub 2020 Aug 3.PMID: 32744761; PMCID: PMC8491627.
Versteeg AL, Sahgal A, Laufer I, Rhines LD, Sciubba DM, Schuster JM, Weber MH, Lazary A, Boriani S, Bettegowda C, Fehlings MG, Clarke MJ, Arnold PM, Gokaslan ZL, Fisher CG; AO Spine Knowledge Forum Tumor. Correlation Between the Spinal Instability Neoplastic Score (SINS) and Patient Reported Outcomes. GlobalSpine J. 2023 Jun;13(5):1358-1364. doi: 10.1177/21925682211033591. Epub 2021 Jul26. PMID: 34308697; PMCID: PMC10416601.
Mattogno PP, Marciano F, Catalino MP, Mattavelli D, Cocca P, Lopomo NF, Nicolai P, Laws ER Jr, Witterick I, Raza SM, Devaiah AK, Lauretti L, Olivi A, Fontanella MM, Gentili F, Doglietto F. Ergonomics in Endoscopic Transsphenoidal Surgery: A Survey of the North American Skull Base Society. J Neurol Surg B Skull Base. 2021 May 17;83(Suppl 2):e380-e385. doi: 10.1055/s-0041-1729906.PMID: 35832944; PMCID: PMC9272277.
Inoue A, Robinson FS, Minelli R, Tomihara H, Rizi BS, Rose JL, Kodama T, Srinivasan S, Harris AL, Zuniga AM, Mullinax RA, Ma X, Seth S, Daniele JR, Peoples MD, Loponte S, Akdemir KC, Khor TO, Feng N, Roszik J, Sobieski MM, Brunell D, Stephan C, Giuliani V, Deem AK, Shingu T, Deribe YL, Menter DG, Heffernan TP, Viale A, Bristow CA, Kopetz S, Draetta GF, Genovese G, Carugo A. Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer. Gastroenterology. 2021Jul;161(1):196-210. doi: 10.1053/j.gastro.2021.03.022. Epub 2021 Mar 19. PMID:33745946; PMCID: PMC8238881.
Phillips LM, Li S, Gumin J, Daou M, Ledbetter D, Yang J, Singh S, ParkerKerrigan BC, Hossain A, Yuan Y, Gomez-Manzano C, Fueyo J, Lang FF. An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus. Neuro Oncol. 2021 Nov 2;23(11):1911-1921.doi: 10.1093/neuonc/noab128. PMID: 34059921; PMCID: PMC8563315.
Chung J, Hamilton G, Kim M, Marini S, Montgomery B, Henry J, Cho AE, Brown DL, Worrall BB, Meschia JF, Silliman SL, Selim M, Tirschwell DL, Kidwell CS, Kissela B, Greenberg SM, Viswanathan A, Goldstein JN, Langefeld CD, Rannikmae K, Sudlow CLM, Samarasekera N, Rodrigues M, Al-Shahi Salman R, Prendergast JGD, Harris SE, Deary I, Woo D, Rosand J, Van Agtmael T, Anderson CD. Rare Missense Functional Variants at COL4A1 and COL4A2 in Sporadic Intracerebral Hemorrhage. Neurology. 2021 Jul 19;97(3):e236-e247. doi:10.1212/WNL.0000000000012227. PMID: 34031201; PMCID: PMC8302151.
Kochat V, Raman AT, Landers SM, Tang M, Schulz J, Terranova C, Landry JP, Bhalla AD, Beird HC, Wu CC, Jiang Y, Mao X, Lazcano R, Gite S, Ingram DR, Yi M, Zhang J, Keung EZ, Scally CP, Roland CL, Hunt KK, Feig BW, Futreal PA, Hwu P, Wang WL, Lazar AJ, Slopis JM, Wilson-Robles H, Wiener DJ, McCutcheon IE, Wustefeld-Janssens B, Rai K, Torres KE. Enhancer reprogramming in PRC2-deficientmalignant peripheral nerve sheath tumors induces a targetable de-differentiated state. Acta Neuropathol. 2021 Sep;142(3):565-590. doi:10.1007/s00401-021-02341-z. Epub 2021 Jul 20. PMID: 34283254.
Puca F, Yu F, Bartolacci C, Pettazzoni P, Carugo A, Huang-Hobbs E, Liu J,Zanca C, Carbone F, Del Poggetto E, Gumin J, Dasgupta P, Seth S, Srinivasan S, Lang FF, Sulman EP, Lorenzi PL, Tan L, Shan M, Tolstyka ZP, Kachman M, Zhang L, Gao S, Deem AK, Genovese G, Scaglioni PP, Lyssiotis CA, Viale A, Draetta GF. Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma. Cancer Discov. 2021 Nov;11(11):2904-2923. doi:10.1158/2159-8290.CD-20-1437. Epub 2021 May 26. PMID: 34039636; PMCID:PMC8711129.
Najem H, Marisetty A, Horbinski C, Long J, Huse JT, Glitza Oliva IC, Ferguson SD, Kumthekar PU, Wainwright DA, Chen P, Lesniak MS, Burks JK, Heimberger AB. CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease. Front Immunol. 2021 Oct 8;12:745893. doi: 10.3389/fimmu.2021.745893.PMID: 34691054; PMCID: PMC8531809.
Versteeg AL, Sahgal A, Rhines LD, Sciubba DM, Schuster JM, Weber MH, Lazary A, Boriani S, Bettegowda C, Fehlings MG, Clarke MJ, Arnold PM, Gokaslan ZL, Fisher CG; AO Spine Knowledge Forum Tumor. Health related quality of life outcomes following surgery and/or radiation for patients with potentially unstable spinal metastases. Spine J. 2021 Mar;21(3):492-499. doi:10.1016/j.spinee.2020.10.017. Epub 2020 Oct 22. PMID: 33098985.
Yang J, Horton JR, Akdemir KC, Li J, Huang Y, Kumar J, Blumenthal RM, Zhang X, Cheng X. Preferential CEBP binding to T:G mismatches and increased C-to-Thuman somatic mutations. Nucleic Acids Res. 2021 May 21;49(9):5084-5094. doi:10.1093/nar/gkab276. PMID: 33877329; PMCID: PMC8136768.
Amit M, Bell D, Hunt PJ, Hanna E, Su SY, Kupferman M, Aashiq M, Takahashi H, Gidley PW, Nader ME, DeMonte F, Raza SM. Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes. J Neurosurg. 2020 Jun 12;134(5):1392-1398. doi:10.3171/2020.3.JNS192630. PMID: 32534492.
Asaad M, Mericli AF, Hanasono MM, Roubaud MS, Bird JE, Rhines LD. Free Vascularized Fibula Flap Reconstruction of Total and Near-total Destabilizing Resections of the Sacrum. Ann Plast Surg. 2021 Jun 1;86(6):661-667. doi:10.1097/SAP.0000000000002562. PMID: 33009144.
Aaroe AE, Glitza Oliva IC, Al-Zubidi N, Nader ME, Kaya D, Ferguson SD, Wang C, Fuller G, Harrison RA. Pearls & Oy-sters: Primary Pineal Melanoma With Leptomeningeal Carcinomatosis. Neurology. 2021 Aug 3;97(5):248-250. doi:10.1212/WNL.0000000000012121. Epub 2021 Apr 30. PMID: 33931525. 71: Pudakalakatti S, Audia A, Mukhopadhyay A, Enriquez JS, Bourgeois D, Tayob N, Zacharias NM, Millward SW, Carson D, Farach-Carson MC, Lang FF, Heimberger AB, Bhat KP, Bhattacharya PK. NMR Spectroscopy-Based Metabolomics of Platelets to Analyze Brain Tumors. Reports (MDPI). 2021 Dec;4(4):32. doi:10.3390/reports4040032. Epub 2021 Oct 1. PMID: 35937580; PMCID: PMC9352435.
Landry JP, Schertz KL, Chiang YJ, Bhalla AD, Yi M, Keung EZ, Scally CP, Feig BW, Hunt KK, Roland CL, Guadagnolo A, Bishop AJ, Lazar AJ, Slopis JM, McCutcheon IE, Torres KE. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020. JAMA Netw Open. 2021 Mar 1;4(3):e210945. doi:10.1001/jamanetworkopen.2021.0945. PMID: 33734413; PMCID: PMC7974640.
Asman P, Prabhu S, Bastos D, Tummala S, Bhavsar S, McHugh TM, Ince NF. Unsupervised machine learning can delineate central sulcus by using the spatiotemporal characteristic of somatosensory evoked potentials. J Neural Eng.2021 Apr 29;18(4):10.1088/1741-2552/abf68a. doi: 10.1088/1741-2552/abf68a. PMID:33836520; PMCID: PMC8718352.
Mohiuddin S, Maraka S, Usman Baig M, Gupta S, Muzzafar T, Valyi-Nagy T, Lindsay H, Moody K, Razvi S, Paulino A, Slavin K, Gondi V, McCutcheon I, Zaky W, Khatua S. Case series of diffuse extraneural metastasis in H3F3A mutant high-grade gliomas: Clinical, molecular phenotype and literature review. J ClinNeurosci. 2021 Jul;89:405-411. doi: 10.1016/j.jocn.2021.05.033. Epub 2021 May27. Erratum in: J Clin Neurosci. 2021 Nov;93:286. doi:10.1016/j.jocn.2021.07.032. PMID: 34053821.
Chen HS, Kumar VA, Johnson JM, Chen MM, Noll KR, Hou P, Prabhu SS, Schomer DF, Liu HL. Effect of brain normalization methods on the construction of functional connectomes from resting-state functional MRI in patients with gliomas. Magn Reson Med. 2021 Jul;86(1):487-498. doi: 10.1002/mrm.28690. Epub2021 Feb 2. PMID: 33533052.
Ravindra VM, Karas PJ, Hartnett S, Patino I, North R, Tatsui CE, Gonda D, Schwabe A, Curry DJ. Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Palliative Rhizotomy: A Novel Technical Application. Oper Neurosurg.2021 Mar 15;20(4):413-418. doi: 10.1093/ons/opaa415. PMID: 33377153.
Fueyo J, Gomez-Manzano C, Lang FF, Alonso MM. Hitchhiking to brain tumors: stem cell delivery of oncolytic viruses. Lancet Oncol. 2021 Aug;22(8):1049-1051.doi: 10.1016/S1470-2045(21)00296-5. Epub 2021 Jun 29. PMID: 34214494. 78: Salzillo TC, Mawoneke V, Weygand J, Shetty A, Gumin J, Zacharias NM, Gammon ST, Piwnica-Worms D, Fuller GN, Logothetis CJ, Lang FF, Bhattacharya PK. Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance. Cells. 2021 Oct 1;10(10):2621. doi: 10.3390/cells10102621. PMID: 34685601; PMCID:PMC8534002.
Johnson JM, Chen MM, Rohren EM, Prabhu S, Chasen B, Mawlawi O, Liu HL, Gule-Monroe MK. Delayed FDG PET Provides Superior Glioblastoma Conspicuity Compared to Conventional Image Timing. Front Neurol. 2021 Nov 16;12:740280. doi:10.3389/fneur.2021.740280. PMID: 34867723; PMCID: PMC8635110.
Cherian J, Chen SR, Puri A, Vakharia K, Levy E, Eshraghi S, Howard BM, TongFC, Cawley CM, Gross B, Alexander MD, Grandhi R, Srinivasan VM, Burkhardt JK, Johnson JN, Kan P. Post market American Experience With Woven EndoBridge Device: Adjudicated Multicenter Case Series. Neurosurgery. 2021 Jul 15;89(2):275-282.doi: 10.1093/neuros/nyab158. Erratum in: Neurosurgery. 2021 Aug 16;89(3):537.doi: 10.1093/neuros/nyab270. PMID: 33989398; PMCID: PMC8660628.
Zuckerman SL, Lee SH, Chang GJ, Walsh GL, Mehran RJ, Gokaslan ZL, Rao G, Tatsui CE, Rhines LD. Outcomes of Surgery for Sacral Chordoma and Impact of Complications: A Report of 50 Consecutive Patients With Long-Term Follow-Up. Global Spine J. 2021 Jun;11(5):740-750. doi: 10.1177/21925682211011444. PMID:34047643; PMCID: PMC8165918.
Gao C, Wang F, Suki D, Strom E, Li J, Sawaya R, Hsu L, Raghavendra A, Tripathy D, Ibrahim NK. Effects of systemic therapy and local therapy on outcomes of 873 breast cancer patients with metastatic breast cancer to brain: MD Anderson Cancer Center experience. Int J Cancer. 2021 Feb 15;148(4):961-970.doi: 10.1002/ijc.33243. Epub 2020 Sep 11. PMID: 32748402.
Meleis A, Larkin MB, Bastos DCA, Muir MT, Rao G, Rhines LD, Cowles CE, Tatsui CE. Single-center outcomes for percutaneous pedicle screw fixation in metastatic spinal lesions: can spontaneous facet fusion occur? Neurosurg Focus.2021 May;50(5):E9. doi: 10.3171/2021.1.FOCUS20671. Erratum in: Neurosurg Focus.2022 Mar;52(3):E16. doi: 10.3171/2022.1.FOCUS20671a. PMID: 33932939.
Traylor JI, Patel R, Muir M, de Almeida Bastos DC, Ravikumar V, Kamiya-Matsuoka C, Rao G, Thomas JG, Kew Y, Prabhu SS. Laser Interstitial Thermal Therapy for Glioblastoma: A Single-Center Experience. World Neurosurg. 2021May;149:e244-e252. doi: 10.1016/j.wneu.2021.02.044. Epub 2021 Feb 19. PMID:33610872.
Shimizu Y, Gumin J, Gao F, Hossain A, Shpall EJ, Kondo A, Parker Kerrigan BC, Yang J, Ledbetter D, Fueyo J, Gomez-Manzano C, Lang FF. Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma. J Neurosurg. 2021 Aug27;136(3):757-767. doi: 10.3171/2021.3.JNS203045. PMID: 34450587; PMCID:PMC10193507.
North RY, Snyder R, Slopis JM, McCutcheon IE. Surgical treatment of common peroneal neuropathy in schwannomatosis: illustrative cases. J Neurosurg Case Lessons. 2021 Jun 28;1(26):CASE21176. doi: 10.3171/CASE21176. PMID: 35854908;PMCID: PMC9245758.
Majd NK, Mastall M, Lin H, Dibaj SS, Hess KR, Yuan Y, Garcia MM, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harriso RA, De Groo JF, Puduvalli VK, Penas-Prado M. Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience. Neurooncol Adv. 2021 Jun 22;3(1):vdab079.doi: 10.1093/noajnl/vdab079. PMID: 34377987; PMCID: PMC8350154.
Dandurand C, Fisher CG, Rhines LD, Boriani S, Charest-Morin R, Gasbarrini A, Luzzati A, Reynolds JJ, Wei F, Gokaslan ZL, Bettegowda C, Sciubba DM, Lazary A, Kawahara N, Clarke MJ, Rampersaud YR, Disch AC, Chou D, Shin JH, Hornicek FJ, Laufer I, Sahgal A, Dea N. Feasibility of achieving planned surgical margins in primary spine tumor: a PTRON study. Neurosurg Focus. 2021 May;50(5):E16. doi:10.3171/2021.2.FOCUS201091. PMID: 33932923.
Pahuta MA, Fisk F, Versteeg AL, Fisher CG, Sahgal A, Gokaslan ZL, Reynolds JJ, Laufer I, Lazary A, Rhines LD, Boriani S, Bettegowda C, Dea N; on behalf of the AO Spine Knowledge Forum Tumor. Calculating Utilities From the Spine Oncology Study Group Outcomes Questionnaire: A Necessity for Economic and Decision Analysis. Spine (Phila Pa 1976). 2021 Sep 1;46(17):1165-1171. doi:10.1097/BRS.0000000000003981. PMID: 34334684; PMCID: PMC8357033.
Krivosheya D, Rao G, Tummala S, Kumar V, Suki D, Bastos DCA, Prabhu SS. Impact of Multi-modality Monitoring Using Direct Electrical Stimulation to Determine Corticospinal Tract Shift and Integrity in Tumors using the Intraoperative MRI. J Neurol Surg A Cent Eur Neurosurg. 2021 Jul;82(4):375-380.doi: 10.1055/s-0039-1698383. Epub 2019 Oct 28. PMID: 31659724.
McCutcheon IE. Stereotactic Radiosurgery to Prevent Local Recurrence of Brain Metastasis After Surgery: Neoadjuvant Versus Adjuvant. Acta Neurochir Suppl. 2021;128:85-100. doi: 10.1007/978-3-030-69217-9_9. PMID: 34191064.
Ghia AJ, Guha-Thakurta N, Song J, Thall P, Briere TM, Settle SH, Sharp HJ, Li J, McAleer M, Chang EL, Tatsui CE, Brown PD, Rhines LD. Phase 1 study of spinal cord constraint relaxation with single session spine stereotactic radiosurgery in the primary management of patients with inoperable, previously irradiated metastatic epidural spinal cord compression. N Am Spine Soc J. 2021May 1;6:100066. doi: 10.1016/j.xnsj.2021.100066. PMID: 35141631; PMCID:PMC8820013.
Shirali AS, Pieterman CRC, Lewis MA, Hyde SM, Makawita S, Dasari A, Thosani N, Ikoma N, McCutcheon IE, Waguespack SG, Perrier ND. It's not a mystery, it’s in the history: Multidisciplinary management of multiple endocrine neoplasia type 1. CA Cancer J Clin. 2021 Sep;71(5):369-380. doi: 10.3322/caac.21673. Epub2021 Jun 1. PMID: 34061974.
Williams JR, Meyer MR, Ricard JA, Sen R, Young CC, Feroze AH, Greil ME, Barros G, Durfy S, Hanak B, Morton RP, Temkin NR, Barber JK, Mac Donald CL, Chesnut RM. Re-examining decompressive craniectomy medial margin distance from midline as a metric for calculating the risk of post-traumatic hydrocephalus. JClin Neurosci. 2021 May;87:125-131. doi: 10.1016/j.jocn.2021.02.025. Epub 2021Mar 20. PMID: 33863519.
Quirarte JA, Kumar VA, Liu HL, Noll KR, Wefel JS, Lang FF. Language supplementary motor area syndrome correlated with dynamic changes in perioperative task-based functional MRI activations: case report. J Neurosurg.2020 Jun 5;134(6):1738-1742. doi: 10.3171/2020.4.JNS193250. PMID: 32502992.
Ahluwalia M, Ali MA, Joshi RS, Park ES, Taha B, McCutcheon I, Chiang V, HongA, Sinclair G, Bartek J Jr, Chen CC. An integrated disease-specific graded prognostic assessment scale for melanoma: contributions of KPS, CITV, number of metastases, and BRAF mutation status. Neurooncol Adv. 2020 Nov 12;3(1):vdaa152.doi: 10.1093/noajnl/vdaa152. PMID: 33506199; PMCID: PMC7810198.
Zakaria R, Prabhu SS. Letter to the Editor Regarding "Safety Analysis of Bilateral Laser Interstitial Thermal Therapy for Treatment of Butterfly Glioma". World Neurosurg. 2021 Mar;147:236-237. doi: 10.1016/j.wneu.2020.10.161. PMID:33685011.
Mohiuddin S, Maraka S, Baig MU, Gupta S, Muzzafar T, Valyi-Nagy T, Lindsay H, Moody K, Razvi S, Paulino A, Slavin K, Gondi V, McCutcheon I, Zaky W, Khatua S. Corrigendum to "Case series of diffuse extraneural metastasis in H3F3A mutant high-grade gliomas: Clinical, molecular phenotype and literature review" [J.Clin. Neurosci. 89 (2021) 405-411]. J Clin Neurosci. 2021 Nov;93:286. doi:10.1016/j.jocn.2021.07.032. Epub 2021 Jul 31. Erratum for: J Clin Neurosci. 2021Jul;89:405-411. doi: 10.1016/j.jocn.2021.05.033. PMID: 34344600.
2020 Publications
Small W Jr, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, AlbuquerqueKV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, ViswanathanAN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK. NRG Oncology/RTOG ConsensusGuidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):413-424. doi:10.1016/j.ijrobp.2020.08.061. Epub 2020 Sep 6. PMID: 32905846; PMCID:PMC7856050.
Yang Z, Shi J, Xie J, Wang Y, Sun J, Liu T, Zhao Y, Zhao X, Wang X, Ma Y,Malkoc V, Chiang C, Deng W, Chen Y, Fu Y, Kwak KJ, Fan Y, Kang C, Yin C, Rhee J,Bertani P, Otero J, Lu W, Yun K, Lee AS, Jiang W, Teng L, Kim BYS, Lee LJ. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat Biomed Eng. 2020 Jan;4(1):69-83. doi:10.1038/s41551-019-0485-1. Epub 2019 Dec 16. Erratum in: Nat Biomed Eng. 2021Aug;5(8):944-945. doi: 10.1038/s41551-021-00725-w. PMID: 31844155; PMCID:PMC7080209.
Chen P, Hsu WH, Chang A, Tan Z, Lan Z, Zhou A, Spring DJ, Lang FF, Wang YA,DePinho RA. Circadian Regulator CLOCK Recruits Immune-Suppressive Microglia intothe GBM Tumor Microenvironment. Cancer Discov. 2020 Mar;10(3):371-381. doi:10.1158/2159-8290.CD-19-0400. Epub 2020 Jan 9. PMID: 31919052; PMCID:PMC7058515.
Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, FitchK, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS,Morcos M, Nwachukwu C, Petereit D, Viswanathan AN. Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2020 Jul-Aug;10(4):220-234. doi: 10.1016/j.prro.2020.04.002.Epub 2020 May 18. PMID: 32473857; PMCID: PMC8802172.
Yang Z, Ma Y, Zhao H, Yuan Y, Kim BYS. Nanotechnology platforms for cancer immunotherapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020Mar;12(2):e1590. doi: 10.1002/wnan.1590. Epub 2019 Nov 7. PMID: 31696664.
Jiang W, Wang Y, Wargo JA, Lang FF, Kim BYS. Considerations for designing preclinical cancer immune nanomedicine studies. Nat Nanotechnol. 2021Jan;16(1):6-15. doi: 10.1038/s41565-020-00817-9. Epub 2020 Dec 21. PMID:33349682; PMCID: PMC8103921.
DeMonte F, Raza SM. Olfactory groove and planum meningiomas. Handb ClinNeurol. 2020;170:3-12. doi: 10.1016/B978-0-12-822198-3.00023-9. PMID: 32586502.
Mehta GU, Raza SM. Management of Skull Base Metastases. Neurosurg Clin N Am.2020 Oct;31(4):659-666. doi: 10.1016/j.nec.2020.06.013. PMID: 32921360.
Zakaria R, Weinberg JS. Challenges Associated with Reoperation in Patientswith Glioma. Neurosurg Clin N Am. 2021 Jan;32(1):129-135. doi:10.1016/j.nec.2020.09.004. Epub 2020 Nov 5. PMID: 33223021.
Ma Y, Dong S, Li X, Kim BYS, Yang Z, Jiang W. Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy. Front Oncol. 2021 Feb 8;10:606906.doi: 10.3389/fonc.2020.606906. PMID: 33628730; PMCID: PMC7897670.
Abdelmeguid AS, Raza SM, Su SY, Kupferman M, Roberts D, DeMonte F, Hanna EY. Endoscopic resection of sinonasal malignancies. Head Neck. 2020Apr;42(4):645-652. doi: 10.1002/hed.26047. Epub 2019 Dec 24. PMID: 31875340.
DeMonte F. Management considerations for malignant tumors of the skull base. J Neurooncol. 2020 Dec;150(3):361-365. doi: 10.1007/s11060-020-03637-y. PMID:33034838.
Javed S, Viswanathan A, Abdi S. Cordotomy for Intractable Cancer Pain: A Narrative Review. Pain Physician. 2020 Jun;23(3):283-292. PMID: 32517394.
McCarty JH. αvβ8 integrin adhesion and signaling pathways in development, physiology and disease. J Cell Sci. 2020 Jun 15;133(12):jcs239434. doi:10.1242/jcs.239434. PMID: 32540905; PMCID: PMC7328133.
Fowler MJ, Cotter JD, Knight BE, Sevick-Muraca EM, Sandberg DI, Sirianni RW.Intrathecal drug delivery in the era of nanomedicine. Adv Drug Deliv Rev. 2020;165-166:77-95. doi: 10.1016/j.addr.2020.02.006. Epub 2020 Mar 3. PMID:32142739; PMCID: PMC8182643.
Yamazaki Y, Liu CC, Yamazaki A, Shue F, Martens YA, Chen Y, Qiao W, Kurti A,Oue H, Ren Y, Li Y, Aikawa T, Cherukuri Y, Fryer JD, Asmann YW, Kim BYS, Kanekiyo T, Bu G. Vascular ApoE4 Impairs Behavior by Modulating Gliovascular Function. Neuron. 2021 Feb 3;109(3):438-447.e6. doi:10.1016/j.neuron.2020.11.019. Epub 2020 Dec 14. PMID: 33321072; PMCID:PMC7864888.
Hatiboglu MA, Akdur K, Sawaya R. Neurosurgical management of patients withbrain metastasis. Neurosurg Rev. 2020 Apr;43(2):483-495. doi:10.1007/s10143-018-1013-6. Epub 2018 Jul 29. PMID: 30058049.
Mehta GU, Raza SM, Su SY, Hanna EY, DeMonte F. Management of olfactoryneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiatedcarcinoma involving the skullbase. J Neurooncol. 2020 Dec;150(3):367-375. doi:10.1007/s11060-020-03537-1. Epub 2020 May 18. PMID: 32424573.
Hsu AL, Chen HS, Hou P, Wu CW, Johnson JM, Noll KR, Prabhu SS, Ferguson SD,Kumar VA, Schomer DF, Chen JH, Liu HL. Presurgical resting-state functional MRIlanguage mapping with seed selection guided by regional homogeneity. Magn ResonMed. 2020 Jul;84(1):375-383. doi: 10.1002/mrm.28107. Epub 2019 Dec 2. PMID:31793025.
Deng W, Wang Y, Liu X, Liu J, Wang L, Yang Z, Yang M, An Y, Tang C, SanfordNN, Kim BYS, Jiang W. Assessment of Trends in Second Primary Cancers in PatientsWith Metastatic Melanoma From 2005 to 2016. JAMA Netw Open. 2020 Dec1;3(12):e2028627. doi: 10.1001/jamanetworkopen.2020.28627. PMID: 33295975;PMCID: PMC7726633.
Srinivasan VM, Ene C, Kerrigan BP, Lang FF. Window of Opportunity Clinical Trials to Evaluate Novel Therapies for Brain Tumors. Neurosurg Clin N Am. 2021Jan;32(1):93-104. doi: 10.1016/j.nec.2020.09.002. Epub 2020 Nov 5. PMID:33223031; PMCID: PMC7927773.
Li Q, Wang Y, Jia W, Deng H, Li G, Deng W, Chen J, Kim BYS, Jiang W, Liu Q, Liu J. Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1Blockade. Clin Cancer Res. 2020 Apr 1;26(7):1712-1724. doi:10.1158/1078-0432.CCR-19-2179. Epub 2019 Dec 17. PMID: 31848190.
Edem I, DeMonte F, Raza SM. Advances in the management of primary bonesarcomas of the skull base. J Neurooncol. 2020 Dec;150(3):393-403. doi:10.1007/s11060-020-03497-6. Epub 2020 Apr 18. PMID: 32306199.
Choi KY, Amit M, Tam S, Bell D, Phan J, Garden AS, Williams MD, FerrarottoR, El-Naggar AK, Raza SM, DeMonte F, Kupferman ME, Hanna EY, Su SY. ClinicalImplication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies. Laryngoscope. 2021 May;131(5):E1468-E1475. doi:10.1002/lary.29102. Epub 2020 Sep 18. PMID: 32946597.
Giridharan N, Glitza Oliva IC, O'Brien BJ, Parker Kerrigan BC, Heimberger AB, Ferguson SD. Targeting the Tumor Microenvironment in Brain Metastasis.Neurosurg Clin N Am. 2020 Oct;31(4):641-649. doi: 10.1016/j.nec.2020.06.011.PMID: 32921358.
Lattier JM, De A, Chen Z, Morales JE, Lang FF, Huse JT, McCarty JH.Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotesglioblastoma cell invasion in the brain microenvironment. Oncogene. 2020Dec;39(50):7253-7264. doi: 10.1038/s41388-020-01503-9. Epub 2020 Oct 10. PMID:33040087; PMCID: PMC7736299.
Yosef N, Xi Y, McCarty JH. Isolation and transcriptional characterization of mouse perivascular astrocytes. PLoS One. 2020 Oct 8;15(10):e0240035. doi:10.1371/journal.pone.0240035. PMID: 33031376; PMCID: PMC7544046.
Tzeng CD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, Bird JE,Shafer A, Davis JW, Adelman DM, Moon B, Reece G, Prabhu SS, DeSnyder SM, SkibberJM, Mehran R, Schmeler K, Roland CL, Tran Cao HS, Aloia TA, Caudle AS, SwisherSG, Vauthey JN. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg. 2020Aug;272(2):e106-e111. doi: 10.1097/SLA.0000000000004092. PMID: 32675511; PMCID:PMC7373457.
de Groot J, Penas-Prado M, Alfaro-Munoz K, Hunter K, Pei BL, O'Brien B,Weathers SP, Loghin M, Kamiya Matsouka C, Yung WKA, Mandel J, Wu J, Yuan Y, ZhouS, Fuller GN, Huse J, Rao G, Weinberg JS, Prabhu SS, McCutcheon IE, Lang FF, Ferguson SD, Sawaya R, Colen R, Yadav SS, Blando J, Vence L, Allison J, Sharma P, Heimberger AB. Window-of-opportunity clinical trial of pembrolizumab inpatients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 Apr 15;22(4):539-549. doi: 10.1093/neuonc/noz185.PMID: 31755915; PMCID: PMC7158647.
Privorotskiy A, Bhavsar SP, Lang FF, Hu J, Cata JP. Impact of anesthesia andanalgesia techniques on glioblastoma progression. A narrative review. NeurooncolAdv. 2020 Sep 16;2(1):vdaa123. doi: 10.1093/noajnl/vdaa123. PMID: 33205044;PMCID: PMC7653686.
Maldaun M, Prabhu S, Tatsui C, Souhami L. Editorial: The Role of ModernNeuro-oncology in the Treatment of Primary CNS Tumors, and Brain and SpinalMetastases. Front Oncol. 2020 Jun 3;10:759. doi: 10.3389/fonc.2020.00759. PMID:32582533; PMCID: PMC7283575.
Bastos DCA, Fuentes DT, Traylor J, Weinberg J, Kumar VA, Stafford J, Li J,Rao G, Prabhu SS. The use of laser interstitial thermal therapy in the treatmentof brain metastases: a literature review. Int J Hyperthermia. 2020Jul;37(2):53-60. doi: 10.1080/02656736.2020.1748238. PMID: 32672122.
von Roemeling CA, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, Yang Z, Yang M, DengW, Bruno KA, Chan CK, Lee AS, Rosenfeld SS, Yun K, Johnson AJ, Mitchell DA,Jiang W, Kim BYS. Therapeutic modulation of phagocytosis in glioblastoma canactivate both innate and adaptive antitumour immunity. Nat Commun. 2020 Mar20;11(1):1508. doi: 10.1038/s41467-020-15129-8. PMID: 32198351; PMCID:PMC7083893.
Boyce-Fappiano D, Gjyshi O, Pezzi TA, Allen PK, Solimman M, Taku N,Bernstein MB, Cabanillas ME, Amini B, Tatsui CE, Rhines LD, Wang XA, Briere TM,Yeboa DN, Bishop AJ, Li J, Ghia AJ. Spine stereotactic radiosurgery formetastatic thyroid cancer: a single-institution experience. J Neurosurg Spine. 2020 Feb 14;32(6):941-949. doi: 10.3171/2019.12.SPINE191269. PMID: 32059183.
Gates EDH, Lin JS, Weinberg JS, Prabhu SS, Hamilton J, Hazle JD, Fuller GN,Baladandayuthapani V, Fuentes DT, Schellingerhout D. Imaging-Based Algorithm for the Local Grading of Glioma. AJNR Am J Neuroradiol. 2020 Mar;41(3):400-407. doi:10.3174/ajnr.A6405. Epub 2020 Feb 6. PMID: 32029466; PMCID: PMC7077885.
Al-Holou WN, Hodges TR, Everson RG, Freeman J, Zhou S, Suki D, Rao G,Ferguson SD, Heimberger AB, McCutcheon IE, Prabhu SS, Lang FF, Weinberg JS, Wildrick DM, Sawaya R. Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes. Neurosurgery. 2020 Jan 1;86(1):112-121. doi:10.1093/neuros/nyz008. PMID: 30799490; PMCID: PMC8253299.
Weathers SP, Penas-Prado M, Pei BL, Ling X, Kassab C, Banerjee P, Bdiwi M,Shaim H, Alsuliman A, Shanley M, de Groot JF, O'Brien BJ, Harrison R, Majd N,Kamiya-Matsuoka C, Fuller GN, Huse JT, Chi L, Rao G, Weinberg JS, Lang FF,Sawaya R, Shpall EJ, Rezvani K, Heimberger AB. Glioblastoma-mediated ImmuneDysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results froma Phase I/II Trial. Clin Cancer Res. 2020 Jul 15;26(14):3565-3577. doi:10.1158/1078-0432.CCR-20-0176. Epub 2020 Apr 16. PMID: 32299815; PMCID:PMC9347965.
Bastos DCA, Rao G, Oliva ICG, Loree JM, Fuentes DT, Stafford RJ, Beechar VB,Weinberg JS, Shah K, Kumar VA, Prabhu SS. Predictors of Local Control of Brain Metastasis Treated With Laser Interstitial Thermal Therapy. Neurosurgery. 2020Jul 1;87(1):112-122. doi: 10.1093/neuros/nyz357. PMID: 31539421.
Kumar VA, Heiba IM, Prabhu SS, Chen MM, Colen RR, Young AL, Johnson JM, Hou P, Noll K, Ferguson SD, Rao G, Lang FF, Schomer DF, Liu HL. The role of resting-state functional MRI for clinical preoperative language mapping. Cancer Imaging.2020 Jul 11;20(1):47. doi: 10.1186/s40644-020-00327-w. PMID: 32653026; PMCID:PMC7353792.
Ott M, Tomaszowski KH, Marisetty A, Kong LY, Wei J, Duna M, Blumberg K, JiX, Jacobs C, Fuller GN, Langford LA, Huse JT, Long JP, Hu J, Li S, Weinberg JS,Prabhu SS, Sawaya R, Ferguson S, Rao G, Lang FF, Curran MA, Heimberger AB.Profiling of patients with glioma reveals the dominant immunosuppressive axis isrefractory to immune function restoration. JCI Insight. 2020 Sep3;5(17):e134386. doi: 10.1172/jci.insight.134386. PMID: 32721947; PMCID:PMC7526457.
Gates EDH, Weinberg JS, Prabhu SS, Lin JS, Hamilton J, Hazle JD, Fuller GN,Baladandayuthapani V, Fuentes DT, Schellingerhout D. Estimating Local Cellular Density in Glioma Using MR Imaging Data. AJNR Am J Neuroradiol. 2021Jan;42(1):102-108. doi: 10.3174/ajnr.A6884. Epub 2020 Nov 26. PMID: 33243897;PMCID: PMC7814791.
Larkin MB, Karas PJ, McGinnis JP, McCutcheon IE, Viswanathan A. Stereotactic Radiosurgery Hypophysectomy for Palliative Treatment of Refractory Cancer Pain: A Historical Review and Update. Front Oncol. 2020 Dec 17;10:572557. doi:10.3389/fonc.2020.572557. PMID: 33392075; PMCID: PMC7773820.
Ferguson SD, Hodges TR, Majd NK, Alfaro-Munoz K, Al-Holou WN, Suki D, deGroot JF, Fuller GN, Xue L, Li M, Jacobs C, Rao G, Colen RR, Xiu J, Verhaak R, Spetzler D, Khasraw M, Sawaya R, Long JP, Heimberger AB. A validated integratedclinical and molecular glioblastoma long-term survival-predictive nomogram.Neurooncol Adv. 2020 Oct 31;3(1):vdaa146. doi: 10.1093/noajnl/vdaa146. PMID:33426529; PMCID: PMC7780842.
Bastos DCA, Weinberg J, Kumar VA, Fuentes DT, Stafford J, Li J, Rao G,Prabhu SS. Laser Interstitial Thermal Therapy in the treatment of brain metastases and radiation necrosis. Cancer Lett. 2020 Oct 1;489:9-18. doi:10.1016/j.canlet.2020.05.014. Epub 2020 Jun 3. PMID: 32504657.
Parker Kerrigan BC, Ledbetter D, Kronowitz M, Phillips L, Gumin J, HossainA, Yang J, Mendt M, Singh S, Cogdell D, Ene C, Shpall E, Lang FF. RNAitechnology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicine. Neurooncol Adv. 2020 Oct 16;2(1):vdaa132. doi:10.1093/noajnl/vdaa132. PMID: 33241214; PMCID: PMC7680176.
Breshears JD, DeMonte F, Habib A, Gidley PW, Raza SM. Management ofRecurrent or Progressing Skull Base Chondrosarcomas: Predictors of Long-Term Outcomes. J Neurol Surg B Skull Base. 2021 Jul;82(Suppl 3):e155-e165. doi:10.1055/s-0040-1701523. Epub 2020 Feb 7. PMID: 34306931; PMCID: PMC8289497.
Hadzipasic M, Giantini-Larsen AM, Tatsui CE, Shin JH. Emerging PercutaneousAblative and Radiosurgical Techniques for Treatment of Spinal Metastases.Neurosurg Clin N Am. 2020 Jan;31(1):141-150. doi: 10.1016/j.nec.2019.08.017. Epub 2019 Oct 21. PMID: 31739924.
Srivatsan A, Mohanty A, Saleem Y, Srinivasan VM, Wagner K, Seeley J,Burkhardt JK, Chen SR, Johnnson JN, Kan P. Cognitive outcomes after unrupturedintracranial aneurysm treatment with endovascular coiling. J Neurointerv Surg.2021 May;13(5):430-433. doi: 10.1136/neurintsurg-2020-016362. Epub 2020 Jul 22.PMID: 32699175.
Srinivasan VM, Gumin J, Camstra KM, Chen SR, Johnson JN, Shimizu Y, ParkerKerrigan BC, Shpall EJ, Lang FF, Kan P. Microcatheter delivery ofneurotherapeutics: compatibility with mesenchymal stem cells. J Neurosurg. 2019Sep 6;133(4):1182-1190. doi: 10.3171/2019.6.JNS19327. PMID: 31491769.
Srinivasan VM, Lang FF, Chen SR, Chen MM, Gumin J, Johnson J, Burkhardt JK,Kan P. Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors. JNeurointerv Surg. 2020 Feb;12(2):197-203. doi: 10.1136/neurintsurg-2019-015137.Epub 2019 Nov 1. PMID: 31676690.
Bastos DCA, Vega RA, Traylor JI, Ghia AJ, Li J, Oro M, Bishop AJ, Yeboa DN,Amini B, Kumar VA, Rao G, Rhines LD, Tatsui CE. Spinal laser interstitialthermal therapy: single-center experience and outcomes in the first 120 cases. JNeurosurg Spine. 2020 Dec 11;34(3):354-363. doi: 10.3171/2020.7.SPINE20661.PMID: 33307530.
Elledge CR, Beriwal S, Chargari C, Chopra S, Erickson BA, Gaffney DK,Jhingran A, Klopp AH, Small W Jr, Yashar CM, Viswanathan AN. Radiation therapyfor gynecologic malignancies during the COVID-19 pandemic: International expertconsensus recommendations. Gynecol Oncol. 2020 Aug;158(2):244-253. doi:10.1016/j.ygyno.2020.06.486. Epub 2020 Jun 15. PMID: 32563593; PMCID:PMC7294297.
Glitza IC, Smalley KSM, Brastianos PK, Davies MA, McCutcheon I, Liu JKC,Ahmed KA, Arrington JA, Evernden BR, Smalley I, Eroglu Z, Khushalani N, MargolinK, Kluger H, Atkins MB, Tawbi H, Boire A, Forsyth P. Leptomeningeal disease inmelanoma patients: An update to treatment, challenges, and future directions. Pigment Cell Melanoma Res. 2020 Jul;33(4):527-541. doi: 10.1111/pcmr.12861. Epub2020 Jan 19. PMID: 31916400; PMCID: PMC10126834.
Catignas KK, Frick LR, Pellegatta M, Hurley E, Kolb Z, Addabbo K, McCartyJH, Hynes RO, van der Flier A, Poitelon Y, Wrabetz L, Feltri ML. αVintegrins in Schwann cells promote attachment to axons, but are dispensable invivo. Glia. 2021 Jan;69(1):91-108. doi: 10.1002/glia.23886. Epub 2020 Aug 3.PMID: 32744761; PMCID: PMC8491627.
Shiers S, Ray PR, Wangzhou A, Sankaranarayanan I, Tatsui CE, Rhines LD, LiY, Uhelski ML, Dougherty PM, Price TJ. ACE2 and SCARF expression in human dorsalroot ganglion nociceptors: implications for SARS-CoV-2 virus neurologicaleffects. Pain. 2020 Nov;161(11):2494-2501. doi: 10.1097/j.pain.0000000000002051.PMID: 32826754; PMCID: PMC7572821.
Milbury K, Weathers SP, Durrani S, Li Y, Whisenant M, Li J, Lim B, WeinbergJS, Kesler SR, Cohen L, Bruera E. Online Couple-Based Meditation Interventionfor Patients With Primary or Metastatic Brain Tumors and Their Partners: Resultsof a Pilot Randomized Controlled Trial. J Pain Symptom Manage. 2020Jun;59(6):1260-1267. doi: 10.1016/j.jpainsymman.2020.02.004. Epub 2020 Feb 13.PMID: 32061834; PMCID: PMC11816621.
de Almeida Bastos DC, Everson RG, de Oliveira Santos BF, Habib A, Vega RA,Oro M, Rao G, Li J, Ghia AJ, Bishop AJ, Yeboa DN, Amini B, Rhines LD, Tatsui CE.A comparison of spinal laser interstitial thermotherapy with open surgery formetastatic thoracic epidural spinal cord compression. J Neurosurg Spine. 2020Jan 3;32(5):667-675. doi: 10.3171/2019.10.SPINE19998. PMID: 31899882.
Gjyshi O, Boyce-Fappiano D, Pezzi TA, Ludmir EB, Xiao L, Kaseb A, Amini B,Yeboa DN, Bishop AJ, Li J, Rhines LD, Tatsui CE, Briere TM, Ghia AJ. Spinestereotactic radiosurgery for metastases from hepatobiliary malignancies:patient selection using PRISM scoring. J Neurooncol. 2020 Jun;148(2):327-334.doi: 10.1007/s11060-020-03522-8. Epub 2020 May 1. PMID: 32358642.
Yu T, Chaganty B, Lin L, Xing L, Ramakrishnan B, Wen K, Hsieh PA, WollacottA, Viswanathan K, Adari H, Cho SF, Li Y, Chen H, Yang W, Xu Y, An G, Qiu L,Munshi N, Babcock G, Shriver Z, Myette JR, Anderson KC, Tai YT. VIS832, a novelCD138-targeting monoclonal antibody, potently induces killing of human multiplemyeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo. Blood Cancer J. 2020 Nov 2;10(11):110. doi: 10.1038/s41408-020-00378-z. PMID:33149123; PMCID: PMC7643177.
Evans LT, DeMonte F, Grosshans DR, Ghia AJ, Habib A, Raza SM. SalvageTherapy for Local Progression following Definitive Therapy for Skull BaseChordomas: Is There a Role of Stereotactic Radiosurgery? J Neurol Surg B SkullBase. 2020 Feb;81(1):97-106. doi: 10.1055/s-0039-1679897. Epub 2019 Feb 21.PMID: 32021756; PMCID: PMC6997007.
Akdemir KC, Le VT, Chandran S, Li Y, Verhaak RG, Beroukhim R, Campbell PJ,Chin L, Dixon JR, Futreal PA; PCAWG Structural Variation Working Group; PCAWGConsortium. Disruption of chromatin folding domains by somatic genomicrearrangements in human cancer. Nat Genet. 2020 Mar;52(3):294-305. doi:10.1038/s41588-019-0564-y. Epub 2020 Feb 5. Erratum in: Nat Genet. 2023Jun;55(6):1079. doi: 10.1038/s41588-023-01318-w. PMID: 32024999; PMCID:PMC7058537.
Vega RA, Ghia AJ, Tatsui CE. Percutaneous Hybrid Therapy for SpinalMetastatic Disease: Laser Interstitial Thermal Therapy and Spinal StereotacticRadiosurgery. Neurosurg Clin N Am. 2020 Apr;31(2):211-219. doi:10.1016/j.nec.2019.11.006. Epub 2020 Jan 22. PMID: 32147012.
Bahig H, Ng SP, Pollard C 3rd, Nguyen TP, Gunn GB, Rosenthal DI, Fuller CD,Frank SJ, Garden AS, Reddy JP, Morrison WH, Ferrarotto R, Hanna EY, DeMonte F,Su SY, Phan J. A prospective evaluation of health-related quality of life afterskull base re-irradiation. Head Neck. 2020 Mar;42(3):485-497. doi:10.1002/hed.26037. Epub 2019 Dec 23. PMID: 31868271; PMCID: PMC9673230.
Akdemir KC, Le VT, Kim JM, Killcoyne S, King DA, Lin YP, Tian Y, Inoue A,Amin SB, Robinson FS, Nimmakayalu M, Herrera RE, Lynn EJ, Chan K, Seth S,Klimczak LJ, Gerstung M, Gordenin DA, O'Brien J, Li L, Deribe YL, Verhaak RG,Campbell PJ, Fitzgerald R, Morrison AJ, Dixon JR, Andrew Futreal P. Somaticmutation distributions in cancer genomes vary with three-dimensional chromatinstructure. Nat Genet. 2020 Nov;52(11):1178-1188. doi: 10.1038/s41588-020-0708-0.Epub 2020 Oct 5. PMID: 33020667; PMCID: PMC8350746.
Versteeg AL, Sahgal A, Rhines LD, Sciubba DM, Schuster JM, Weber MH, LazaryA, Boriani S, Bettegowda C, Fehlings MG, Clarke MJ, Arnold PM, Gokaslan ZL,Fisher CG; AOSpine Knowledge Forum Tumor. Health related quality of lifeoutcomes following surgery and/or radiation for patients with potentiallyunstable spinal metastases. Spine J. 2021 Mar;21(3):492-499. doi:10.1016/j.spinee.2020.10.017. Epub 2020 Oct 22. PMID: 33098985.
Vedantam A, Hassan I, Kotrotsou A, Hassan A, Zinn PO, Viswanathan A, ColenRR. Magnetic Resonance-Based Radiomic Analysis of Radiofrequency Lesion PredictsOutcomes After Percutaneous Cordotomy: A Feasibility Study. Oper Neurosurg. 2020Jun 1;18(6):721-727. doi: 10.1093/ons/opz288. PMID: 31665446.
Sturdza A, Viswanathan AN, Erickson B, Yashar C, Bruggeman A, Feddock J, Klopp A, Beriwal S, Gaffney D, Han K, Kamrava M. American Brachytherapy Societyworking group report on the patterns of care and a literature review ofreirradiation for gynecologic cancers. Brachytherapy. 2020 Mar-Apr;19(2):127-138. doi: 10.1016/j.brachy.2019.11.008. Epub 2020 Jan 6. PMID:31917178.
Chen Z, Morales JE, Avci N, Guerrero PA, Rao G, Seo JH, McCarty JH. Thevascular endothelial cell-expressed prion protein doppel promotes angiogenesisand blood-brain barrier development. Development. 2020 Sep 23;147(18):dev193094.doi: 10.1242/dev.193094. PMID: 32895288; PMCID: PMC7522017.
Vega RA, Traylor JI, Patel R, Muir M, Bastos DCA, Prabhu SS. CombinedSurgical Resection and Laser Interstitial Thermal Therapy for Glioblastoma:Technical Note. J Neurol Surg A Cent Eur Neurosurg. 2020 Jul;81(4):348-354. doi:10.1055/s-0040-1709163. Epub 2020 May 3. PMID: 32361984.
Ballester LY, Meis JM, Lazar AJ, Prabhu SS, Hoang KB, Leeds NE, Fuller GN.Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion. J Neuropathol ExpNeurol. 2020 Mar 1;79(3):347-351. doi: 10.1093/jnen/nlz140. PMID: 32016322.
Narayan RS, Molenaar P, Teng J, Cornelissen FMG, Roelofs I, Menezes R, DikR, Lagerweij T, Broersma Y, Petersen N, Marin Soto JA, Brands E, van Kuiken P,Lecca MC, Lenos KJ, In 't Veld SGJG, van Wieringen W, Lang FF, Sulman E, Verhaak R, Baumert BG, Stalpers LJA, Vermeulen L, Watts C, Bailey D, Slotman BJ,Versteeg R, Noske D, Sminia P, Tannous BA, Wurdinger T, Koster J, Westerman BA.A cancer drug atlas enables synergistic targeting of independent drugvulnerabilities. Nat Commun. 2020 Jun 10;11(1):2935. doi:10.1038/s41467-020-16735-2. PMID: 32523045; PMCID: PMC7287046.
Amit M, Bell D, Hunt PJ, Hanna E, Su SY, Kupferman M, Aashiq M, Takahashi H,Gidley PW, Nader ME, DeMonte F, Raza SM. Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes. J Neurosurg. 2020 Jun 12;134(5):1392-1398. doi:10.3171/2020.3.JNS192630. PMID: 32534492.
Raza SM, Habib A, Wang WL, Gildey PW, Conley AP, Nader ME, Hanna EY, Su SY,DeMonte F. Surgical Management of Primary Skull Base Osteosarcomas: Impact of Margin Status and Patterns of Relapse. Neurosurgery. 2020 Jan 1;86(1):E23-E32.doi: 10.1093/neuros/nyz360. PMID: 31515560.
Haydu LE, Lo SN, McQuade JL, Amaria RN, Wargo J, Ross MI, Cormier JN, LucciA, Lee JE, Ferguson SD, Saw RPM, Spillane AJ, Shannon KF, Stretch JR, Hwu P,Patel SP, Diab A, Wong MKK, Glitza Oliva IC, Tawbi H, Carlino MS, Menzies AM, Long GV, Lazar AJ, Tetzlaff MT, Scolyer RA, Gershenwald JE, Thompson JF, DaviesMA. Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma. J Clin Oncol.2020 May 1;38(13):1429-1441. doi: 10.1200/JCO.19.01508. Epub 2020 Jan 28. PMID:31990608; PMCID: PMC7193747.
Asa SL, Asioli S, Bozkurt S, Casar-Borota O, Chinezu L, Comunoglu N, Cossu G, Cusimano M, Delgrange E, Earls P, Ezzat S, Gazioglu N, Grossman A, GuaraldiF, Hickman RA, Ikeda H, Jaffrain-Rea ML, Karavitaki N, Kraljević I, La Rosa S,Manojlović-Gačić E, Maartens N, McCutcheon IE, Messerer M, Mete O, Nishioka H,Oz B, Pakbaz S, Pekmezci M, Perry A, Reiniger L, Roncaroli F, Saeger W, Söylemezoğlu F, Tachibana O, Trouillas J, Turchini J, Uccella S, Villa C, YamadaS, Yarman S. Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution,not clinical revolution. Pituitary. 2020 Jun;23(3):322-325. doi:10.1007/s11102-019-01015-0. PMID: 31834538.
Mericli AF, Murariu D, Nemir S, Rhines LD, Walsh G, Adelman DM, Baumann DP,Butler CE. Soft-Tissue Reconstruction after Composite Vertebrectomy and ChestWall Resection for Spinal Tumors. Plast Reconstr Surg. 2020May;145(5):1275-1286. doi: 10.1097/PRS.0000000000006792. PMID: 32332552.
Kennamer BT, Gridley DG, Rhines LD, Nair GR, Lettieri SC, Davis KM, Feiz-Erfan I. Natural History of a Patient with Sacral Chordoma: Case Report andLiterature Review. World Neurosurg. 2020 Jul;139:132-135. doi:10.1016/j.wneu.2020.03.214. Epub 2020 Apr 13. PMID: 32298828.
Ziu M, Kim BYS, Jiang W, Ryken T, Olson JJ. The role of radiation therapy intreatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update. J Neurooncol. 2020Nov;150(2):215-267. doi: 10.1007/s11060-020-03612-7. Epub 2020 Nov 19. PMID:33215344.
Majd N, Waguespack SG, Janku F, Fu S, Penas-Prado M, Xu M, Alshawa A, Kamiya-Matsuoka C, Raza SM, McCutcheon IE, Naing A. Efficacy of pembrolizumab inpatients with pituitary carcinoma: report of four cases from a phase II study. JImmunother Cancer. 2020 Dec;8(2):e001532. doi: 10.1136/jitc-2020-001532. PMID:33427689; PMCID: PMC7757504.
Hafeez MU, Kan P, Srivatsan A, Moore S, Jafari M, De La Garza C, Hafeez K,Nascimento FA, Srinivasan VM, Burkhardt JK, Chen S, Johnson J, Saleem Y.Comparison of First-Pass Efficacy Among Four Mechanical Thrombectomy Techniques:A Single-Center Experience. World Neurosurg. 2020 Dec;144:e533-e540. doi:10.1016/j.wneu.2020.08.209. Epub 2020 Sep 3. PMID: 32891839.
Bond MR, Versteeg AL, Sahgal A, Rhines LD, Sciubba DM, Schuster JM, WeberMH, Fehlings MG, Lazary A, Clarke MJ, Boriani S, Bettegowda C, Arnold PM,Gokaslan ZL, Fisher CG. Surgical or Radiation Therapy for the Treatment ofCervical Spine Metastases: Results From the Epidemiology, Process, and Outcomesof Spine Oncology (EPOSO) Cohort. Global Spine J. 2020 Feb;10(1):21-29. doi:10.1177/2192568219839407. Epub 2019 Mar 31. PMID: 32002346; PMCID: PMC6963359.
Debnam JM, Said RB, Liu HH, Sun J, Wang J, Wei W, Suki D, Mayer RR, Chi TL,Ketonen L, Guha-Thakurta N, Weinberg JS. Ventricular apparent diffusioncoefficient measurements in patients with neoplastic leptomeningeal disease.Cancer Imaging. 2020 Jun 29;20(1):41. doi: 10.1186/s40644-020-00305-2. PMID:32600415; PMCID: PMC7322838.
Vega RA, Traylor JI, Habib A, Rhines LD, Tatsui CE, Rao G. MinimallyInvasive Separation Surgery for Metastases in the Vertebral Column: A Technical Report. Oper Neurosurg. 2020 Jun 1;18(6):606-613. doi: 10.1093/ons/opz233. PMID:31529099.
Srinivasan VM, Gumin J, Camstra KM, Collins DE, Chen MM, Shpall EJ, ParkerKerrigan BC, Johnson JN, Chen SR, Fueyo J, Gomez-Manzano C, Lang FF, Kan P. Endovascular Selective Intra-Arterial Infusion of Mesenchymal Stem Cells LoadedWith Delta-24 in a Canine Model. Neurosurgery. 2020 Dec 15;88(1):E102-E113. doi:10.1093/neuros/nyaa470. PMID: 33231254; PMCID: PMC7735865.
Gao C, Wang F, Suki D, Strom E, Li J, Sawaya R, Hsu L, Raghavendra A,Tripathy D, Ibrahim NK. Effects of systemic therapy and local therapy onoutcomes of 873 breast cancer patients with metastatic breast cancer to brain:MD Anderson Cancer Center experience. Int J Cancer. 2021 Feb 15;148(4):961-970.doi: 10.1002/ijc.33243. Epub 2020 Sep 11. PMID: 32748402.
Viswanathan A, Vedantam A, Williams LA, Koyyalagunta D, Abdi S, DoughertyPM, Mendoza T, Bassett RL, Hou P, Bruera E. Percutaneous Cordotomy for PainPalliation in Advanced Cancer: A Randomized Clinical Trial Study Protocol.Neurosurgery. 2020 Aug 1;87(2):394-402. doi: 10.1093/neuros/nyz527. PMID:32012217; PMCID: PMC7360878.
Mullarkey MP, Nehme G, Mohiuddin S, Ballester LY, Bhattacharjee MB, TrivediD, Shah MN, Fuller GN, Zaky W, Sandberg DI. Posttreatment Maturation ofMedulloblastoma into Gangliocytoma: Report of 2 Cases. Pediatr Neurosurg.2020;55(4):222-231. doi: 10.1159/000509520. Epub 2020 Sep 3. PMID: 32882694.
Habib A, Hanasono MM, DeMonte F, Haider A, Breshears JD, Nader ME, GidleyPW, Su SY, Hanna EY, Raza SM. Surgical Management of Skull BaseOsteoradionecrosis in the Cancer Population - Treatment Outcomes and Predictorsof Recurrence: A Case Series. Oper Neurosurg. 2020 Sep 15;19(4):364-374. doi:10.1093/ons/opaa082. PMID: 32324878; PMCID: PMC7490162.
Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC,Fitch J, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, MayadevJS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN. The ASTRO clinicalpractice guidelines in cervical cancer: Optimizing radiation therapy forimproved outcomes. Gynecol Oncol. 2020 Dec;159(3):607-610. doi:10.1016/j.ygyno.2020.09.015. Epub 2020 Sep 22. PMID: 32972783.
Jiang T, Pellizzer G, Asman P, Bastos D, Bhavsar S, Tummala S, Prabhu S,Ince NF. Power Modulations of ECoG Alpha/Beta and Gamma Bands Correlate WithTime-Derivative of Force During Hand Grasp. Front Neurosci. 2020 Feb 14;14:100.doi: 10.3389/fnins.2020.00100. PMID: 32116533; PMCID: PMC7033626.
Mericli AF, Boukovalas S, Roubaud MS, Kai-Cheng Chu C, Bird J, Lewis VO,Rhines LD, Chang EI, Adelman DM, Hanasono MM. Restoration of Spinopelvic Continuity with the Free Fibula Flap after Limb-Sparing Oncologic Resection Is Associated with a High Union Rate and Superior Functional Outcomes. PlastReconstr Surg. 2020 Sep;146(3):650-662. doi: 10.1097/PRS.0000000000007095. PMID:32459735.
Diao K, Song J, Thall PF, McGinnis GJ, Boyce-Fappiano D, Amini B, Brown PD,Yeboa DN, Bishop AJ, Li J, Briere TM, Tatsui CE, Rhines LD, Chang EL, Ghia AJ. Low risk of radiation myelopathy with relaxed spinal cord dose constraints in denovo, single fraction spine stereotactic radiosurgery. Radiother Oncol. 2020 Nov;152:49-55. doi: 10.1016/j.radonc.2020.07.050. Epub 2020 Jul 31. PMID:32745668.
Anakwenze CP, McGovern S, Taku N, Liao K, Boyce-Fappiano DR, Kamiya-MatsuokaC, Ghia A, Chung C, Trifiletti D, Ferguson SD, Li J, Yeboa DN. Association Between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection. World Neurosurg. 2020 Sep;141:e133-e144.doi: 10.1016/j.wneu.2020.05.030. Epub 2020 May 11. PMID: 32407910.
Mericli AF, Boukovalas S, Rhines LD, Adelman DM, Hanasono MM, Chang EI. Free Fibula Flap for Restoration of Spinal Stability after Oncologic Vertebrectomy Is Predictive of Bony Union. Plast Reconstr Surg. 2020 Jan;145(1):219-229. doi:10.1097/PRS.0000000000006382. PMID: 31592949.
Dea N, Versteeg AL, Sahgal A, Verlaan JJ, Charest-Morin R, Rhines LD,Sciubba DM, Schuster JM, Weber MH, Lazary A, Fehlings MG, Clarke MJ, Arnold PM, Boriani S, Bettegowda C, Laufer I, Gokaslan ZL, Fisher CG. Metastatic Spine Disease: Should Patients With Short Life Expectancy Be Denied Surgical Care? An International Retrospective Cohort Study. Neurosurgery. 2020 Aug1;87(2):303-311. doi: 10.1093/neuros/nyz472. PMID: 31690935; PMCID: PMC7360875.
Khatua S, Cooper LJN, Sandberg DI, Ketonen L, Johnson JM, Rytting ME, LiuDD, Meador H, Trikha P, Nakkula RJ, Behbehani GK, Ragoonanan D, Gupta S,Kotrotsou A, Idris T, Shpall EJ, Rezvani K, Colen R, Zaky W, Lee DA,Gopalakrishnan V. Phase I study of intraventricular infusions of autologous exvivo expanded NK cells in children with recurrent medulloblastoma and ependymoma. Neuro Oncol. 2020 Aug 17;22(8):1214-1225. doi:10.1093/neuonc/noaa047. PMID: 32152626; PMCID: PMC7594549.
Srivatsan A, Srinivasan VM, Chen S, Kan P, Johnson JN. Intra-ArterialGlycoprotein IIb/IIIa Inhibitor Treatment for Symptomatic IntracranialAtherosclerotic Stenosis Presenting as Large Vessel Occlusions. Cureus. 2020 Jul17;12(7):e9243. doi: 10.7759/cureus.9243. PMID: 32821589; PMCID: PMC7430682.
Vedantam A, Vigneswaran K, Rao G, Walsh GL, Rhines LD, Tatsui CE. Use ofNavigated Ultrasonic Bone Cutting Tool for En Bloc Resection of ThoracicChondrosarcoma: Technical Report. Oper Neurosurg. 2020 Oct 15;19(5):551-556.doi: 10.1093/ons/opaa239. PMID: 32745212.
Dupuis M, Shen Y, Curcio C, Meis JM, Wang WL, Amini B, Rhines L, Reuther J,Roy A, Fisher KE, Conley AP, Andrew Livingston J. Successful treatment oflipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusioninhibitor. Clin Sarcoma Res. 2020 Aug 6;10:14. doi: 10.1186/s13569-020-00136-6.PMID: 32782782; PMCID: PMC7412810.
Grant SR, Brown PD, Tatsui CE, Ghia AJ. Seed, soil, and spine stereotacticradiosurgery: A unique case of metastatic dissemination. J Radiosurg SBRT.2020;6(4):325-328. PMID: 32185094; PMCID: PMC7065899.
Noticewala SS, Ludmir EB, Bishop AJ, Chung C, Ghia AJ, Grosshans D,McGovern S, Paulino AC, Wang C, Woodhouse KD, Yeboa DN, Prabhu SS, Weathers SP,Das P, Koong AC, McAleer MF, Li J. Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Adv Radiat Oncol. 2020 May 27;5(4):743-745.doi: 10.1016/j.adro.2020.04.040. PMID: 32775785; PMCID: PMC7251361.
Quirarte JA, Kumar VA, Liu HL, Noll KR, Wefel JS, Lang FF. Languagesupplementary motor area syndrome correlated with dynamic changes inperioperative task-based functional MRI activations: case report. J Neurosurg.2020 Jun 5;134(6):1738-1742. doi: 10.3171/2020.4.JNS193250. PMID: 32502992.
Ahluwalia M, Ali MA, Joshi RS, Park ES, Taha B, McCutcheon I, Chiang V,Hong A, Sinclair G, Bartek J Jr, Chen CC. An integrated disease-specific gradedprognostic assessment scale for melanoma: contributions of KPS, CITV, number of metastases, and BRAF mutation status. Neurooncol Adv. 2020 Nov 12;3(1):vdaa152.doi: 10.1093/noajnl/vdaa152. PMID: 33506199; PMCID: PMC7810198.
McCutcheon IE. Commentary: Rare Primary Embryonal Carcinoma in the Brachial Plexus: A Case Report and Literature Review. Neurosurgery. 2020 Aug1;87(2):E156-E157. doi: 10.1093/neuros/nyz469. PMID: 31690934.